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Abstract 
The β-resorcylic acid (1) unit can be found in a number of biologically active natural 
products including montagnetol (2), hair-growth stimulant pochonin G (3), anti-
oxidant erythrin (4), antifungal agents 15G256β (5) and mycotoxin (S)-zearalenone 
(6). A conventional total synthesis of 15G256β (5), from β-resorcylic acid units, was 
fraught with difficulties.1 Consequently, we established a novel biomimetic strategy 
for the synthesis of natural product 6, by utilising a late stage aromatisation step, 
starting from polyketide precursor 7. Two main issues needed to be solved: a flexible 
synthesis to build polyketides and mild conditions to construct the aromatic ring.  
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Diketo-dioxinone 10 was found to be an equivalent of a polyketide. Its synthesis was 
accomplished by reaction of deprotonated dioxinone 8 and benzotriazole derivative 9 
(obtained from thermolysis of dioxinone 8 2). 
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Mild conditions were found to construct the aromatic ring 11 using a weak base 
followed by an acid work-up. A strategy to build resorcylates in one step from diketo-
dioxinone 10 was also discovered.2-3 
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This strategy was then applied to the total synthesis of (S)-zearalenone (6) employing 
dioxinone derivate 12 and alcohol 13 to afford polyketide 14. Conversion into (S)-
zearalenone (6) was accomplished by aromatisation and trans-selective ring closing 
metathesis.3 
 
In an analogous manner to (S)-zearalenone (6), the biomimetic total synthesis of both 
enantiomers of montagnetol (2) and erythrin (4) were completed, allowing assignment 
of their absolute stereochemical configuration.2 
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Similarly, an analogue of pochonin G 19 was synthetised, using a C-acylation reaction 
of the keto-dioxinone 16 dianion with Weinreb amide 17 followed by a cascade 
sequence consisting of ketene generation, alcohol 18 trapping, aromatization and ring 
closing metathesis. 
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From the key diketo-dioxinone building block 10, heteroaromatic 20 as well as 
resorcylate 15 were synthesised.2 
 
 
1 
 Frederiksen M. U., PhD thesis. 
2
 Basset, J.-F.; White, A. J. P.; Barrett, A. G. M.; Leslie, C.; Hamprecht, D. Tetrahedron Lett. 2010, 51, 
783. 
3
 Navarro I., Basset J. F., Hebbe S., Major M. M., Werner T., Howsham C., Bräckow J., Barrett A.G.M. 
J. Am. Chem. Soc. 2008, 130, 10293. 
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INTRODUCTION  
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1.1 Natural Products as Leads in Drug Development 
Since ancient times nature has proved to be an important source of useful drugs. 
During several billion years of evolution such diversity has developed that it is 
currently estimated that there are approximately 250,000 different plant species, up to 
30 million insects, 1.5 million fungi and similar numbers of algae and prokaryotes in 
existence. From all varieties of plant species, at least one million different natural 
products have been isolated.1 
 
Natural products are typically secondary metabolites, produced by plants, fungi, 
bacteria, protozoans, insects and animals in response to external stimuli such as 
nutritional changes, infection and competition. Most secondary metabolites are 
derived from just a few building blocks; the acetate C2-unit (polyketides*), the 
phenylalanine/tyrosine-derived C9-unit (phenylpropanoids), the isopentenyl 
diphosphate C5-unit and some amino acids.2-6  
 
 
 
Figure 1. Example of drugs derived from natural products. 
 
                                                 
*
 The term polyketide was coined by Collie to define products containing multiple carbonyl or hydroxyl 
groups, each separated by one carbon atom, as in the structural element 
CH2C(=O)CH2CH(OH)CH2C(=O)- 
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Figure 2. More examples of drugs derived from natural products. 
 
The biosynthetic pathway towards the formation of polyketides will be a source of 
inspiration for our work and will be discussed in more detail in this thesis. 
 
In 1988 the database NAPRALERT already contained more than 88,000 secondary 
metabolites, and every year some 4,000 new ones are reported. It is clear that nature 
provides an enormous potential for the discovery of new bioactive compounds. This 
has resulted in the use of a large number of medicinal plants to treat various diseases. 
Well-known examples of valuable natural products used widely in today’s medical 
and animal health industries include lovastatin (21) (anticholesterolemic agent), 
tacrolimus (22) (immunosuppressive agents), doxorubicin (23) (antitumor agents), 
erythromycin (24) (antibiotic), and amphotericin B (25) (fungicidal agent) (Figures 1 
and 2). In 1998, 119 plant-derived compounds were used in western medicine. In 
2004, 43% of the world’s 35 best-selling pharmaceutical agents, were derived from 
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natural products.7 That means that the hit rate amongst natural products is apparently 
much higher than in libraries derived by random synthesis, in which 10,000 
compounds are said to be necessary to develop one new drug. 
 
In spite of this apparent success, the popularity of natural products is diminishing due 
to three main factors:8 
• As pharmaceutical drug discovery has become more sophisticated (ie going from 
whole cell-based assays to more pharmacologically relevant assays based on enzyme 
inhibition and receptor interaction), natural product extracts are considered too impure 
to be tested. 
• Where automated high-throughput screening is an important tool in pharmaceutical 
companies, natural products are disadvantaged compared to compound collections 
with known structures, since the time taken to progress from a hit to knowing the 
structure is considerably longer. 
• Medicinal chemists are usually hesitant to get on a synthetic program towards 
scaffolds based on natural products due to their chemical complexity, such as complex 
networks of chirality and multiple hydroxyl moieties. The structure activity 
relationship optimisation for such leads is often complex, consequently costly, and 
usually the hit becomes the candidate. 
 
Based on these observations, the need for constant development of novel and efficient 
methodologies to synthesise natural products is essential in order to make them more 
attractive for drug discovery. In this thesis a new synthetic method to generate natural 
products, inspired by their biological synthetic pathway, will be presented. From a key 
building block, diketo-dioxinone 26a, which can be viewed as a chemical equivalent 
of a polyketide, a panel of bioactive natural products, as well as heteroaromatic 
compounds have been produced. (All the di- and tri-keto-esters 26a exist as mixtures 
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of keto and enol tautomers (26b and 26c). However, for convenience, in this PhD 
thesis they are drawn as single entities as 26a.) (Scheme 1). 
 
 
 
Scheme 1. Diketo-dioxinone 26. 
 
1.2 Project Background 
The starting point of this PhD thesis is the natural product 15G256-β (5) (Figure 3). It 
was isolated from the marine fungus Hypoxylon oceanicum LL-15G2569 in 1998 and 
exhibits a broad spectrum of activity against pathogenic fungi. It shows a MIC 
(minimum inhibitory concentration) of 0.5 µg/mL against Neurospora crassa (OS-
1).10 The natural product contains five chiral centres and two β−resorcylic acid units. 
 
 
15G256-β (5) 
 
Figure 3. 15G256-β (5) isolated from LL-15G256. 
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The high symmetry of 15G256-β (5) allows disconnection of the framework into just 
two fragments, acids 27 and 28 with (R)-β-hydroxybutyric acid (27) being 
commercially available. Using the following retrosynthetic approach (Scheme 2), 
members of the Barrett group have attempted the synthesis using a sequential 
esterification and macroactonisation approach.11 This route was found to be fraught 
with difficulties, attributed to steric hindrance around the carboxylic acid group. 
Mitsunobu reactions also failed and led to β-elimination and moreover, having the 
alcohol of the resorcylic acid 28 unprotected can also lead to the formation of the 
isochroman-1-one (29). The synthetic problems of the previous approach led us to 
consider a new synthetic route. 
 
 
 
Scheme 2. First retrosynthesis analysis of 15G256-β (5) and synthetic difficulties. 
 
Biomimetic synthesis has long been an interesting field in organic chemistry, not only 
to explore in detail the biosynthetic pathway of natural products but also to provide 
different solutions to conventional synthetic problems; consequently we decided to 
look at this molecule’s biosynthetic origin. 
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1.3 RALs: Biosynthesis and Activity 
In order to achieve our goal, we decided to get back to a more simple family of natural 
products which also contain the 6-alkyl-2,4-dihydroxybenzoic acid unit 30, namely 
the β-Resorcylic Acid Lactones (RALs)12 31. RALs are a large family of natural 
compounds isolated from fungi over the past 60 years. RALs commonly contain a 12 
or 14-membered ring lactone adjoined to the aromatic unit, with varying functionality 
around the macrocycle (Figure 4). 
 
 
 
Figure 4. 6-alkyl-2,4-dihydroxybenzoic acid unit 30 and RAL scaffold. 
 
It is known that RALs arise from a polyketide pathway.13 They are in fact made from 
the sequential condensation of thioacetate units 32 and 33 to form a highly reactive 
tetracarbonyl 36 (via polycarbonyls 34 and 35) which aromatises readily by an 
intramolecular aldol-dehydration type reaction to form the aromatic unit 31 (Scheme 
3).14-18 
 
 
Scheme 3. Biosynthesis of RALs. 1/2 
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Scheme 3. Biosynthesis of RALs. 2/2 
 
(S)-zearalenone (6),19 hypothemycin (37),20 aigialomycin D (38),21 radicicol (39),22 
pochonin C (40),23 pochonin D (41)24 are members of the RALs family. These 
compounds also show a wide range of biological activities, ranging from estrogenic 
agonists to anti-malarials (Figure 5).12 
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Figure 5. Examples from the resorcylic acid lactone family of natural products. 
 
This class of natural products has been the subject of a considerable synthetic study. 
Most reported total syntheses employ 6-alkyl-2,4-hydroxybenzoic acids as 
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intermediates, and proceed via stepwise derivatization of these key building blocks.12 
Such strategies are often limited by moderate yields in the macrolactonization step 
and/or the need for multiple protecting group manipulations. 
 
1.4 Retrosynthetic Strategy 
Based on these observations our retrosynthetic strategy was to construct the aromatic 
unit from a triketo-ester in the same way that nature builds resorcylate units (Scheme 
4). 
 
 
 
Scheme 4. Cyclisation-aromatisation to form 15G256-β (5) and zearalenone (6). 
 
Before attempting the synthesis of 15G256-β (5), we decided to test the methodology 
on zearalenone (6) to develop a general method for forming resorcylic acid units, 
which could be applied to other biomimetic natural product syntheses. 
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1.5 Harris’ Work on Polyketides 
The retrosynthetic analysis was inspired from Harris’s work on the synthesis of poly-
β-carbonyl chains. One of the most representative examples reported was the self-
condensation of  methyl acetoactetate 43 upon deprotonation with a strong base to 
form tetra acetic acid methyl ester 44 (Scheme 5).25 
 
 
 
Scheme 5. Synthesis of triketo methyl ester by Harris et al. 
 
Having those intermediates in hand, Harris et al demonstrated that they can undergo 
many cyclisation reactions analogous to those carried out in nature, without enzyme 
catalysis.26-30. They observed that four possible cyclisations can occur from triketo-
ester 44 or triketo-acid 46 compounds (Scheme 6). The first one is the aldol 
condensation-dehydration under strong basic conditions in methanol to give 
resorcylate 11. The second ring formation which can occur in basic aqueous medium 
is a Claisen (Dieckmann) cyclisation giving acetophenone 45. The third and fourth 
ring closures can take place respectively with sulfuric acid and acetic anhydride to 
afford correspondingly 4-pyrones 47 and 4-hydroxy-2-pyrones (enol lactones) 48 
(Scheme 6).  
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Scheme 6. Condensations of triketo-ester or triketo-acid compounds under different 
conditions 
 
In 1980, Barrett and Barton31 improved the aromatisation step by using a pH 9.2 
buffer to promote the aldol condensation and obtained resorcylate 11 in a 72% yield. 
Triketo-ester 44 was formed from the condensation of dianion 49 and ketone 50 
(Scheme 7). 
 
 
Scheme 7. Improved strategy developed by Barrett and Barton to form resorcylate 11. 
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Whilst this procedure has been proven to be a highly powerful tool for various ring 
formations, its associated disadvantages make it unsuitable as it is. These include: i) 
the use of particularly harsh reaction conditions (strong basic and acid reagents) to 
perform the aldol-dehydration reaction which would not be compatible with acid or 
base sensitive groups; ii) the problems associated with the low yielding, non flexible 
and non versatile strategy to synthesise the polyketide25 starting materials. Our main 
goal was focused on solving these two issues. 
 
1.6 Background on (S)-Zearalenone (6) 
Zearalenone (6) (Figure 6) is a secondary metabolite isolated in 1962 from the 
microfungi Fusarium graminearum.19 It led to vaginal eversion in female animals and 
the growth of mammary glands in both male and female animals.5 It was later shown 
that the estrogen agonistic properties of zearalenone (6) were the product of a direct 
interaction on the estrogen receptor in competition with 17-estradiol32 and that the 
macrocycle of zearalenone was able to adopt a conformation which mimics that of the 
steroid.33 The anabolic properties of Zearalenone and its derivatives have been used as 
a bovine growth stimulant and marketed under the trade name Ralgro®. Zearalenone is 
a mycotoxin which has also been shown to have antibacterial properties.34,35 Urry et 
al. confirmed the structure of zearalenone36 and it is considered the primary member 
of the β-resorcylic acid lactones (RALs) family. Today zearalenone is manufactured 
industrially via fermentation. 
 
 
 
Figure 6. (S)-Zearalenone (6). 
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The widespread interest in zearalenone’s anabolic properties stimulated a number of 
syntheses of this molecule with the first synthesis reported in 1968.37 It has also 
served as a testing ground for new cyclisation methodologies as exemplified by the 
development of the Corey–Nicolaou macrolactonization,38 Masamune’s thioester-
lactonization, 39 and more recently the ring-closing metathesis.40 
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Scheme 8. Conventional starting materials for zearalenone (6) synthesis. 
 
Conventional retrosyntheses of zearalenone (6) divide the molecule into two portions: 
an aromatic moiety and a functionalised aliphatic chain, both of which must be 
prepared and then joined appropriately. To date, several total syntheses of both 
racemic and naturally occurring (S)-(–)-zearalenone (6) have been completed. All 
methods use readily available resorcylic ester 51 or orsellinic ester 11 derivatives as 
starting materials. This in itself presented problems due to low yielding 
functionalisation of these commercially available aromatic molecules (Scheme 8).  
 
These syntheses have employed three main strategies: final stage 
macrolactonisation,41,42 intramolecular alkylation of stabilised carbanions43-46 and 
most recently metal-catalysed C=C bond formation (Figure 7). 
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Figure 7. Strategies in the synthesis of zearalenone (6). 
 
Unfortunately, deprotection of the phenol groups was found to be low yielding (50-
55%).47 Further problems were encountered in the macrolactonisation and 
esterification reactions. The carboxyl group is deactivated and sterically hindered by 
the phenol ring, reducing reactivity and hence affording poor yields. 
 
1.7 Retrosynthetic Analysis of (S)-Zearalenone (6) 
Our biomimetic strategy led us to consider intermediate 7 which can be obtained with 
two synthons 54 and 55 via a late-stage esterification/aromatization reaction followed 
by ring-closing metathesis (Scheme 9).  
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Scheme 9. Retrosynthetic strategy for the construction of (S)-zearalenone (6). 
 28 
In order to perform the esterification/macrolactonisation a new strategy was required. 
Although successful in a multitude of natural product syntheses containing 
macrolides, the Corey-Nicolaou double activation technique,38 the Masamune 
method,39 the Mukaiyama strategy,48 the Keck method49 and the Yamagushi 
activation50 were not adopted due to incompatibility with the acid/base sensitive 
polyketide intermediate 54. In addition all the aforementioned methods share an 
activated carboxyl derivative in their methodology, usually built from a carboxylic 
acid. However it is known that acetoacetic acid (56) decomposes at a moderate rate to 
acetone (57) and carbon dioxide51 (Scheme 10). The acetoacetic acid (56) has a half-
life of 140 minutes at 37 °C in water. 
 
 
Scheme 10. Acetoacetic acid decomposition in water. 
 
It would therefore be advantageous to incorporate a masked, activated carbonyl 
functionality that would be compatible with a variety of transformations, and when 
unmasking would generate the active species under mild, neutral conditions. In this 
context Boeckman developed a method relying on the interesting property of 
dioxinone containing 58 which undergoes a retro-hetero Diels Alder reaction at high 
temperature to form an acetylketene 59 which can be trapped in situ by a hydroxyl 
group to reveal the macrolactone 60 in good yield (Scheme 11).52 
 
 
 
Scheme 11. Boeckman macrolactonisation. 
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Consequently synthon 54 could be generated from the thermal decomposition of 12.53-
55
 The synthetic route to alcohol 13 has already been developed within the Barrett 
group via acetal protection of ketone 61 obtained from the “cleveage” of lactone 62 
using a Grignard derived from 5-bromo-1-pentene.56 
The diketo-dioxinone derivative 12 could be obtained via a Mukaiyama aldol reaction 
of aldehyde 63 and the silyl enol ether 6457of dioxinone 8 (Scheme 12). 
 
 
Scheme 12. Retrosynthesis of compounds 13 and 12. 
 
1.8 Brief Review on Keto-Dioxinone and Diketo-Dioxinone 
In order to synthesise intermediate 12 a good understanding of dioxinone chemistry 
was necessary. The following section will attempt to highlight developments in 
dioxinone chemistry roughly following the timelines of their discoveries. To make the 
reading of this PhD thesis easier, 2,2,6-trimethyl-4H-1,3-dioxin-4-one (8) will be 
referred to as dioxinone or diketene acetone adduct, 2,2-dimethyl-6-(2-oxopropyl)-
4H-1,3-dioxin-4-one (16) will be also called keto-dioxinone and 1-(2,2-dimethyl-4-
oxo-4H-1,3-dioxin-6-yl)pentane-2,4-dione (10) will be defined as diketo-dioxinone or 
diketone (Figure 8). 
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Figure 8. Dioxinone 8, keto-dioxinone 16 and diketo-dioxinone 10. 
 
1.8.1 Synthesis of dioxinone (diketene acetone adduct)  
The earliest report of the formation of 1,3-dioxinone 8 was published by Naylor in 
1948.58 He reported the formation of a product with a molecular formula C7H10O3 in 
low yield from the reaction of ketene (65) with acetone catalysed by zinc chloride 
(Scheme 13). 
 
 
Scheme 13. First synthesis of dioxinone 8. 
 
Five years later, Carroll and Bader carried on the research and synthesised several 1,3 
dioxinone adducts from diketene (66) and various ketones; for example refluxing a 
solution of diketene (66) in acetone with a catalytic amount of p-toluenesulfonic acid 
gave dioxinone 8 (Scheme 14).59 
 
 
Scheme 14. Synthesis of dioxinone 8. 
 
In 1980, Andreichikov and co-workers have developed a strategy to synthesise 
substituted dioxinone 69 from furan-2,3-dione 67 and cyclohexanone (68).60 They 
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reported that refluxing these compounds in benzene led to intermediate 69 in 92% 
yield (Scheme 15). 
 
 
Scheme 15. Synthesis of subsituted dioxinone 69. 
 
Soon after Sato et al. developed new synthetic routes to build substituted dioxinone 
72. For example treatment of 2-methyl-3-oxobutanoic acid (70) with prop-1-en-2-yl 
acetate (71) under acidic conditions gave, in 55% yield, 2,2,5,6-tetramethyl-4H-1,3-
dioxin-4-one (72). The yield of the reaction was improved by using acetone (57) 
instead of ester 71 and by using tert-butyl 2-methyl-3-oxobutanoate (73) instead of 
acid 70 (Scheme 16).61 
 
 
Scheme 16. Synthesis of subsituted dioxinone 72. 
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Hyatt reported that refluxing isopropenyl acetoacetate (74) with a catalytic amount of 
p-toluenesulfonic acid in toluene gave dioxinone 8. They also observed that the 
presence of a catalytic amount of acid was essential for the reaction to proceed 
(Scheme 17).62 
 
 
Scheme 17. Synthesis of dioxinone 8 under Hyatt’s conditions. 
 
In 1987, Winkler et al. developed a new method for the synthesis of polysubstituted 
dioxinone using anisyl ketoesters.63 For example, reacting anisyl cyclohexanone 
carboxylate 75 with TFAA and TFA in acetone gave, after 12h, dioxinone 76 in 95% 
yield (Scheme 18). 
 
 
Scheme 18. Synthesis of dioxinone 76 under Winkler’s conditions. TFAA = trifluoroacetic 
anhydride. 
 
In 1984, Sato and co-workers reported an original way to synthesis functionalised 
diketene acetone adduct 78.64 Refluxing compound 77 in acetone gave dioxinone 78 
in 99% yield. It was thought that thermolysis of the acylated Meldrum acid 77 initiates 
the formation of a transient acylketene which could then participate in a hetero-Diels-
Alder reaction with acetone to give dioxinone 78 (Scheme 19). 
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Scheme 19. Synthesis of dioxinone 78 under Sato’s conditions. 
 
1.8.2 Mechanism of thermolysis 
In 1953, Carroll and Bader reported that diketene acetone adduct 8 can react with 
hydroxyl groups under acid catalysis to reveal acetoacetate compounds; for example 
refluxing a mixture of diketene acetone adduct 8 with a trace of p-toluenesulfonic acid 
in 1-butanol afforded n-butyl acetoacetate 79 (Scheme 20).59 
 
 
 
Scheme 20. Synthesis of n-butyl acetoacetate 79. 
 
After being largely ignored for over 20 years, the thermolysis mechanism of 
dioxinone 8 was only suggested for the first time in 1976 by Jager and Wenzelburger 
when they observed the formation of 1,3 oxazines 81 whilst diketene acetone adduct 8 
was refluxing with isocyanate 80.65 They postulated that high temperature induced a 
retro-hetero-Diels-Alder reaction, to form in situ acylketene 82 which can then take 
part in a hetero-Diels-Alder reaction with isocyanate 80 to give 1,3 oxazines 81 
(Scheme 21). 
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Scheme 21. Formation and trapping of  acylketene 82 with isocyanate 80. 
 
In 1984, further evidence of the mechanism was provided by Hyatt et al.66 They 
reported that in the absence of a nucleophile, thermolysis of dioxinone 8 led to the 
hydroxypyranone 83 in good yield. A dimerisation of two molecules of acetylketene 
82 via a hetero- Diels-Alder reaction was postulated (Scheme 22). 
 
 
 
Scheme 22. Thermolysis of 1,3-dioxinone 8 in absence of nucleophile. 
 
They also reported that it was unnecessary to add a base or acid to the reaction simply 
to perform the acetoacetylation. The β-keto acid derivate 84 can be obtained in high 
yield, by refluxing dioxinone 8 in xylene in the presence of a nucleophile such as an 
alcohol, amine or thiol to provide respectively β-keto esters, β-keto amides or β-keto 
thio esters. Since then, the mechanism of acetoacetylation has been extensively 
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studied and observations confirm the theory of the formation of an acetylketene 82 as 
an intermediate, which can be trapped in situ by a nucleophile to reveal the β-keto 
acid derivate 84. Mechanistic studies have been comprehensively reviewed and will 
not be discussed in detail (Scheme 23).67 
 
 
 
Scheme 23. Mecanism of the acetoacetylation reaction. Nu = R-O, R-NH or R-S. 
 
1.8.3 Synthesis of keto-dioxinone (dimethyl-oxopropyl-dioxinone) 
In 1981, Smith68 and co-workers observed that the addition of alkyl iodide 86 to the 
kinetic extended lithium enolate of the dioxinone 8 gave a mixture of α and γ-
alkykated products 87 and 88 respectively, in a ratio of 2:3. Alternatively, in 1991, 
Kaneko and Sato discovered that when dioxinone 8 was treated with one equivalent of 
lithium diisopropylamide and hexamethylphosphoramide, followed by the addition of 
0.5 eq. of chloroacetyl chloride (89), a selective electrophilic addition on the γ-
position of the lithium enolate of dioxinone 85 was obtained in 65% yield to give 
÷
t reference of keto-dioxinones in the chemical literature. Kaneko and Sato 
achieved the synthesis of the chloroketo-dioxinone 90 as a precursor for the 
enantioselective synthesis of (S)- and (R)-6-(2,3-dihydroxypropyl)-l,3-dioxin-4-ones 
91.69 
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Scheme 24. First synthesis of a keto-dioxinone intermediate. 
 
Using half of an equivalent of the acyl halide 92 to synthesise 6-(2-
oxoalkyl)dioxinones 94, was reported essential to avoid the formation of over O-
acylation; for example, treatment of 8 with lithium diisopropylamide, followed by 
addition of one equivalent of benzoyl chloride 92 gave product (Z)-93 as the only 
product in 43% yield, whereas treatment of 8 with 0.5 mol equivalent of benzoyl 
chloride 92 gave selectively ketodioxinone 94 in 48% yield. The use of acetic 
anhydride instead of acetyl chloride did not improve the overall yield (Scheme 25).53 
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Scheme 25. Importance of the quantity of acyl chloride 92 engaging in the acylation reaction. 
 
Having this intermediate 94 in hand Sato et al. carried on research. When intermediate 
94 was heated in toluene for 10 minutes in the absence of a nucleophile, 2-pyrone 96 
was isolated in 71% yield. The proposed mechanism for the cyclisation event is shown 
in Scheme 26.  
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Scheme 26. Mechanism of the formation of 2-pyrone 96. 
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It is thought that ketene 95a, formed via a hetero-Diels-Alder, is in equilibrium with 
both ketene 95b and 95c. The mechanistic pathway goes through intermediate 95c in 
order to form pyrone 96. Indeed, a 6-exo-dig closure will be more favoured than a 6pi 
electrocylic cyclisation. 
 
In 2005, Katritzky et al. proposed an alternative method to improve the yield of 
electrophilic addition onto the lithium enolate of dioxinone by using 
acylbenzotriazoles instead of acyl halides.70 Benzotriazole derivatives are activated 
amides, easier to handle and more acid functional group tolerant than acyl chlorides. 
For example using this strategy 2,2-dimethyl-6-(2-oxo-2-phenylethyl)-4H-1,3-dioxin-
4-one (94) was obtained in 65% yield using benzotriazole derivative 97 (Scheme 27). 
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Scheme 27. Improvement of the synthesis of 94. Bt = benzotriazolyl. 
 
This methodology does, however, suffer from some limitations. For example, during 
the reaction between 1-(1H-1,2,3-benzotriazol-1-yl)-2-(phenylsulfanyl)-1-ethanone 
(98) and the lithium enolate of dioxinone 8,  none of the desired keto-dioxinone was 
isolated. However, both unreacted dioxinone 8 and N,N-diisopropylacetamide 100 
(41% yields) were afforded (Scheme 28). The proposed mechanism for the formation 
of 100 is shown in Scheme 30. They presume that the acidic α-hydrogen in 98 was 
deprotonated by the lithium enolate of dioxinone 8 to form a transient ketene 99. This 
reactive intermediate could then react with N,N-diisopropylamine to yield acetamide 
100. 
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Scheme 28. Mechanism of formation of acetamide 100. 
 
Soon after, Devadas and co-workers were able to avoid this issue by using LiHMDS 
as a less nucleophilic base in order to form the lithium enolate of dioxinone 8.71 Using 
this strategy, they succeeded to synthesise keto-dioxinone 102 using acid chloride 
101. This intermediate was used to synthesis pyridone 103 which is a modulator of 
p38 MAP kinase (Scheme 29). 
 
 
 
Scheme 29. Synthesis of pyridine 103. 
 
In 2003, Tadano and co-workers developed an alternative method to synthesise 
dimethyl-oxoalkyl-dioxinones employing a two step procedure.57,72 The strategy 
involves a vinylogous Mukaiyama aldol reaction of the silylenol ether of dioxinone 
105 with aldehyde 104 to give an alcohol, followed by Dess-Martin oxidation to give 
the desired keto-dioxinone 106. The method described above was successfully utilized 
in the total synthesis of (+)-macquarimicin (108). Intermediate 107 was obtained via a 
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Stille coupling as a key step. The natural product 108 was synthesised from 107 using 
an intramolecular Diels-Alder as the main transformation (Scheme 30).  
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Scheme 30. Synthesis of (+)-macquarimicin A (108) via keto-dioxinone. 
 
Closely related to the previous method Omura and co-workers have described a 
strategy to form keto-dioxinone 111 which was a key synthetic intermediate for the 
total synthesis of a novel NADH-fumarate reductase inhibitor, verticipyrone (114).73 
Dioxinone 109 was successfully converted into 2-dimethyl-6-(2-oxoalkyl)-1,3-dioxin-
4-ones (111) in 64% yield over two steps. The synthesis was accomplished using an 
aldol addition of acetaldehyde (110) to the γ-position of the lithium enolate (the 
α−position was substituted and therefore un-reactive) followed by a Swern oxidation 
to afford ketone 111. Treatment with sodium methoxide in methanol gave 112, 
followed by a regioselective O-methylation with methylfluorosulfonate to provide 
methoxy-γ-pyrone 113 which is a key intermediate in the natural product 
verticipyrone (114) (Scheme 31). 
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Scheme 31. Synthesis of verticipyrone (114) via keto-dioxinone 111. 
 
Kiegiel et al. were the first group to publish a synthesis of keto-ester-dioxinone 117.74 
When heating bisdioxinone 116 in tert-butanol under controlled conditions, mono-
tert-butyl ester 117 was obtained in 57% yield. Compound 116 was synthesised from 
both malonyl chloride 115 and ketene 65 in acetone providing 116 in 60% yield 
(Scheme 32). 
 
 
 
Scheme 32. Synthesis keto-ester-dioxinone 117 
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1.9 Summary of Objectives 
Due to the synthetic issues reported in the synthesis of natural product 15G256β (5), a 
new biomimetic approach inspired by Harris’ work was suggested which would 
consist of a late stage construction of the resorcylic acid unit. In order to develop this 
new methodology, synthesis of (S)-zearalenone (6) will serve as a testing ground.  
Two main issues need to be solved: a flexible synthesis to build polyketides and 
milder conditions to construct the aromatic ring. 
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CHAPTER TWO: 
(S)-ZEARALENONE 
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As described in the previous chapter, two main intermediates, alcohol 13 and diketo-
dioxinone 12 were required to synthesise the natural product zearalenone (6). We will 
first discuss the synthesis of alcohol 13, then we will move on to the formation of 
diketo-dioxinone 12 (Figure 9). 
 
 
 
Figure 9. Alcohol 13 and diketo-dioxinone 12. 
 
2.1 Synthesis of Alcohol 13 
2.1.1 Previous syntheses of alcohol 13 analogues 
In 1992, Kitching and co-workers75 reported the racemic synthesis of alcohol 120. 
Treatment of δ-hexanolactone 62 with Grignard reagent 119 gave unpurified ketone 
120 in 75% yield. The slow addition of the Grignard 119 to lactone 62 was performed 
at low temperature to avoid any further addition to product 120 (Scheme 33). This 
alcohol 120 was reported to be acid sensitive and decomposed during column 
chromatography. 
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Scheme 33. Reagents and conditions: i) Mg, Et2O, 40 °C, 1 h; ii) 119, THF, –78 °C, 2 h, 
75%. 
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Furstner et al 40 reported the synthesis of chiral alcohol 127 in a six step procedure, 
from commercially available (R)-propylene oxide 121. Ring opening with 
vinylmagnesium bromide in the presence of catalytic amounts of CuCl(COD) gave 
alcohol 122 which was immediately protected as TBS-ether 123 under standard 
conditions. Hydrozirconation of the double bond followed by reaction with tert-butyl 
isocyanide and iodine, as described by Buchwald et al.76, delivered nitrile 124 in 77% 
yield. Treatment of 124 with 4-pentenylmagnesium bromide afforded ketone 125, 
which was converted into (R)-127 by two routine protecting group manipulations 
(Scheme 34). 
 
 
 
Scheme 34. Reagents and conditions: i) vinylmagnesium bromide, CuCl(COD) (10 mol %), 
THF, -78 °C to RT; ii) TBSCl, imidazole, DMF, RT, 16 h, 63% (over 2 steps); iii) (a) 
Cp2ZrHCl, CH2Cl2, RT, 2 h; (b) t-BuNC, RT, 2 h; (c) I2, benzene, 0 °C, 30 min, 77%; (vi) 4-
pentenylmagnesium bromide, Et2O, reflux, 4 h, 68%; (v) ethylene glycol, p-TsOH.H2O cat., 
benzene, reflux, 12 h, 73%; (vi) n-Bu4NF, THF, RT, 24 h, 89%. 
 
In 1991, Keinan et al47 synthesised alcohol 134, which has structural similarity to 
alcohol 13. Synthesis of chiral alcohol 134 involved the stereroselective reduction of 
diketone 130 with Thermoanaerobium broki alcohol dehydrogenase (TBADH). This 
enzyme is selective for the less hindered ketone. The product, acetal 134, is then 
utilised in the total synthesis of (S)-(–)-zearalenone resulting in an optical purity 
exceeding 99.5% (Scheme 35). 
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Scheme 35. Reagents and conditions: i) a) K2CO3, acetone-DMF, reflux, 24 h; b) aq. KOH 
(3%), EtOH, 80 °C, 2 h; c) aq. HCl (3 M), 20 °C, 1 h; ii) TBADH, propan-2-ol, pH 7.9 
(phosphate buffer), 40 °C, 48 h; iii) Ac2O, pyridine, 60 °C, 24 h; iv) ethylene glycol, PPTS, 
PhH, reflux; v) KOH (2 M), MeOH, 20 °C, 3 h. 
 
2.1.2 First attempted synthesis of alcohol 13 
The first attempted synthesis of alcohol 13 was inspired by the first method described 
above (Scheme 33). Alcohol 120 was synthesised by reaction of δ-hexanolactone 62 
with Grignard reagent 119, prepared in-situ from 5-bromo-1-pentene (118). 1H-NMR 
showed that the crude product 120a exists in approximately 30% as its cyclised 
hemi-acetal form 120b. Alcohol 120 proved unstable to chromatography, even on 
neutral alumina, therefore the next step was attempted without purification. Oxidation 
with DMP furnished the diketone 135. Treatment of 135 with Thermoanaerobium 
brokii alcohol dehydrogenase (TBADH) was unsuccessful and gave a complex 
mixture (Scheme 36). 
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Scheme 36. Reagents and conditions: i) Mg, Et2O, 40 °C, 1 h; ii) 119, THF, –78 °C, 2 h; iii) 
DMP, CH2Cl2, 76% over 2 steps; iv) TBADH, propan-2-ol, pH 7.9 (phosphate buffer), 40 °C, 
48 h. 
 
2.1.3 Second strategy for the synthesis of alcohol 13 with CAL-B 
Based on Kitching and Keinan’s work, Barrett and Major77 developed a synthesis of 
alcohol 13 via a kinetic resolution using enzyme CAL-B.78-80 Candida antarctica lipase 
B (CAL-B) is a serine esterase which displays enantioselectivity toward secondary 
alcohols. 
 
Kazlauskas et al. have reported that commercially available CAL-B can perform an 
enantioselective transesterification from vinyl acetate 137 to racemic secondary 
alcohol 136.81 The transesterification is an equilibrium. However, the acetaldehyde 
(110) formed during this reaction, evaporates and hence pulls the equilibrium to the 
right (Scheme 37).  
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Scheme 37. General scheme reporting the mode of action of enzyme CAL-B (R1<R2). 
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This enzyme can be therefore used in the kinetic resolution of alcohol 140, by 
eliminating the undesired chiral alcohol by selectively acetylating the (R)-alcohol 127 
to ester 141 (Scheme 38). 
 
 
 
Scheme 38. Suggested kinetic resolution of alcohol 140 with the enzyme CAL-B. 
 
Following Barrett and Major’s77 procedure, alcohol 120, previously described, was 
acetylated with acetic anhydride in the presence of pyridine to provide intermediate 
142. Protection of the ketone in 143 with ethylene glycol and PPTS followed by basic 
hydrolysis of the acetate moiety afforded the desired alcohol 140 as a racemic mixture 
(Scheme 39). A straight forward ketone protection from 120 was unsuccessful, only 
starting material was recovered.  
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Scheme 39. Reagents and conditions: i) Ac2O, pyridine, 80 °C, 24 h, 71% over 2 steps;  ii) 
ethylene glycol, PPTS, PhH, 120 °C, 18 h, 87%; iii) KOH (3M aq.), MeOH, 20 °C, 3 h, 98%. 
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A kinetic resolution of alcohol 140 was then carried out with the enzyme CAL-B. In 
order to recover the desired alcohol 13 in good yield, the following strategy was 
applied (Scheme 40): the first step allowed the formation of the (R)-acetate 141 in 
good enantiomeric excess. (S)-Alcohol 144 was also obtained, but with a low 
enantiomeric excess. However, after a further three hours treatment with CAL-B, an 
enantiomeric excess greater than 99% was obtained along with a mixture of acetylated 
products 145. The enantiomeric purity of (S)-alcohol 13 was determined by chiral GC* 
(optical rotation for S-(+)-13 was [α]D 25 = +6.7 (c 3.14 CH2Cl2) and in the literature40 
optical rotation for R-(-)-127 is [α]D 25 = -6.8 (c 1.02 CH2Cl2)). 
 
 
 
Scheme 40. Reagents and Conditions: i) 0.01 eq. CAL-B, 3 eq vinyl acetate, hexane, 35 °C, 
80 min, 46% conversion into acetate 141 ; ii) 0.01 eq. CAL-B, 3 eq vinyl acetate, hexane, 35 
°C, 3 h; 38% of alcohol 13 over two steps. 
                                                 
*
 Measurements performed by Steven R. Lenger and Simon R. Linke (AstraZeneca, Process Research 
and Development, Avlon Works). 
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2.2 Synthesis of the Dioxinone Derivative 12 
As planned in the retrosynthetic study (Scheme 12), dioxinone derivate 12 should 
react with the previously described (S)-alcohol 13. A synthesis of diketo-dioxinone 12 
(Figure 10) is described herein. 
 
 
Figure 10. Dioxinone derivate 12. 
 
With the aim of building this unprecedented class of intermediates, we required a 
model system that displays similar chemical reactivity to intermediate 12. It was 
envisaged that methylketo-dioxinone 10 (Figure 11) could act as a suitable model for 
synthetic studies. Before presenting the synthesis of intermediate 10, it is necessary to 
highlight some interesting reactivity of dioxinone 8.  
 
 
Figure 11. Dioxinone derivate 10. 
 
2.2.1 Studies towards the synthesis of diketo-dioxinone 10 
2.2.1.1  Reactivity of dioxinone 8 and keto-ester dioxinone 156 
As previously mentioned in the introduction (Section 1.8.3), Smith68 reported the 
unselective addition of alkyl halides to the extended enolate of dioxinone to give a 
mixture of α and γ-alkylated products. Alternatively, according to Sato et al.,53 C-
acylation using acyl chloride (0.5 equivalents) gave selective addition to the γ-
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position. In attempts to optimise the yields of additions to the γ-position of dioxinone, 
we decided to investigate the unreported addition of an aldehyde to the dioxinone 
extended enolate (Scheme 41). Treatment of dioxinone 8 with LiHMDS at -78 °C 
gave lithium enolate 85. Addition of one equivalent of acetaldehyde (110) leads to a 
carbonyl addition on the α-postion to give dioxinone 146 in 32% yield; however using 
2.4 equivalents of acetaldehyde (110), 42% of alcohol 146 was isolated as well as 
12% of diol 147. In addition, we examined the effects of the number of equivalents of 
acyl chloride used in the C-acylation of intermediate 85. With one equivalent of acetyl 
chloride (148), a double acylation was observed to give ester 149 which is consistent 
with Sato’s observation.53 Upon addition of 0.5 equivalents of acylchloride 148, only 
keto-dioxinone 16 was obtained in 55% yield (Scheme 41). A decrease in yield was 
observed when only 0.3 equivalents of electrophile 148 was used; only 42% of ester 
16 was isolated. These results gave us a more accurate idea of the reactivity of 
dioxinone 8, and consequently helped us in our future retrosynthetic studies. 
 
 
 
Scheme 41. Reagents and Conditions: i) LiN(SiMe3)2, THF, -78 °C, 50 min; ii) acetaldehyde 
(110), THF, RT, 2 h, 42%; iii) acetyl chloride (148) 1 eq., THF, -78 °C, 30 min, 25%; iv) 
acetyl chloride (148) 0.5 eq., THF, -78 °C, 30 min, 55%. 
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Whilst investigating the reactivity of dioxinone 8, it was found that the addition of 0.3 
equivalents of commercially available methyl malonyl chloride (150) to the dioxinone 
enolate 85 afforded ester-keto-dioxinone 151 in 61% yield. However with 0.8 
equivalents of the electrophile 150, only starting material was recovered (Scheme 42). 
As the number of equivalents of methyl chloroformylacetate (150) seemed to be 
crucial for the reaction to proceed, a plan was envisaged, using deprotonated 
dioxinone 8 as a nucleophile and acid chloride 155 as the electrophile to form 
dioxinone derivative 156. This intermediate was an important synthetic intermediate 
for one of our routes towards diketo-dioxinone 10 (see section 2.2.1.5). Allyl ester 155 
was synthesised via a two step procedure. The first step was the thermolysis of 
Meldrum’s acid (152) with allyl alcohol (153) to afford the known allyl ester 15482 in 
good yield. The second step was the acid chloride 155 formation under standard 
conditions which was used in the next step without further purification. Several 
experimental conditions were screened to attempt the generation of keto-ester 
dioxinone 156. The results are presented below (Scheme 42, Table 1). 
 
 
 
Scheme 42. Reagents and Conditions: i) LiN(SiMe3)2, THF, -78 °C, 30 min; ii) 150 (0.3 eq.), 
THF, RT, 8 h, 61%; iii) Prop-2-en-1-ol (153), 80 oC, 12 h, 30%; iv) (COCl)2, CH2Cl2, 0 °C to 
RT, 3 h; v) LiN(SiMe3)2, THF, -78 °C, 30 min; vi) conditions see table 1. 
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Entry Reagents and conditions Result 
1 155 (1 eq.), 4.10-2 M, THF, RT, 8 h 8 recovered 
2 155 (0.8 eq.), 4.10-2 M, THF, RT, 8 h Trace of 156 
3 155 (0.4 eq.), 4.10-2 M, THF, RT, 8 h 52% of 156 
4 155 (0.33 eq.), 4.10-2 M, THF, RT, 8 h 58% of 156 
5 155 (0.3 eq.), 4.10-2 M, THF, RT, 8 h 61% of 156 
6 155 (0.2 eq.), 4.10-2 M, THF, RT, 8 h 57% of 156 
7 155 (0.3 eq.), 2.10-1 M, THF, RT, 3 h 53% of 156 
 
 
Table 1. Different reaction conditions tested to synthesis diketo-dioxinone 156. 
 
Under optimised conditions, using 3.5 equivalents of dioxinone 8, ester-diketo 
dioxinone 156 was obtained in 61% yield (Table 1, Entry 5). Whilst only two 
equivalents of dioxinone enolate 85 were needed to prepare keto-dioxinone 16, three 
equivalents of intermediate 85 were necessary to obtain keto-ester dioxinone 156. It 
was thought that kinetic lithium dioxinone enolate 85 was able to deprotonate the α-
position of acyl chloride 155 to form a highly reactive ketene 157 which could quickly 
react with another lithium enolate 85 to afford intermediate 158. Subsequently another 
dioxinone derivative 85 could deprotonate the newly formed keto-dioxinone 158. A 
higher concentration might also avoid any second additions to product 159 (Scheme 
42, Table 1, entry 7 and Scheme 43). 
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Scheme 43. Proposed mechanism of formation of keto-ester-dioxinone 156. 
 
Having reported some interesting dioxinone 8 reactivity properties, we can move on to 
the synthesis of intermediate 10. Throughout the entirety of my research, diketo-
dioxinone 10 was found to be an important compound and was frequently used as a 
model system for the optimisation of certain steps (Section 2.3), a key intermediate for 
natural product synthesis (Chapter 3) and also a building block for the synthesis of 
polysubstituted heteroaromatic compounds (Chapter 4). The following section will 
describe different strategies employed to synthesise diketo-dioxinone 10. The 
description of these different processes will be ordered from the lowest yielding 
method to the highest and will not follow chronologically. Some of these approaches 
were discovered in collaboration with co-workers within the Barrett group; when 
appropriate, their contribution will be recognised in the following section. 
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2.2.1.2 Attempted synthesis of diketo-dioxinone 10 using diketene (66) 
The first attempt was performed by adding diketene (66) to the lithium enolate of 
dioxinone 8; unfortunately a complex mixture was obtained. In addition, given the fact 
that diketene (66) was no longer commercially available, this strategy was deemed 
unsuitable and consequently was abandoned (Scheme 44). 
 
 
 
Scheme 44. Reagents and Conditions: i) LiN(SiMe3)2, THF, -78 °C, 30 min; ii) 66 (0.3 eq.), 
THF, RT, 8 h. 
 
2.2.1.3 Attempted synthesis of diketo-dioxinone 10 using diphenyl-dioxinone 165 
The second method relied on the reactions of substituted dioxinones 160. Barrett and 
Navarro83 reported a strategy where they succeeded to modulate the rate of 
thermolysis of dioxinones by introducing different substituents. They observed the 
results after 2.5 hours, when alcohol 161 was heated at 75 °C with substituted 
dioxinones including: strained spiro-fused 163, dimethyl 8, phenyl-methyl 164 and 
diphenyl 165. The best result was observed with diphenyl-dioxinone 165 (Scheme 45, 
Table 2). The difference of decomposition speed was thought to be due to the overlap 
of the phenyl π-system with σ* of the O-CO bond.  
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Scheme 45. Acylation of alcohol 161 at 75 °C. 
 
 
 
Table 2. Conversion of dioxinones 160 to 162 whilst heating with alcohol 161. 
 
Based on those observations, it was decided to use the most reactive 
diphenyldioxinone 165, which was made from ester 166 and diphenyl ketone 167 
(Scheme 46). However, when this intermediate 165 was added to dioxinone lithium 
enolate of 8, only starting material was recovered after 24 hours (Scheme 46). 
 
 
 
Scheme 46. Reagents and Conditions: i) acetophenone (167), Ac2O, H2SO4, 0 °C, 15 h, 53 %; 
ii) LiN(SiMe3)2, THF, -78 °C, 30 min; iii) 165 (0.3 eq.), THF, RT, 24 h. 
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2.2.1.4 Attempted synthesis of diketo-dioxinone 10 using a ketone enol ester 
The third trial was based on the reported observation by first Young et al.84 and then 
by Tidwell and co-workers,85 who noticed the formation of β-diketones from ketone 
enol esters via an intermolecular acylation. For example treatment of enol 168 with 
potassium acetate afforded β-diketone 169 in 63% yield (scheme 47).  
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Scheme 47. Synthesis of β-diketone 169 from enol 168. 
 
Following this methodology, addition of two equivalents of lithium diisopropylamide 
(in place of potassium acetate) to enol 149 (2.2.1.1) failed to give diketodioxinone 10, 
but instead acid 170 was recovered in 12% yield as the major product (Scheme 48). 
An X-ray of solid 170, provided proof of the predicted structure (Figure 12). The 
mechanism for the formation of the unexpected side product 170 is still undetermined.  
 
 
 
Scheme 48. Reagents and Conditions: i) LDA (2 eq.), THF, -78 °C to RT, 12%. 
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Figure 12. X-ray of intermediate 170. 
 
2.2.1.5 Attempted synthesis of diketo-dioxinone 10 using allyl ester 156 
In 2008, Barrett and Navarro77 developed a new strategy to synthesise functionalised 
diketo-dioxinones based on a Claisen type condensation. The synthesis started with a 
C-acylation of dioxinone 156 with acyl chloride 171 to give allyl ester 172. 
Subsequent palladium-catalyzed deallylation-decarboxylation provided the key 
diketo-dioxinone 173 in 89% yield (Scheme 49). Using this approach, the marine 
antifungal agent 15G256β (5) was obtained in 7% overall yield. 
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Scheme 49. Synthesis of the marine antifungal agent 15G256β (5). 
 
Using this method, synthesis of methyldiketo-dioxinone 10 was carried out using allyl 
ester 156 (synthesis reported section 2.2.1.2) and acetyl chloride 148. Magnesium 
chloride mediated C-acylation gave dioxinone derivate 174 in 43% yield. Subsequent 
palladium-catalyzed deallylation-decarboxylation, gave diketo-dioxinone 10 in 40% 
yield (Scheme 50).  
 
 
Scheme 50. Reagents and Conditions: i) MgCl2, Pyridine, CH2Cl2, 35 min 0 °C then 148, 0° 
C to RT, 30 min, 43%; ii) Pd(PPh3)4 (4 mol %), morpholine (2 eq.), CH2Cl2, 30 min, 0 °C, 
40%. 
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2.2.1.6 Attempted synthesis of diketo-dioxinone 10 using Weinreb amides 
In 2009, Barrett and Poeverlein83 found a high yielding strategy to functionalised 
dioxinone 8. Indeed, treatment of one equivalent of dioxinone 8 with LiHMDS 
followed by addition of zinc chloride and one equivalent of N-acetylimidazole (175), 
gave keto-dioxinone 16 in 64% yield. The dianion of 16 was generated using 2.2 
equivalents of lithium di-isopropylamide and allowed to react with Weinreb amide 
176 to provide the required diketo-dioxinone 173 (70%). They reported that the use of 
the Weinreb amide 176 as the electrophile was found to be essential to avoid any O- 
and/or double C-alkylations. The method described above was successfully utilized in 
the synthesis of ent-W1278A (177, n = 2) (Scheme 51). 
 
 
 
Scheme 51. Synthesis of ent-W1278A (177, n = 2). 
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Following the same strategy developed by Barrett and Poeverlein, diketo-dioxinone 
10 was synthesised in 69% yield from ketodioxinone 16 (previously described in 
2.2.1.1) and commercially available Weinreb amide 178 (Scheme 52). 
 
 
 
Scheme 52. Reagents and Conditions: i) LDA (2 eq.), THF, -78 °C, 30 min; ii) 178 (0.5 eq.), 
THF, -40 °C, 1 h, 69%. 
 
2.2.1.7 Attempted synthesis of diketo-dioxinone 10 using benzotriazole 
intermediates 
In 2007, an efficient synthesis was developed to give dioxinone 10.86 This compound 
was synthesised by thermolysis of commercially available dioxinone 8, which 
underwent a retro-Diels–Alder reaction at 90 °C to form acyl-ketene 82, which was 
trapped with benzotriazole 179 to form amide 9 in quantitative yield. Subsequent 
crossed Claisen condensation via reaction of the lithium enolate from dioxinone 8 
with amide 9 gave diketo-1,3-dioxinone 10 as a 5:95 mixture of keto–enol tautomers 
in 53% yield over two steps (Scheme 53). This synthesis is easily scalable, the most 
convergent, and the highest yielding method of all the other strategies reported. 
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Scheme 53. Reagents and Conditions: i) PhMe, 179, 90 °C ii) LiN(SiMe3)2, THF, -78 °C, 30 
min; iii) 9 (0.3 eq.), THF, RT, 8 h, 53%. 
 
Having effectively built the model diketodioxinone 10 via different methods, 
construction of intermediate 12 (Figure 13), necessary for the synthesis of the natural 
product zearalenone (6), was the next challenge. Different routes to this compound 
will be discussed in the next section, with the highest yielding route being described 
last 
 
 
Figure 13. Dioxinone derivative 12. 
 
2.2.2 Attempted synthesis of diketo-dioxinone 12 using allyl ester 156 
The route using allyl ester intermediate 156 (Section 2.2.1.5) was unsuccessful. 
Treatment of compound 156 with crotonoyl chloride (180) did not afford ester 181 
(Scheme 54). 
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Scheme 54. Reagents and Conditions: i) MgCl2, pyridine, CH2Cl2, 30 min, 0 °C then 180, 0° 
C to RT, 1 h. 
 
Following this disappointing result, a modified route to form dioxinone 12 was 
envisaged. C-acylation of allyl ester 156 with acid chloride 171 followed by palladium 
catalysed deallylation gave intermediate 173 in 74% yield over two steps. 
Deprotection gave alcohol 182 in 92% yield. Different methods were attempted to 
perform the elimination reaction to give intermediate 12, but none of them were 
successful (Scheme 55, Table 3). Consequently another method was investigated. 
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Scheme 55. Reagents and Conditions: i) MgCl2, Pyridine, CH2Cl2, 35 min, 0 °C then 171, 0° 
C to RT, 30 min, 83%; ii) Pd(PPh3)4 (4 mol %), morpholine (2 eq.), CH2Cl2, 0 °C, 30 min, 
89%; iii) HF, pyridine, THF, RT, 6 h, 92%; iv) conditions see table 3. 
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Entry Reagents and conditions Result 
1 Burgess dehydrating reagent87, THF, 18 h S.M. 
2 
Martin’s sulfurane dehydrating reagent88, 
CH2Cl2, 3 h 
Decomposition 
3 MsCl, Et3N, Et2O, RT, 8 h89 Decomposition 
 
 
Table 3. Different reaction conditions tested to synthesise diketo-dioxinone 12. 
 
2.2.3 Attempted synthesis of diketo-dioxinone 12 using benzotriazole 
intermediates 
Inspired by the benzotriazole strategy used to build diketone 10 (Section 2.2.1.7), it 
was envisaged that the reactive intermediate 12 could be prepared from dioxinone 
184. As compound 184 was unprecedented in the chemical literature, it was decided to 
make it from an acylated Meldrum’s acid 185 (Scheme 56). This method to prepare 
substituted dioxinones was reported by Sato et al.64 (Section 1.8.1).  
 
 
 
Scheme 56. Retrosynthesis study to build diketo-dioxinone 12 via intermediate 184. 
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C-acylation of Meldrum’s acid (152) was performed using crotonoyl chloride (180) 
under basic conditions. Subsequent thermolysis of intermediate 185 in acetone gave 
unsaturated dioxinone 184 in 30% yield over two steps. This compound was then 
heated at 90 °C with benzotriazole 179 to form the highly reactive amide 183. Crossed 
Claisen condensation via reaction of the lithium enolate of dioxinone 8 with amide 
183 gave diketo-dioxinone 12 in 14% yield over two steps (Scheme 57). The overall 
yield is low compared to the one obtained during the formation of methyldiketo-
dioxinone 10 using this methodology (Section 2.2.1.7). The difference in results was 
attributed to a possible 1-4 addition of benzotriazole to 183. 
 
 
 
Scheme 57. Reagents and Conditions: i) 180, pyridine, CH2Cl2, 0 °C, 2 h, 48% ii) acetone 
(57), PhMe, 90 °C, 5 h, 62%; iii) 8, PhMe, 90 °C, 11 h; iv) LiN(SiMe3)2, THF, -78 °C, 30 
min; v) 183 (0.3 eq.), THF, RT, 8 h, 14%. 
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2.2.4 Attempted synthesis of diketo-dioxinone 12 using a Mukaiyama 
aldol reaction and a late step isomerisation 
Tadano et al have reported the formation of β-hydroxyketone 106 using a Mukaiyama 
aldol reaction as a key step (Section 1.8.3).72 A similar pathway was investigated to 
make diketodioxinone 12 after isomerisation of intermediate 186 which could be 
synthesised from aldehyde 187 and the silyl enol ether 64 (Scheme 58).  
 
 
 
Scheme 58. Retrosynthetic analysis of diketo-dioxinone 12 via intermediate 186. 
 
The known α-chloro-alcohol 190 was synthesised by a Barbier procedure, in the 
presence of indium, from chloroacetaldehyde 188 and allyl bromide 189, both 
commercially available.90 Treatment of intermediate 190 with potassium cyanide and 
sodium iodide gave the nitrile 191. Protection of the hydroxyl group of 192 and 
reduction of the resultant silylated product provided aldehyde 193 (Scheme 59). 
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Scheme 59. Reagents and Conditions: i) 1eq. In, H2O, RT, 5h, 94%; ii) 1.5 eq. KCN, 3 eq. 
NaI, 78 °C, 5 h; iii) 2 eq. TBSCl, 4 eq. imidazole, DMF, 0 °C, 13 h, 81% 2 steps; iv) 1.5 eq. 
DIBAL-H, PhMe, -52 °C, 2 h, 96%. 
 
A vinylogous Mukaiyama aldol reaction was then performed between aldehyde 193 
and dienolate 64 to afford a 1:1 diastereomeric mixture of the dioxinone derivative 
194. The dienolate 6491 was prepared from the commercially available 2,2,6-
trimethyl-1,3-dioxin-4-one 8. Oxidation of 194 with DMP,92 followed by deprotection 
of the alcohol gave 196. Deprotection of the silyl group in 196 required the use of 
hydrofluoric acid in water (Scheme 60). The employment of TBAF did not remove the 
protecting group. From 194, a straight forward deprotection of the alcohol followed by 
a double oxidation was not successful.  
 
 
 
Scheme 60. Reagents and Conditions: i) 1.2 eq. HMPA, 1.1 eq. iPr2NH, 1.1 eq. n-BuLi, 1.2 
eq. TBSCl, -78 °C, 1h, 76%; ii) 1.05 eq. 64, 1.3 eq. BF3.OEt2, -78 °C, 45 min, 45%; iii) 2 eq. 
DMP, CH2Cl2, RT; vi) 10 eq. HF (48% aq), RT, 8 h, 51% 2 steps. 
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Having alcohol 196 in hand, different oxidative methods were then tested to obtain 
intermediate 197 (Scheme 61, Table 4). 
 
 
 
Scheme 61. Reagents and Conditions: i) conditions see table 4. 
 
Entry Reagents and conditions Result 
1 (COCl)2, DMSO, CH2Cl2, -78 °C, then Et3N93 product detected 
2 Al(Oi-Pr)3, acetone94 S.M. only 
3 PCC, 4Å molecular sieves95 S.M. only 
4 TPAP, NMO, 4Å molecular sieves96 product detected 
5 MnO2 S.M. only 
6 IBX97 S.M. + product detected 
7 2 eq. DMP, 0.1 mol/L92 10% of 197 
8 2 eq. DMP, 0.04 mol/L 32% of 197 
 
 
Table 4. Different oxidation reagents tested on 197. 
 
Only DMP was able to produce the desired dioxinone 197. In addition, the 
concentration was shown to be essential to obtain a good yield. Treatment of 196 with 
DMP at a concentration of 0.04 mol/L in DCM gave 197 in 32% yield (Table 4, entry 
8).  
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In order to get the desired ketodioxinone 12, it was necessary to isomerise the allylic 
double bond of 197 into a more stable, unsaturated ketone (Scheme 58). Different 
strategies were applied unsuccessfully; however an interesting result was spotted. 
 
The first method involved the treatment of 197 with triethylamine98 for eight hours in 
THF under reflux, to give the unexpected resorcylate 198 in a good yield. When the 
same reaction was carried out for two days product 199 was formed. However, the 
conversion was not complete (Scheme 62) and the yield of 199 was poor. Even though 
results were interesting (they will be discussed extensively in chapter 4), a new 
pathway was investigated to obtain intermediate 12 in good yield. 
 
 
 
Scheme 62. Reagents and Conditions: i) 3 eq. Et3N, THF reflux, 8 h, 82 %; ii) 20 eq. Et3N, 
THF reflux, 2 days, 7 % of 199. 
 
2.2.5 Attempted synthesis of diketo-dioxinone 12 using a Mukaiyama 
aldol reaction  
A different strategy for the synthesis of diketone 12 was developed based upon the use 
of a Mukaiyama-aldol vinylogous addition reaction of the silyl-enolate of dioxinone 
64 with the known aldehyde 20399 (Scheme 63). The synthesis of aldehyde 203 started 
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from the aldol reaction of crotonaldehyde (200) and ethyl acetate. The resulting 
alcohol 201 was protected and then DIBAL-H reduction of the ester 202 gave 
selectively aldehyde 203. Different Lewis acids were investigated as catalysts for the 
Mukaiyama-aldol addition (Table 5) and trifluoroboron etherate was found to be the 
best (Table 5, entry 3) and provided intermediate 204 in 61% yield. DMP oxidation of 
the secondary alcohol moiety in 204, followed by TBS-deprotection with hydrofluoric 
acid and a second oxidation of the resultant allylic alcohol gave the desired diketone 
12 in 43 % yield from 204. The same optimized conditions described for the oxidation 
of 196 were again found to be successful. 
 
 
 
Scheme 63. Reagents and Conditions: i) EtOAc, LDA, THF, -70 °C, 2 h, 92%; ii) imidazole, 
TBSCl, CH2Cl2, RT, 4 h, 99%; iii) 1.5 eq. DIBAL-H, PhMe, -85 °C, 2.5 h, 90% iv) see table 5 
for reagents and conditions; v) 2 eq. DMP, CH2Cl2; vi) 10 eq. HF (48% aq), MeCN, RT, 30 
min, 82% over 2 steps vii) 2 eq.DMP, CH2Cl2, 56%. 
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Entry Reagents and conditions Result (yield of 204) 
1 1.05 eq. 64, 1.3 eq. TiCl4, CH2Cl2, -78 °C, 1 h 35% 
2 1.05 eq. 64, 1.3 eq. Me2AlCl, CH2Cl2, -78 °C, 1 h 32% 
3 1.05 eq. 64, 1.3 eq. BF3.OEt2, CH2Cl2, -78 °C, 1 h 61% 
 
 
Table 5. Different Lewis acids in the Mukaiyama-aldol addition. 
 
2.2.6 Attempted synthesis of diketo-dioxinone 12 using Weinreb amides 
Another route to form dioxinone 12 was also investigated using a Weinreb amide 
intermediate following Poeverlein’s strategy (Section 2.2.1.6). Diketo-dioxinone 12 
was obtained in 26% yield, from keto-dioxinone 16 and Weinreb amide 207 (Scheme 
64). This strategy showed to be the highest overall yielding method to prepare key 
intermediate 12. 
 
 
 
Scheme 64. Reagents and Conditions: i) 2 eq. LDA, THF, -78 °C, 30 min; ii) 0.5 eq. 207, 
THF, -40 °C, 1 h, 26%. 
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2.3 Aromatisation Studies 
Having key intermediates diketo-dioxinone 12 and alcohol 13 in hand, we had to find 
the most suitable aromatisation conditions for the resorcylic ring construction. An 
initial set of experiments were conducted on model diketo-dioxinone 10 (Figure 14). 
 
 
 
Figure 14. Dioxinone derivate 10. 
 
2.3.1 Aromatisation studies using diketo-dioxinone 10 
As previously described (Section 1.8.2), thermolysis of dioxinone 10 in toluene gave a 
ketene intermediate 208 via a retro hetero-Diels-Alder reaction which was trapped in 
situ by methanol to give the triketo-ester 44. Polyketide 44 showed to be a complex 
mixture of keto and enol tautomers according to 1H-NMR spectrum (Scheme 65). 
Deuterium exchange occurs in methanol-d4, leading to the disappearance of the keto-
enol proton in the 1H-NMR spectrum. This intermediate 44 was stable at room 
temperature and although cannot be purified by column chromatography, it was easy 
to isolate, simply by evaporation of the solvent and was of sufficient purity to use in 
the next step. It was also found that ester 44 was sensitive to base or acid.  
 
 
 
Scheme 65. Reagents and Conditions: i) 5 eq. MeOH, PhMe, 110 °C, 5 h, quantitative. 
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With compound 44 in hand, different conditions were applied in attempts to aromatise 
the product selectively, through an aldol condensation to give a resorcylic acid ring 11 
(Scheme 66, Table 6). We will first discuss the temperature and the quantities of base 
needed to carry out a selective aldol-dehydration reaction and then we will examine 
milder basic and acidic conditions to perform this aromatisation. 
 
The studies commenced with the use of different buffers as described by Barrett et 
al.17 (Section 1.5). Unfortunately, only small traces of the desired resorcylic acid 11 
were observed (Scheme 66, Table 6, entries 1-2). As reported by Harris et al.,16 the 
use of an aqueous solution of potassium hydroxide at 0 °C led to acetophenone 45 as 
the major product via a Claisen condensation (Table 6, entry 3). However, contrary to 
what Harris and co-workers have mentioned, it was found that the temperature, and 
not the presence of water in the reaction, was a crucial parameter to obtain aromatic 
45 as a major product. When the reaction was carried out at -20 °C with potassium 
hydroxide in methanol, intermediate 45 was isolated in 52 % yield (Table 6, entries 4-
5). Treatment of triketo-ester 44 under acidic conditions gave a complex mixture, but 
no starting material was recovered (Table 6, entry 6).  
 
 
 
Scheme 66. Reagents and Conditions: i) conditions see table 6, 7 and 8. 
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Entry Reagents and conditions Result 
1 pH 9.2 buffer, THF traces of  11 
2 pH 5.6 buffer, THF traces of  11 
3 
0 °C, 5 eq. KOH, 10 min, 1:1 water:THF then 
HCl, aqueous to pH=1 
29% of 45 and 9% of 11 
4 -20 °C, 5 eq. KOH, 10 min, 1:1 water:THF 
then HCl, aqueous to pH=1 
41% of 45 and 10% of 11 
5 -20 °C, 5 eq. KOH, 10 min, MeOH then HCl, 
aqueous to pH=1 
52% of 45 and 12% of 11 
6 HCl, MeOH other products 
 
 
Table 6. Testing different conditions to synthesise resorcylate 11. 
 
The addition of potassium hydroxide in methanol at room temperature was tested and 
in this case a very polar product was formed. Upon a neutral aqueous work-up, and 
column chromatography, a complex mixture was recovered in which no aromatic 
protons were observed by 1H-NMR (Table 7, entry 1). We thought it to be a mixture 
of different tautomers of alcohol 209. If compound 44 is treated with potassium 
hydroxide, followed by the addition of HCl, a single compound was observed and the 
1H-NMR of the product showed aromatic protons (Table 7, entries 2-3). This indicated 
that in basic media, an undehydrated aldol cyclisation reaction occurred and then 
dehydration to the resorcylic ester happened in acidic media. At room temperature, the 
cyclisation also showed a high degree of regiospecificity. The resorcylic ester 11 was 
isolated in 87% yield (Table 7, entry 2); other cyclisation products were not observed. 
Adding HCl in methanol to the acidification process increased the yield to 89% (Table 
7, entry 3). Stirring the acidified solution for one hour increased the yield to 90% 
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(Table 7, Entry 4). Based on this observation, it seems that the dehydration of ester 11 
is a slow process. In addition, as illustrated above, the formation of acetophenone 45 
via a Claisen condensation100 was more favoured at low temperatures, whereas 
resorcylate 11 was selectively produced via an aldol reaction at higher temperatures. It 
became apparent that product 45 was generated under kinetic control and ester 11 
under thermodynamic control.  
 
Entry Reagents and conditions Result 
1 5 eq. KOH, MeOH 209*  
2 5 eq. KOH, 30 min , MeOH then HCl, 
aqueous to pH=1 
87% of 11  
3 5 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1 
89% of 11 
4 5 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1, stir 1 h 
90% of 11 
 
 
Table 7. More testing of different conditions to perform resorcylate 11. 
 
As presented in table 8 we then investigated the aromatisation reaction using a variety 
of different basic and acidic conditions. It was found that a minimum of 3 equivalents 
of KOH was required to perform the aldol condensation (Table 8, entries 1-3). Acidic 
work-up using HCl produced the desired ester 11 in the highest yield (Table 7, entry 
3; Table 8, entries 4, 5 and 9). Interestingly, the use of cesium carbonate instead of 
potassium hydroxide gave also resorcylate 11 in good yield (Table 8, entries 7 and 9). 
                                                 
*
 According to GCMS 
 76 
The use of a basic resin gave a very poor yield of 11 (Table 8, entry 6) and using 
potassium carbonate only gave a modest yield (Table 8, entry 8). 
 
Entry Reagents and conditions Result 
1 
2 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1 
8% of 11 
2 
3 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1 
76% of 11 
3 
3.5 eq. KOH, 30 min, MeOH then HCl, 
MeOH to pH=1 
81% of 11 
4 5 eq. KOH, 30 min, MeOH then AcOH  56% of 11 
5 5 eq. KOH, 30 min, MeOH then TFA 73% of 11 
6 
Basic resin Amberlite IRA-400 then HCl, 
MeOH to pH=1 
12% of 11 
7 
5 eq. Cs2CO3, MeOH then HCl, MeOH to 
pH=1 
87% of 11 
8 
20 eq. K2CO3, MeOH then HCl, MeOH to 
pH=1 
62% of 11 
9 5 eq Cs2CO3, MeOH then TFA to pH=1 74% of 11 
 
 
Table 8. More conditions to optimise formation of 11. 
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2.3.2 Aromatisation studies using diketo-dioxinone 197 and 12 
The optimized procedures, identified by the screening of different experimental 
conditions, were hence utilized with diketo-dioxinone 197 and 12. 
 
Starting from diketone 197, an aromatisation reaction was carried out under these 
optimised conditions; thus treatment of polyketide 210 with five equivalents of cesium 
carbonate followed by addition of hydrochloric acid afforded resorcylic ring 211 in 
92% yield (Scheme 67). 
 
 
 
Scheme 67. Reagents and Conditions : i) 5 eq. MeOH, PhMe, 110 °C, 4 h; ii) 5 eq. Cs2CO3 in 
MeOH then aqueous HCl, to pH=1, 92% over 2 steps. 
 
We also were interested in investigating the Claisen type condensation100 as an 
alternative reaction to provide different natural product motifs. Keto-ester 212 
(obtained from dioxinone 12) was added to a methanoic solution of potassium 
hydroxide at -20 °C. The reaction was highly dependent on temperature; the reaction 
was quenched by pouring the mixture into an aqueous hydrochloric acid solution 
cooled with ice. Ketone 213, which was only soluble in diethyl ether, was directly 
converted into the known flavanonid analogue 214101 by refluxing in acetic acid.102 
(Scheme 68). 
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Scheme 68. Reagents and Conditions : i) 5 eq. MeOH, PhMe, 110 °C, 4 h; ii) KOH, MeOH, -
20 °C then aqueous HCl, to pH=1; iii) AcOH, reflux, 2 h, 43% over 3 steps. 
 
Flavonoids 215 are a large class of natural products (Figure 15), which show a broad 
range of biological activities such as anti-allergic, anti-inflammatory,103 anti-
microbial104 and anti-cancer.105  
 
 
Figure 15. Molecular structure of the flavone backbone. 
 
This biomimetic synthesis of chroma-4-one 214 was inspired by Harris’s synthesis of 
pinocembrin (217) which was obtained in 63% yield from polyketide 216.30 As 
illustrated above, keto-dioxinones can therefore be employed for the preparation of 
flavonoids natural products (Scheme 69). 
 
 
 
Scheme 69. Synthesis of pinocembrin (217) by Harris and co-workers. 
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2.3.3 Aromatisation studies without using basic or acidic conditions 
An interesting aromatisation reaction was also observed without using basic or acidic 
conditions. Treatment of dioxinone 10 with isopropanol in a sealed tube at 100 °C, 
gave the orselinate 218 in an excellent yield (Scheme 70). The fact that the reaction 
was performed under pressure seems to be an important factor in successfully carrying 
out the aromatisation. When intermediate 10 was heated under reflux in isopropanol, 
no aromatic product was observed. In addition, when dioxinone 10 was heated in 
toluene with methanol or alcohol 219 in a sealed tube at 100 °C, no orselinates 11 or 
220 were obtained. A lower pressure inside the tube appeared to be the reason of those 
results (Scheme 70). 
 
 
 
Scheme 70. Reagents and Conditions: i) isopropanol, sealed tube, 100 °C, 10 h, 98%; ii) 
isopropanol, reflux, 85 °C, 10 h; iii) MeOH, sealed tube, 80 °C, 10 h; iv) 219, PhMe, sealed 
tube, 100 °C, 10 h. 
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Consequently, another strategy was developed using a two step procedure. For 
example the synthesis of ester 220 was made from the thermolysis of dioxinone 10 
with alcohol 219. The resulting polyketide intermediate was then heated in 
isopropanol in a sealed tube at 100 °C to afford resorcylate 220 in a good yield 
(Scheme 71). 
 
 
 
Scheme 71. Reagents and Conditions: i) 219, PhMe, 100 °C, 5 h; ii) isopropanol, sealed tube, 
100 °C, 8 h, 72% over 2 steps. 
 
Interestingly, it was also discovered that the use of molecular sieves can allow the 
formation of resorcylates under specific conditions. For example, when dioxinone 10 
was treated with 4 Ǻ molecular sieves in a mixture of isopropanol and DCM in a 
sealed tube at 100 °C, resorcylate 218 was obtained in a 98% yield. The same results 
were observed when methanol or alcohol 219 were used. Sadly, this mild strategy was 
unsuccessful with keto-dioxinone 12 either with alcohol 219 or alcohol 13. It was 
deemed that the size of the molecules was critical for the reaction to proceed with 
molecular sieves. Though this strategy was appealing, the cesium carbonate mediated 
aromatisation will be the method of choice to build the resorcylate (Scheme 72). 
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Scheme 72. Reagents and Conditions: i) 5 eq. isopropanol, m.s. 4Å, sealed tube, CH2Cl2, 100 
°C, 10 h, 98%; ii) MeOH, m.s. 4Å, sealed tube, CH2Cl2, 100 °C, 10 h, 82%; iii) 5 eq. 219, m.s. 
4Å, sealed tube, CH2Cl2, 100 °C, 10 h, 72%; iv) 5 eq. 219, m.s. 4Å, sealed tube, CH2Cl2, 100 
°C, 10 h; v) 12, m.s. 4Å, sealed tube, CH2Cl2, 100 °C, 10 h. 
 
2.4 Total Synthesis of (S)-Zearalenone (6) 
Having alcohol 13 and diketo-dioxinone 12 in hand and the optimised conditions for 
the aromatisation step, it was possible to complete the total synthesis of S-(-)-
zearalenone (6). 
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Two different approaches were investigated: the first one was to perform a cross-
metathesis of intermediates 13 and 12, followed by an intra-molecularl 
macrolactonisation. The second one was to carry out the esterification-aromatisation 
first and then execute a ring closing metathesis. However, the cross-metathesis of 
intermediates 13 and 12 using Hoveyda-Grubbs catalyst II generation 223106 was 
unsuccessful (Scheme 73). Consequently, studies toward esterification were favoured. 
 
 
 
Scheme 73. Reagents and Conditions: i) 223 (10 mol%), CH2Cl2, 40 °C.  
 
2.4.1 Aromatisation step 
Thermal decomposition of diketone 12 formed the acylketene 225 which was trapped 
by enantiopure alcohol 13. Polyketide 14 was produced quantitatively. The compound 
14 is, according to the NMR, a mixture of different possible keto-enolic forms 
(Scheme 74).  
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Scheme 74. Reagents and Conditions: i) xylenes, 150 °C, 8 min, quantitative. 
 
After the success of the test reactions to build such resorcylates (Section 2.3), the 
same conditions were applied to the synthesis of the precursor of zearalenone (6). The 
resorcylate 222 was isolated in 91% yield from a cyclisation reaction carried out with 
potassium hydroxide in methanol and then treated with aqueous HCl to pH=1 (Table 
9, entry 1); other cyclisation products were not observed. However, acidic conditions 
led to cleavage of the acetal group. Therefore, different aromatisation conditions were 
investigated in order to come across a milder reaction (Scheme 75, Table 9, entries 2-
5). It was observed that under milder acidic condition, acidification until pH=7 
(Scheme 75, Table 9, entries 2-3) or with acid resin Dowex 50WX8-400 (Scheme 75, 
Table 9, entry 4), the yield dropped down. This result was attributed to the fact that 
the dehydration step, leading to the aromatic ring 222 was not complete. However, 
prolonged exposure with HCl (Scheme 75, Table 9, entry 5) leads to ketone 226 in 
good yield. The use of acetic acid or trifluoroacetic acid (Scheme 75, Table 9, entries 
6-7) did not improve the yield of the aromatisation. 
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Scheme 75. Reagents and Conditions: i) conditions see table 8 
 
Entry Reagents and conditions Result 
1 5 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1 
91% of 222 and trace of 
226 
2 5 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=7 
61% of 222 
3 5 eq. KOH, 30 min, MeOH then acid resin 
Dowex 50WX8-400 
74% of 222 and trace of 
226 
4 5 eq. KOH, MeOH then HCl, MeOH to 
pH=7, then stir overnight in DCM 
70% of 222 
5 5 eq. KOH, 30 min, MeOH then HCl, MeOH 
to pH=1 stir 1 h 
82% of 226 
6 5 eq. KOH, 30 min, MeOH then acetic acid to 
pH=1 
31% of 226 
7 5 eq. KOH, 30 min, MeOH then TFA to 
pH=1 
73% of 226 
 
 
Table 9. Different conditions applied to form resorcylate 222. 
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In order to optimize the formation of ketone 226 diverse conditions were investigated. 
Different resins were tested such as basic resin Amberlite IRA-400 (Scheme 75, Table 
10, entries 1-2) and acid resin Dowex 50WX8-400 (Scheme 75, Table 10, entries 2, 
5). Only the Dowex 50WX8-400 appeared to be effective to promote the dehydration 
(Scheme 75, Table 10, entries 3-5). The combination with cesium carbonate and resin 
Dowex 50WX8-400 afforded resorcylate 226 in good yield (Scheme 75, Table 10, 
entry 5). 
 
Entry Reagents and conditions Result 
1 Basic resin Amberlite IRA-400 with acid 
resin Dowex 50WX8-400 
Mixture of products 
2 Basic resin Amberlite IRA-400  then HCl, 
MeOH to pH=1 
Mixture of products 
3 5 eq. Cs2CO3, MeOH then HCl, MeOH to 
pH=1 
75% of 222 and trace of 
226 
4 5 eq. Cs2CO3, MeOH then TFA to pH=1 74% of 226 
5 5 eq. Cs2CO3, toluene then resin Dowex 
50WX8-400 overnight 
75% of 226 
 
 
Table 10. Different conditions applied to form resorcylate 226. 
 
2.4.2 Ring closing metathesis 
The construction of macrocycles by ring-closing metathesis (RCM)107 is often used as 
the key step in the synthesis of natural products containing large rings. This reaction is 
attractive because of its high functional group compatibility and the possibility for 
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further transformations. Ring-closing metathesis (RCM) of alkenes allows the 
synthesis of cyclic compounds from small 5- or 6-membered rings up to large 
macrocycles.108 Disadvantages include control over the stereochemistry of the double 
bond formed and finding the appropriate reaction conditions to maximize yield and 
minimize the formation of by-products. The key intermediate is a metallacyclobutane, 
which can undergo cycloreversion either towards the product or back to starting 
materials. When the olefins in the substrate are terminal, the driving force for RCM is 
the removal of ethene from the reaction mixture.109 
 
In the synthesis of zearalenone (6) two different catalysts have been tested: the Grubbs 
catalyst second generation 227 and the Hoveyda-Grubbs catalyst second generation 
223 (Figure 16). 
 
 
Figure 16. Catalysts used for the RCM. 
 
With the resorcylic ester 222 in hand, studies were initiated to explore the ring closing 
metathesis (RCM). Attempts to perform this reaction using the second generation 
Grubbs catalyst 227 and the Hoyveda-Grubbs catalyst 223 were unsuccessful. Using 
catalyst 223, a mixture of three products was obtained in the ratio indicated below 
(Scheme 76). Purification of those products was unsuccessful due to their very close 
retention factor on silica gel. The ratio was determined by NMR and LCMS.  
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Scheme 76. Reagents and Conditions: i) 223 (10 mol%), PhMe (8.10-4 M), 80 °C, 8 h. 
 
However, deprotected product 226 underwent ring closing metathesis with the second 
generation Hoveyda-Grubbs catalyst 223 to give stereoselectively (E/Z 86:14) the 
final product S-(-)-zearalenone (6) in 71% yield (Scheme 77). It was thought that the 
ring closing metathesis occurred more smoothly with intermediate 226 than with 
compound 222 because ester 226 is structurally closer to the natural product 
zearalenone (6) and consequently more inclined to adopt the appropriate conformation 
to ring close under the metathesis conditions.  
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Scheme 77. Reagents and Conditions: i) 223 (10 mol%), PhMe (1.7 x 10-3 M), 80 °C, 71% of 
E isomer. 
 
2.4.3 One pot strategy 
By a simple modification of the reaction conditions (Scheme 78), we found that this 
four-step reaction sequence could be telescoped and performed with just a single 
chromatographic purification resulting in the isolation of natural product 6 in a highly 
convergent synthesis. 
 
 
 
Scheme 78. Reagents and Conditions: i) PhMe, 110°C, 2 h; ii) Cs2CO3, MeOH, 12 h; iii) 
Dowex 50WX8-400, 24 h; iv) 223 (10 mol%), PhMe, 80°C, 8 h, 63% four steps. 
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2.5 Conclusions 
In summary, we report a new strategy for the synthesis of resorcylate natural products 
using a late stage biomimetic highly selective aromatization reaction and its 
application to a concise total synthesis of S-(-)-zearalenone (6) in eight steps with an 
overall yield of 11.5% (Scheme 79). No previous synthesis exceeded 7% as an overall 
yield.110  
 
 
Scheme 79. Overview of zearalenone synthesis. 
 
In addition, we reported three efficient ways to synthesis diketo-dioxinone 10. 
The first one using allylester 156: 
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The second one using Weinreb amide 178: 
 
 
 
And the third one using benzotriazole derivative 9: 
 
 
 
We also established mild conditions to construct the aromatic ring 11 using a soft base 
followed by an acid work-up. We also discovered ways to built resorcylates in one 
step from diketo-dioxinone 10: 
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CHAPTER THREE:  
(+)-MONTAGNETOL AND  
(+)-ERYTHRIN  
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3.1 Background to Montagnetol and Erythrin 
The orsellinic acid unit (1) occurs widely in natural products, including the natural 
products montagnetol (2) and erythrin (4).111 This feature is also present in 
globosumone A (231) and B (232),112 phomozin (233),113 orsellide A (234), C (235), 
D (236) and E (237)114 (Figure 17). 
 
 
 
Figure 17. Natural products containing the orsellininc acid unit (1). 
 
Having diketo-dioxinone 10 in large amounts (section 2.2.1.7), we realised that from 
this intermediate 10, we were able to perform the total syntheses of natural products 
(+)-montagnetol (2) and (+)-erythrin (4). 
 
We planned to undertake their biomimetic total syntheses in an analogous manner to 
(S)-zearalenone (6) (Chapter 2). Thus, (+)-montagnetol (2) should be obtained from 
diketo-dioxinone 10 and alcohol 238. The natural product (+)-erythrin (4) should be 
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achieved via a selective phenol trapping of montagnetol derivate 239 with the 
acylketene generated from diketo-dioxinone 10 (Scheme 80). 
 
 
 
Scheme 80. Retrosynthetic analysis of (+)-montagnetol (2) and (+)-erythrin (4).  
 
Natural products (+)-montagnetol (2) and (+)-erythrin (4) were both extracted from 
the lichen Roccella montagnei by V.S. Rao and T. R. Seshadri.111 Erythrin (4), which 
is the chromogen of Roccella tinctoria (extract present in litmus),115 was also reported 
as a potent natural antioxidant.116 From a racemic synthesis, the structures of 
montagnetol (2) and erythrin (4) have been elucidated by Seshadri and co-workers.117  
 
The previous synthesis of montagnetol (2) started with the benzylation of 
commercially available methyl orsellinate 11. Subsequent ester hydrolysis gave the 
orsellinic acid dibenzyl ether 240. This intermediate 240 was then condensed with cis-
2-butene-1,4-diol (241) in the presence of N,N’-dicyclohexylcarbodiimide to afford 
ester 242. Subsequent treatment with Milas’ reagent (H2O2 in t-butanol with cat. 
OsO4) provided a racemic mixture of montagnetol dibenzyl ester 243a (2S,3R) and 
243b (2R,3S). The protecting benzyl groups were then removed by catalytic 
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hydrogenation over palladium on charcoal to afford a racemic mixture of montagnetol 
244 (2S,3R) and 2 (2R,3S) (Scheme 81). 
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Scheme 81. Racemic synthesis of (±)-montagnetol by Seshadri et al. 
 
Similarly erythrin was synthesised starting with the condensation of 
tricarbethoxylecanoric acid 245 (prepared from lecanoric acid) with cis-2-butene-1,4-
diol (241) in the presence of N,N’-dicyclohexylcarbodiimide to afford ester 246. Upon 
dihydroxylation using Milas’ reagent followed by decarbethoxylation gave a racemic 
mixture of erythrin 248 (2S,3R) and 4 (2R,3S) via esters 247 (Scheme 82). 
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Scheme 82. Racemic synthesis of (±)-erythrin by Seshadri et al. 
 
Thus, at this time, the absolute configuration of (+)-montagnetol (2) and (+)-erythrin 
(4) was not assigned. Herein we report the synthesis of both enantiomers of (+)-
montagnetol (2) and (+)-erythrin (4) and hence the determination of their absolute 
stereochemical configuration. 
 
3.2 Total Synthesis of (+)-Montagnetol 
The synthesis started with the formation of both enantiomers of alcohol 252 (a and b). 
The choice of protecting group for alcohols 252 was directed by the observations of 
V.S. Rao and T. R. Seshadri, who reported a racemisation of (+)-montagnetol (2) 
under aqueous conditions118 via a transesterification (Scheme 83). Consequently, the 
use of a benzyl protecting group was adequate and avoids any aqueous work-up at the 
final deprotection stage. 
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Scheme 83. Racemisation of (+)-montagnetol (2) under aqueous conditions reported by 
Seshadri and co-workers.  
 
Both enantiomers 252a and 252b were synthesized from erythronolactone 250a and 
250b respectively. Erythronolactone 250a was obtained from D-isoascorbic acid 249 
in 94% yield.119 Following a previously reported synthesis,120 treatment of lactones 
250a and commercially available 250b with eight equivalents of benzylbromide and 
four equivalents of silver oxide, gave esters 251a and 251b respectively. Reduction 
with lithium aluminium hydride afforded alcohols 252a and 252b respectively, in 
good yields (Scheme 84). The thermolytic ketene generation, trapping and 
aromatization was then applied to the total syntheses of (+)-montagnetol (2) and (+)-
erythrin (3), as well as their respective enantiomers. 
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Scheme 84. Reagents and Conditions: i) NaHCO3, H2O2, H2O, RT, 2 h, 94%; ii) 8 eq. BnBr, 4 
eq. Ag2O, Et2O, RT, 3 days; iii) LiAlH4, THF, 0 °C, 20 min. 
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Thermolysis of dioxinone 10 in the presence of benzyl-protected erythritols 252a and 
252b, gave the triketo-esters 253a and 253b respectively. 1H-NMR analysis in CDCl3 
showed that these compounds exist as a complex mixture of both keto and enol 
tautomers. Aromatisation, followed by hydrogenolysis of the benzyl groups, gave 
compound 244 (X-ray Figure 18, Appendix 3) and (+)-montagnetol (2) respectively 
via esters 254a and 254b correspondingly (Scheme 85). The optical rotations of 
compounds 244, (2S,3R) and 2, (2R,3S) were [α]20D = -10.1 (acetone, c = 0.5) and 
[α]20D = +11.0 (acetone, c = 0.4) respectively. These data were compared with those 
of the isolated natural (+)-montagnetol [α]20D = +12.6 (acetone).111 
 
 
 
Scheme 85. Reagents and Conditions: i) PhMe, 110 °C, 5 h; ii) Cs2CO3, MeOH, RT, 1 h then 
aq. HCl (1M), RT, 15 min; iii) Pd/C, H2, EtOAc, RT, 6 h. 
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Figure 18. X-ray of (2S,3R)-(-)-montagnetol (224). 
 
The two enantiomers of montagnetol, 244 and 2, were evaluated by chiral HPLC 
analysis to confirm their enantiomeric purity (Appendix 4). The examination of their 
optical rotations, compared with the natural product, showed that the compound 2 
(2R,3S) had the true configuration. Natural product (+)-montagnetol is (2R,3S)-2,3,4-
trihydroxybutyl 2,4-dihydroxy-6-methylbenzoate. 
 
3.3 Total Synthesis of (+)-Erythrin 
Reaction between dioxinone 10 and phenol 254b at 110 °C failed to give the 
corresponding aryl triketo-ester 255. Only the starting material 254b and the 
compound 256 were recovered, indicating that phenol 254b was of insufficient 
nucleophilicity (Scheme 86). 
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Scheme 86. Reagents and Conditions: i) PhMe, 110 °C, 53% of 256. 
 
Based on this result, we undertook a control reaction which showed that thermolysis 
of dioxinone 10 in toluene gave the pyrone 256 in 68% yield (Scheme 87). This 
unprecedented strategy to build 4-hydroxy-6-(2-oxopropyl)-2H-pyran-2-one (256) 
could be a flexible method to synthesise pyrones and the natural product elasnin 
(257)121 which is a specific inhibitor of human leukocyte elastase, an important 
enzyme in the pathology of inflammatory diseases such as pulmonary emphysema.122 
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Scheme 87. Reagents and Conditions: i) PhMe, 110 °C, 68%. 
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Consequently, another strategy was investigated, starting from resorcylate 15* which 
underwent an esterification reaction with phenol 254a under basic conditions to afford 
diesters 258 in 34% yield. The yield of this step was too low for a scale up, therefore 
another method was also investigated (Scheme 88).  
 
 
 
Scheme 88. Reagents and Conditions: i) DMF, NaH, 100 °C, 38%. 
 
A more classical approach was applied, starting from the protected orsellinic acid 
240,113 which underwent an esterification reaction with phenol 254a or 254b using 
activation with trifluoroacetic anhydride123 to provide the diesters 259a and 259b 
respectively. Debenzylation by hydrogenolysis afforded 248 and 4 respectively 
(Scheme 89). The optical rotations of compounds 248, (2S,3R) and 4, (2R,3S) 
(Appendix 5) were [α]20D = -8.2 (MeOH, c = 0.2) and [α]20D = +9.0 (MeOH, c = 0.2) 
respectively. These data were compared with those of the isolated natural (+)-erythrin, 
kindely provided by Prof. V. Karunaratne, [α]20D = +7.3 (MeOH, c = 0.2).  
 
                                                 
*
 A synthesis of resorcylate 15 from diketo-dioxinone 10 will be described in chapter 4. 
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Scheme 89. Reagents and Conditions: i) TFAA, PhMe, RT, 2 h; ii) Pd/C, H2, EtOAc, RT, 6 h. 
 
Both enantiomers of (_)-erythrin (248) and (+)-erythrin (4) were compared with an 
authentic sample of the natural product by chiral HPLC analysis (Appendix 6). This 
was fully consistent with the natural product 4 having the (2R,3S) stereochemistry. 
The natural product (+)-erythrin is 3-hydroxy-5-methyl-4-(((2R,3S)-2,3,4-
trihydroxybutoxy)carbonyl)phenyl 2,4-dihydroxy-6-methylbenzoate. 
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3.4 Conclusions  
In conclusion, we have reported a highly convergent strategy to built orsellinate 
natural products. This strategy is rapid and higher yielding than the commonly used 
syntheses of these natural products, which use readily available resorcylic ester 
derivates as starting materials.113 We also described the synthesis of both enantiomers 
of montagnetol and erythrin, allowing assignment of their absolute stereochemical 
configuration (Scheme 90).86 
 
 
 
Scheme 90. Overview of montagnetol and erythrin syntheses. 
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CHAPTER FOUR:  
HETEROAROMATIC  
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4.1 Investigation towards the Synthesis of Polysubstituted 
Aromatics 
4.1.1 Synthesis of benzodioxinones 
In section 2.2.4, an unexpected side reaction was reported from keto-dioxinone 197. 
Under basic conditions, this compound aromatised readily to afford benzodioxinone 
198 in good yield (Scheme 91). 
 
 
 
Scheme 91. Reagents and Conditions: i) 3 eq.Et3N, THF, reflux, 8 h, 82 %. 
 
These interesting observations led to the pursuit of a plausible mechanism to explain 
the formation of 198. Diketo-dioxinone 10 was used as a model system to study this 
reaction. Compound 10 was obtained on a gram scale through the synthetic pathway 
reported in section 2.2.1.7. The screen identified triethylamine as the reagent of choice 
(Scheme 92, Table 11, entry 6), giving resorcylate 15 in 96% yield. Neither p-
toluenesulfonic acid (Scheme 92, Table 11, entry 1) nor acetic acid (Scheme 92, Table 
11, entry 2) showed evidence of aromatisation. These results confirmed that 
intermediate 10 was stable under acidic conditions at room temperature. However, 
under basic conditions dioxinone 10 was quickly converted into ester 15 (Scheme 92, 
Table 11, entries 4-8). Interestingly, using the secondary amine, morpholine, led to a 
full recovery of starting material, whereas with DABCO, diketone 10 was consumed 
(Scheme 92, Table 11, entries 3-4). 
 
 105 
O
O O O O
10 15
OO
O
HO
i
 
 
Scheme 92. Reagents and Conditions: i) conditions see table 11. 
 
Entry Reagents and conditions Result 
1 p-TSA (excess), THF, RT, 5 h S.M. 
2 AcOH (excess), THF, RT, 5 h S.M. 
3 Morpholine (excess), CH2Cl2, RT, 5 h S.M. 
4 DABCO (excess), CH2Cl2, RT, 5 h 79% of 15 
5 DMAP (excess), CH2Cl2, RT, 5 h 95% of 15 
6 Et3N (excess), CH2Cl2, RT, 5 h 96% of 15  
7 Cs2CO3 (excess), THF, RT, 5 h 43% of 15 
8 NaOH aq (excess), THF, RT, 5 h
 
64% of 15  
 
 
Table 11. Different reaction conditions tested to afford intermediate 15. 
 
The mechanism of this reaction is a base-catalysed aldol-type reaction also named the 
Knoevenagel condensation.124 Upon deprotonation with triethylamine, 10 gave 
reactive intermediate 260 which can form β-hydroxydicarbonyl 261. Dehydration of 
alcohol 262 affords product 15 (Scheme 93). 
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Scheme 93. Proposed mechanism for the aromatisation reaction of resorcylate 15. 
 
4.1.2 Synthesis of polysubstituted benzodioxinones 
With these encouraging results in hand, experiments towards the synthesis of more 
complex products were conducted. To this extent, the effect of basic media on allyl 
ester 174 (section 2.2.1.5) was investigated. To our delight, aromatic 263 was isolated 
in a excellent yield when 174 was mixed with triethylamine (Scheme 94).  
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Scheme 94. Reagents and Conditions: i) Et3N, CH2Cl2, RT, 90 min, 98 %. 
 
According to Danishefsky et al.,125 the acetal of resorcylate 265 can also be viewed as 
an activated ester and consequently can perform transesterification reactions. Thus, 
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this strategy could be an efficient way to synthesise diesters 264 in which functional 
groups R1, R2, R3 and R4 can be different (Scheme 95). 
 
 
 
Scheme 95. Synthetic strategy to build functionalised diesters 264. 
 
4.1.3 Synthesis of polysubstituted benzodioxinone via a Keck 
macrolactonisation 
A similar compound 266 was formed in a different fashion from acid 170 (section 
2.2.1.4). A Keck macrolactonisation49 afforded novel species 266 in good yield 
(Scheme 96). 
 
HO O
O O O
170 266
OO
O
OH
i
 
 
Scheme 96. Reagents and Conditions: i) DCC, DMAP, CH2Cl2, 40 °C, 5 h, 86 %. 
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4.2. Investigations towards the Synthesis of Bicyclic and 
Heteroaromatic Compounds 
4.2.1 Attempted synthesis of pyridinones 
After the success of the previous approaches to build polysubstituted aromatics, we 
deemed to establish a new strategy to construct bicyclic frameworks and 
heteroaromatics from intermediates diketo-dioxinone 273. 
 
Initially, we hoped to synthesise pyrazolopyridinone 267, isoxazolopyridinone 268 
and isothiazolopyridinone 269 derivatives from pyrazol 270, isoxazol 271 and 
isothiazol 272 intermediates following the retrosynthetic pathway described in scheme 
97. The nucleophilic reagent would have to be added to a solution containing 
dioxinone 273 at high temperature (Scheme 97). 
 
 
 
Scheme 97. Synthetic strategy to build respectively pyrazolopyridinone 267, 
isoxazolopyridinone 268 and isothiazolopyridinone 269 derivatives. 
 
Before attempting the in situ trapping with diketone 10, reagents were first tested on 
the commercially available dioxinone 8. Treatment of compound 8 with N-
hydroxylphthalimide (274) gave the moderately stable hydroxamate 275.* In addition, 
in order to test the reactivity of dioxinone with amines, thermolysis of intermediate 8 
with N,O-dimethylhydroxylamine (276) or hydrazine (278) afforded respectively the 
                                                 
*
 Hydroxamate 275 decomposed completely at room temperature after 8 h. 
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known acetoacetamide 277126 and methyl-pyrazolone 279127 in good yields (Scheme 
98).  
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Scheme 98. Reagents and Conditions: i) PhMe, 90 °C, 90 min, 43 %; ii) PhMe, 90 °C, 7 h, 99 
%; iii) PhMe, 110 °C, 8 h, 62 %. 
 
Taking these results into account, studies were initiated to investigate the effect of 
these reagents to diketo-dioxinone 10. Initial explorations were directed towards the 
reaction of N-hydroxylphthalimide (274) with the highly electrophilic ketene 
generated from thermolysis of dioxinone 10 at 90 °C. This reaction was also tested 
using N-aminophthalimide (280) as a nucleophile (Scheme 99). Disappointingly, the 
desired products were not detected by 1H-NMR spectroscopy. Compounds 281 and 
282 seemed to be unstable intermediates. Consequently, another strategy was 
developed. 
 
 
Scheme 99. Reagents and Conditions: i) PhMe, 90 °C, 60 min. 
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4.2.2 Towards the synthesis of bicyclic framework 283 
According to the chemical literature, it is well known that acylketene 82 (formed in 
situ, via thermolysis of dioxinone 8) can perform a hetero-Diels-Alder reaction with a 
wide range of dienophiles.65 Inspired by this appealing property of dioxinone 8, it was 
deemed to form bicyclic framework 283 from diketo-dioxinone 10 and dienophile 285 
via a hetero-Diels-Alder reaction followed by a basic treatment to aromatise 
intermediates 284 following the method reported in section 4.1.1 (Scheme 100). 
 
 
 
Scheme 100. Retrosynthetic analysis of aromatic 283. X1 can be -C=, =C=, -C≡ and X2 can 
be C, N, O, S. 
 
Initially, treatment of dioxinone 8 with cyanamide 286, nitrile 287 or 
phenylmethanamine 290 gave respectively amine 288, the known diethylamine 289128 
and oxazinone 291129. However, when diketo-dioxinone 10 was treated with any one 
of those reagents (cyanamide 286, nitrile 287 or phenylmethanamine 290), 
decomposition of the starting material 10 was observed at 80 °C and no desired 
products 292 or 293 or 294 were detected (Scheme 101). The failure of these 
experiments led us to conclude that the ketone moieties in compound 10 might 
interfere in the course of the reaction.  
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Scheme 101. Reagents and Conditions: i) PhMe, 90 °C, 12 h, 99 %; ii) PhMe, 90 °C, 5 h, 41 
%; iii) PhMe, 80 °C, 5 h. 
 
Although the synthesis of pyrazolopyridinone 267 or compounds 283 via 
ketodioxinone 10 was attractive in terms of convergence and overall efficiency, it was 
ultimately proved flawed due to the inherent reactivity of the ketones in compound 10. 
This synthetic venture was therefore abandoned in favour of other approaches. 
 
4.2.3 Synthesis of pyrazolopyridine 20 
Instead of executing a thermolysis of the dioxinone group during the first stage, it was 
decided to build dioxinone 295 by functionalising the ketone motifs and then opening 
up the dioxinone (Scheme 102).  
 112 
 
 
Scheme 102. Retrosynthetic analysis of dioxinone 295. X1 and X2 can be C, N, O or S. 
 
Diketone 10 was selectively converted to dihydro-isoxazole 296 in high yield by 
treating with hydroxylamine hydrochloride. Trifluoroacetic acid promoted 
dehydration to afford isoxazole 297 (Scheme 103).  
 
 
 
Scheme 103. Reagents and Conditions: i) hydroxylamine hydrochloride, pyridine, RT, 5 h, 
89 %; ii) TFA, CH2Cl2, RT, 8 h, 77 %. 
 
An examination of the literature revealed that in 1988 Chiarino and co-workers 130 
reported the synthesis of isoxazolo-pyridinol 299 from isoxazole 298 in 56% yield. 
The nucleophilicity of the isoxazole ring as well as an appropriate temperature 
appeared to be sufficient to achieve the ester addition (Scheme 104).  
 
 
 
Scheme 104. Synthesis of isoxazolo-pyridinol 299 by Chiarino and co-workers. 
 
In view of the success of these results, dioxione 297 was refluxed for one hour in 
order to obtain isoxazole 300 (Scheme 105). However, a complex polymer was 
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obtained and no starting material was recovered. Thus, this synthetic strategy was 
deemed unsuitable. 
 
 
Scheme 105. Reagents and Conditions: i) PhMe, 80 °C, 1 h. 
 
Although the previous method failed to deliver a heteroaromatic ring, synthesis of a 
pyrazole ring instead of an isoxazole offered a good alternative. Diketo-dioxinone 10 
was converted into pyrazole 301 using hydrazine in good yield (Scheme 106). The 1H-
NMR spectroscopy of dioxinone 301 in DMSO-d6 showed that the proton attached to 
the nitrogen atom was adjacent to the methyl group of the pyrazole, which was 
identified with N15 HMBC methods (see Appendix 7).  
 
 
 
Scheme 106. Reagents and Conditions: i) hydrazine, THF, RT, 5 h, 89 %. 
 
Having this key intermediate 301 in hand, thermolysis of the dioxinone was studied. 
At 90 °C, after two hours, starting material was consumed. 1H-NMR spectra 
interpretation was not trivial. Indeed heteroaromatic 20 can exist as a mixture of 
different tautomers (Scheme 107). The ratio of these tautomers varies from one 
deuterated solvent to another. With DMSO-d6 the ratio was found to be 15% of 20a, 
5% of 20b, 60% of 20c and 20% of 20d, while with deuterated methanol the ratio was 
found to be 40 % of 20a and 60 % of 20c. It should be noted that the 1H-NMR spectra 
in deuterated methanol was taken within 5 minutes of adding MeOD, some protons of 
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pyrazolopyridine 20 were interchanging with deuterium atom of the solvent after an 
extended period in MeOD. 
 
 
 
Scheme 107. Reagents and Conditions: i) 1.4 x 10-3 M, PhMe, 2 h, 90 °C, 92%. 
 
In the chemical literature, only one patent131 reported the synthesis of dihydroxy-
pyrazolo[1,5-a]pyridine 305 via pyrazole 303 and diethyl malonate 304. Intermediate 
305 was a precursor for the synthesis of nitrile 306 which was found to be MAPKAP-
K2 (mitogen-activated protein kinase activated protein kinase 2) inhibitor. They also 
reported that pyrazolo[1,5-a]pyridine derivative 306a, represented in scheme 108, 
exists in tautomeric forms 306b and 306c. 
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Scheme 108. Different tautomeric forms of pyrazolopyridine 306. 
 
The concentration of the solution was found to be an important factor for the reaction 
to proceed cleanly.  Indeed, if the reaction was carried out with a concentration of 3 x 
10-2 M (Scheme 109, Table 11, entries 1-3), a side product was formed which had 
twice the mass of product 20 minus the mass of water. This would correspond to a 
dimmer of 20 which undergoes dehydration. Thus, a program was initiated to find the 
adequate concentration and suppress the formation of the side product 307 (Scheme 
109, table 12). The ratio of pyrazolopyridine 20 and compound 307 was determined 
by UPLC-MS. The mechanistic pathway might proceed via a 6pi electrocyclic 
cyclisation. 
 
 
 
Scheme 109. Reagents and Conditions: i) see table 12. 
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Entry Reagents and conditions Result (Ratio 20:307) 
1 8.3 x 10-1 M, PhMe, 2 h, 90 °C 72:28 
2 3.5 x 10-1 M, PhMe, 2 h, 90 °C 87:13 
3 2.5 x 10-2 M, PhMe, 2 h, 90 °C >99:1 
4 1.1 x 10-3 M, PhMe, 2 h, 90 °C 92%* 
5 4.6 x 10-4 M, PhMe, 2 h, 90 °C 93%* 
6 2.6 x 10-3 M, PhMe, 30 min, 110 °C
 
98:2 
7 1 x 10-3 M, THF, 30 min, 130 °C, MW 91%* 
8 9.6 x 10-4 M, PhMe, sealed tube, 90 min, 90 °C  91%* 
 
 
Table 12. Different reaction conditions tested which led to intermediate 20 and its tautomers 
MW = microwave irradiation. 
 
In this study, the optimum concentration was found to be around 10-3 M (Scheme 109, 
Table 12, entries 4-5). At this concentration, only intermediate 20 was formed (see 
UPLC-MS Appendix 8). With a higher temperature, the formation of side product 307 
increased (Scheme 109, Table 12, entry 6). The use of microwave irradiation and a 
sealed tube speeded up the reaction (Scheme 109, Table 12, entries 7-8). The low 
concentration necessary to perform the reaction was an issue during scale up. At 
concentrations higher than 7 x 10-2 M, it was thought that the conformation of the 
highly electrophilic ketene 302 might also favour intermolecular trapping. Therefore, 
with the intention of building a transient activated ester from ketene 302, it seemed 
necessary to develop an alternative route.  
 
                                                 
*
 Isolated yield of 20 
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Thus, a program was initiated relying on the in situ formation of a mixed anhydride or 
benzotriazole derivative 308. The use of mixed anhydrides was an appealing avenue 
as the activated carboxylic anhydride would be formed readily and under mild 
conditions (Scheme 110, Table 13, entries 1-2). However, this tactic proved to be 
capricious and a large number a side products were formed according to UPLC-MS. 
Complex mixtures were also observed when benzotriazole was refluxed with pyrazole 
301 (Scheme 110, Table 13, entry 3).  
 
 
 
Scheme 110. Reagents and Conditions: i) see table 13. 
 
Entry Reagents and conditions Result 
1, X = OAc 3 x 10-3 M, AcOH, PhMe, 2 h, 110 °C Complex mixture 
2, X = OAc 2 x 10-3 M, AcOH, 2 h, 150 °C, MW Complex mixture 
3, X = Bt 4 x 10-3 M, BtH, THF, PhMe, 2 h, 90 °C Complex mixture 
 
 
Table 13. Different reaction conditions tested to form intermediate 20 and its tautomers. MW 
= microwave irradiation. 
 
Alternatively, dioxinone 301 was heated in methanol to afford the isolable 
acetoacetate 309 in 73% yield. This intermediate was then refluxed in acetic acid to 
give the desired pyrazolopyridine 20 in a good yield (Scheme 111). 
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Scheme 111. Reagents and Conditions: i) MeOH, PhMe, 90 °C, 5 h, 73 %; ii) AcOH, THF, 
80 °C, 5 h, 72 %. 
 
Any attempt to further functionalise pyrazolopyridine 20 and its isomers was found to 
be fraught with difficulties (Scheme 112, Table 14).  
 
 
 
Scheme 112. Reagents and Conditions: i) see table 14. 
 
Entry Reagents and conditions Result 
1, R = Bn BnBr, NaH, DMF, 0 to 20 °C, 5 h Complex mixture 
2, R = Me MeI, K2CO3, DMF, RT, 8 h Complex mixture 
3, R = TBS TBSCl, imidazole, CH2Cl2, RT, 2 h Complex mixture 
 
 
Table 14. Different reaction conditions to functionalise intermediate 20. 
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4.3. Conclusions 
In summary, we report a high yielding strategy to build polysubstitued resorcylates 15 
and 263 from diketo-dioxinones.86 This key building block is also utilised in the 
synthesis of bicylic frameworks as well as heteroaromatic 20 (Scheme 113). 
 
 
 
Scheme 113. Summary of the reactions developed in this chapter. 
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CHAPTER FIVE:  
DESCHLORO-POCHONIN H  
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5.1 Background on Pochonin H and Pochonin G  
Both Pochonin G (3) and Pochonin H (311) (Figure 19) were isolated from a culture 
broth of the fungus Pochonia chlamydosporia var. Chlamydosporia, obtained from a 
soil sample collected in Fujioka city, Tochigi Prefecture, Japan in 1994 by Shinonaga 
and co-workers.132 Biological assessment of pochonins G and H as hair-growth 
stimulants revealed interesting results. Pochonin G (3) shows an IC50 of 8.15 µM 
against WNT-5A expression. WNT-5A (wingless-type mouse mammary tumor virus 
integrations site family, member 5A) is a member of the WNT family which is 
important for intercellular signaling glycoproteins that regulate organ formation 
during the fetal stage. In addition, pochonin G (3) and H (311) display no cytotoxicity 
against dermal papilla cells. To date, there are no reported chemical syntheses of 
either pochonin G (3) or pochonin H (311). 
 
 
 
Figure 19. Pochonin G and H. 
 
5.2 Retrosynthetic Analysis 
We first planned to undertake the total synthesis of pochonin H (311). Our 
retrosynthetic analysis was based on previous work carried out during the total 
synthesis of (S)-zearalenone (6).77 Pochonin H (311) could be obtained in the final 
step via RCM. The aromatic ring could be constructed by an in situ acylketene 
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trapping with the commercially available alcohol 18 followed by an aromatisation 
reaction. Diketo-dioxinone 312 should be available from the electrophilic addition of 
keto-dioxinone 16 with Weinreb amide 17 (Scheme 114). 
 
 
 
Scheme 114. Retrosynthetic strategy for the construction of pochonin H (311). 
 
5.3 Towards the Synthesis of Pochonin H 
5.3.1 Synthesis of Weinreb amide 17 
5.3.1.1 Towards the Synthesis of Weinreb amide 17: using an Arndt-Eistert 
homologation 
It was first envisaged that Weinreb amide 17 could be synthesised using an Arndt-
Eistert homologation133 from commercially available furan 315 followed by a Stille 
cross-coupling of bromide 314 to give allyl furan 313.134,135 A simple functional group 
interconversion can provide the desired Weinreb amide 17 (Scheme 115). 
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Scheme 115. Retrosynthetic strategy for the construction of Weinreb amide 17. 
 
Treatment of acid 315 with thionyl chloride followed by addition of diazomethane 
gave α-diazo ketone 316. However, when intermediate 316 was treated with silver 
oxide or silver benzoate with triethylamine in methanol, the Wolff rearrangement did 
not occur (Scheme 116).  
 
 
 
Scheme 116. Reagents and Conditions: i) SOCl2, CH2Cl2:PhH 1:10, 0 °C, 5 h; ii) TMSCH2N2, 
Et2O, RT, 1 h, 87%; iii) ArCO2Ag or AgO, Et3N, MeOH, RT, 5 h. 
 
An alternative strategy was to perform the Stille cross-coupling first and then do the 
homologation reaction. Diazomethane was used to synthesise methyl ester 317 from 
acid 315. Successful reaction of bromo-furan 317 with allyltributylstannane (318) was 
accomplished in DMA at 90 °C, using tetrakis(triphenylphosphine)palladium(0) to 
give ester 319 in 64% yield. Saponification of the resulting allyl-furan with lithium 
hydoroxide in methanol gave acid 320. However, Arndt-Eistert homologation again 
failed to provide ester 313 (Scheme 117). 
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Scheme 117. Reagents and Conditions: i) TMSCH2N2, Et2O, RT, 2 h, 99%; ii) 318, 
Pd2(PPh3)4, DMA, 90 °C, 16 h, 64%; iii) LiOH.H2O, MeOH, RT, 5 h, 62%; iv) SOCl2, 
CH2Cl2:PhH 1:10, 0 °C, 5 h; then TMSCH2N2, Et2O, RT, 1 h, 87%; v) ArCO2Ag, Et3N, 
MeOH, RT, 5 h. 
 
5.3.1.2 Towards the Synthesis of Weinreb amide 17: using a homolgation via 
nitrile strategy 
We then investigated another way to perform the homologation, using a three step 
procedure.136 The synthesis of acid 322 started with the reduction of ester 319 with 
LiAlH4 to afford alcohol 321 in 91% yield. Sequential mesylation and nucleophilic 
substitution with sodium cyanide followed by nitrile hydrolysis gave acid 322 in 8 % 
yield over three steps (Scheme 118).  
 
 
 
Scheme 118. Reagents and Conditions: i) LiAlH4, THF, 0 °C, 10 min, 91%; ii) MsCl, Et3N, 
CH2Cl2, 0 °C, 30 min; iii) NaCN, DMF, 85 °C, 6 h; iv) NaOH (25%), EtOH, reflux, 7 h (8 %, 
3 steps). 
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5.3.1.3 Towards the Synthesis of Weinreb amide 17: from furanyl acetate 323 
The overall yield of the previous approach was less than 8%. Therefore an alternative 
strategy was developed, based on the direct synthesis of furanyl acetate 323. We first 
attempted the direct formation of tert-butyl furanyl acetate 323 from furan (324) and 
tert-butyl bromoacetate (325) (Scheme 119). 
 
 
 
Scheme 119. Retrosynthetic strategy for the construction of furanyl acetate 325. 
 
Unfortunately, deprotonation of furan (324) in the 2’ position, followed by addition of 
tert-butyl bromoacetate (325) at low temperature, gave ketone 326 in 63% yield 
(Scheme 120). 
 
 
Scheme 120. Reagents and Conditions: i) n-BuLi, (i-Pr)2NH, then 325, THF, -78 °C, 6 h, 
63%. 
 
5.3.1.4 Towards the Synthesis of Weinreb amide 17 via a radical coupling 
Whilst investigating strategies to build the substituted furan, we found a procedure137 
from 1992 by Baciocchi et al. describing an efficient way to synthesise furanyl-acetate 
in one step using a radical coupling. The reaction was carried out using ethyl 2-
iodoethanolate (327), 0.5 equivalents of iron (II) sulfate heptahydrate, 18 equivalents 
of furan (324) and 1.9 equivalents of hydrogen peroxide in DMSO at room 
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temperature for three hours. Ethyl 2-(furan-2-yl)ethanol (328) was obtained in 93% 
yield (Scheme 121).  
 
 
 
Scheme 121. Synthesis of furanyl acetate 328 by Bacioccchi. 
 
The proposed mechanism by Baciocchi and co-workers starts with the redox 
decomposition of hydrogen peroxide by the iron (II) salt 329, known as Fenton's 
chemistry138 (Scheme 122, equation 1). The hydroxyl radical formed 330, reacts 
quickly with DMSO 333, used as a solvent to afford radical 334 (Scheme 122, 
equation 2). The radical adduct of DMSO, 334 undergoes a fast, β-scission (Scheme 
122, equation 3) to form methyl radical 335. The key step of this procedure is the 
iodine abstraction by the methyl radical 335 from the alkyl iodide 327 (Scheme 122, 
equation 4) to give iodomethane and radical 338.139,140 The rate of this reaction is 
higher than most of the other possible competitive reactions of the methyl radical, and 
the rate constant is also strongly affected by the stability of the alkyl radical  formed, 
338 which is stabilized by the electron-withdrawing group in its α-position.141 
Consequently this ambiphilic carbon-centered radical 338 can be utilized for the 
oxidative homolytic substitution of electron-rich aromatic furan (324) to give desired 
compound 328 (Scheme 122, equation 5 and 6).142,143 
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Scheme 122. Mechanism for the synthesis of furanyl acetate 328. 
 
Reagents quantities had to be optimized by Baciocchi and co-workers to minimize 
side reactions. DMSO, 333, which reacts with hydroxyl radical 330, is used as a 
solvent in order to reduce the fast and competitive reduction of the hydroxyl radical by 
the Fe(II) salt 329 (Scheme 123, equation 7) as well as the reaction with alkyl iodide 
327 to give 340 (Scheme 123, equation 8). The Fe(II) salt, which is a catalyst (Scheme 
123, consumed in equation 1 and regenerated in equation 6), is in fact used as 0.5 
equivalents; this is due to the fact that a certain amount of it is consumed in 
termination steps (Scheme 123, equation 9 and 7). The amount of hydrogen peroxide 
utilized is larger than stoichiometric because it is also consumed in a partial amount in 
the oxidation of sulfinic acid (336) to sulfonic acid (341) (Scheme 123, equation 10). 
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Hydrogen abstraction from sulfinic acid (336) by the methyl radical 335 (Scheme 123, 
equation 11) also appears to be a significant side reaction (Scheme 123).142 
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Scheme 123. Possible side reactions. 
 
In addition, furan (324) is used in a large excess to obtain only mono-substitution. 
With less furan or a larger amount of alkyl iodide, formation of disubstituted product, 
(344) was observed (Scheme 124).142 
 
 
 
Scheme 124. Side reaction occurring with less furan or more of alkyl iodide. 
 
Following Baciocchi’s procedure, ester 328 was furnished in 98% yield, and used as 
the starting material to build Weinreb amide 17. Reduction of functionalized furan 
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328 led to alcohol 345 in 93% yield. In order to introduce a chain at the 5’ position of 
functionalized furan 345, another Baciocchi radical coupling was performed following 
an improved synthetic procedure developed by Neier et al.144 to give the known ethyl 
ester 346 in 75% yield. The moderate yield is due to the fact that not all of the alkyl 
iodide was consumed during the reaction. Alcohol 346 was then oxidized with DMP 
to afford aldehyde 347 in 98% yield. Having this intermediate in hand a Wittig 
olefination reaction would have led to the desired allyl chain 349. However, treatment 
of 347 with the in situ formed methylenetriphenylphosphorane (350) led to 
decomposition and was attributed to the base sensitivity of intermediate 347. 
Aldehyde 347 only performed a clean Wittig reaction145 with (tert-
butoxycarbonylmethylene) triphenylphosphorane (348). Given the difficulties 
associated with the last step in this sequence, this route was deemed unsuitable for a 
scale up synthesis and consequently was abandoned (Scheme 125). 
 
 
 
Scheme 125. Reagents and Conditions: i) FeSO4, 7H2O, H2O2, DMSO, RT, 8 h, 98%; ii) 
LiAlH4, THF, 0 °C, 1.5 h, 93%; iii) FeSO4, 7H2O, H2O2, DMSO, RT, 8 h, 75%; iv) DMP, 
CH2Cl2, RT, 20 min, 98%; v) 348, THF, -78 °C, 1 h, 52%. 
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5.3.1.5 Synthesis of Weinreb amide 17 via a Stille coupling 
Baciocchi and co-workers have only reported the used of iodo-esters or iodo-nitriles 
as radical precursors for the homolytic substitution reaction of furan (324). Therefore 
we decided to directly use 2-iodo-N-methoxy-N-methylacetamide (352) as an 
alternative coupling partner. This intermediate was made from the commercially 
available 2-chloro-N-methoxy-N-methylacetamide (351) via a Finkelstein146 reaction. 
To our delight, the radical coupling still worked with Weinreb amide 352, using the 
same conditions as previously described. The introduction of the allyl group at the 5’ 
position of the 2-substituted furan 353 was first attempted using two equivalents of 
LiHMDS or t-BuLi, followed by addition of allylbromide (189). However, this initial 
approach was unsuccessful; only intermediate 354 was obtained in good yield 
(Scheme 126). 
 
 
 
Scheme 126. Reagents and Conditions: i) NaI, acetone, RT, 8 h, 98%; ii) FeSO4,7H2O, H2O2, 
DMSO, RT, 8 h, 98%; iii) 2 eq. LiHMDS, 189, THF, -78 °C, 1 h, 36%. 
 
A second approach was investigated using a Stille coupling as the key step. Treatment 
of Weinreb amide 353 with a brominating agent did not selectively functionalise the 
furan at the 5’ position. The α-position of the amide 353 was more reactive toward N-
bromosuccinimide, consequently two equivalents of brominating agent were added at 
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low temperature to functionalize both the α-position of the amide and the 5’ position 
of the furan. In order to get the monobromo-substituted furan 357, a simple 
Reformatsky147 type reaction was applied. A selective debromination of the α-
bromoamide was performed using zinc and acetic acid in THF. If the reaction was 
carried out in methanol, ether 356 was formed in 84% yield (Scheme 127).  
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Scheme 127. Reagents and Conditions: i) NBS, CH2Cl2, -78 °C to 0 °C, 8 h, 79%; ii) Zn, 
AcOH, MeOH, RT, 1 h, 84%; iii) Zn, AcOH, THF, RT, 1 h, 63%. 
 
Having intermediate 357 in hand, a Stille coupling was attempted using 1.5 
equivalents of allyltributylstannane (318) and 0.1 equivalent of 
tetrakis(triphenylphosphine)palladium(0) in DMA at 90 °C (Scheme 128, Table 15, 
entry 1). However, reduced furan 353 was observed in a 25% ratio, starting material 
357 in a 10% ratio and desired allyl substituted furan 17 in a 65% ratio. Although the 
formation of furan 357 was acceptable, purification was difficult due to impossible 
separation from 353. Therefore improvements to the Stille coupling reaction were 
investigated (Scheme 128, Table 15). It should be noted that formation of des-
brominated furan was not observed when the Stille coupling was performed with furan 
317. Different hypothesis were then investigated. We first added an excess of cesium 
carbonate to deprotonate the α-position of the amide to attempt to avoid this side 
reaction (Table 15, entry 2). Unfortunately no improvements were observed. We then 
thought to add a phosphine ligands. As far as we know, no Stille coupling reaction has 
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been performed in the literature using phosphine ligands such as X-Phos (359), tBu-
X-Phos (360) or Xantphos (361). 
 
 
 
Scheme 128. Reagents and Conditions: i) conditions see Table 15. 
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Entry Reagents and conditions Result 
1 
318, Pd2(PPh3)4 (5 mol%),  
DMA, 90 °C, 20 h 
25% of 353, 10% of 357,  
65% of 17* 
2 
318, Pd2(PPh3)4 (5 mol%), Cs2CO3 
DMA, 90 °C, 20 h 
21% of 353, 12% of 357, 
67% of 17* 
3 
318, Pd2dba3 (10 mol%), 359 (30 mol%),  
DMA, 90 °C, 8 h 
67% of 17† 
4 
318, Pd2dba3 (10 mol%), 360 (30 mol%),  
DMA, 90 °C,  8h 
70% of 17†  
5 
318, Pd2dba3 (10 mol%), 361 (30 mol%),  
DMA, 90 °C, 8 h 
67% of 17†  
6 
318, Pd2dba3 (3 mol%), 360 (9 mol%),  
DMA, 90 °C, 8 h 
69% of 17†  
 
 
Table 15. Different reaction conditions tested on 358. 
 
To our delight, using these ligands suppressed the formation of reduced furan 353 and 
increased the rate of the reaction (Table 15, entries 3-6). Optimal conditions used 3 
mol% of bis(dibenzylideneacetone)palladium(0) and 9 mol% of tBu-X-Phos (360) to 
give allyl furan 17 in 69% yield (Table 15, entry 6).  
 
Having Weinreb amide 17 in hand, synthesis of diketo-dioxinone 312 was possible 
using a C-acylation reaction. This strategy has already been discussed in chapter 2.83 
Treatment of keto-dioxinone 16 with lithium di-iso-propylamide at –78 °C gave 
                                                 
*
 Ratio determined by analysis of the 1H NMR of the crude material. 
†
 Isolated yield. (no furan 353 and 357 observed) 
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dianion 362, followed by addition of Weinreb amide 17 at –40 °C provided the 
required diketo-dioxinone 312 in 63% (Scheme 129). 
 
 
 
Scheme 129. Reagents and Conditions: i) LDA (2eq.), THF, -78 °C to -40 °C; ii) 17, THF, -
40 °C, 1 h, 63%. 
 
5.3.2 Synthesis of deschloro-pochonin H 
5.3.2.1 First synthesis of deschloro-pochonin H via ring closing metathesis 
Having successfully made key intermediate 312, our attention was then focused on the 
already optimized reaction involving the formation of the aromatic ring. Thermolysis 
of the keto-dioxinone 312 and in situ trapping of the triketo-ketene 363 with alcohol 
18 gave triketo-ester 364. This intermediate was smoothly aromatized with cesium 
carbonate followed by an acid work-up86 to provide the resorcylate 365 in good yield 
(78%) (Scheme 130). Subsequent ring closing metathesis in toluene (10-3 M) using the 
second generation Hoveyda-Grubbs catalyst 223 led to intermediate 366 in 8% yield 
(Scheme 130, Table 16, entry 1). GCMS analysis indicated that 84% of the starting 
material has dimerised. The reaction was carried out at a lower concentration of 10-6 
M (Table 16, entry 2). However, even at this dilution, only 12% of the desired 
resorcylate 366 was isolated. We suspected the intramolecular hydrogen bond 
between the ester of the resorcylate and the adjacent phenolic proton on intermediate 
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365 to be responsible for this unexpected result. It was thought that the hydrogen 
bonding aligned the ester group with the aromatic ring and consequently decreased the 
flexibility of the upper olefin, resulting in a difficult intramolecular metathesis with 
the allylic group. In order to break the undesired hydrogen bond, the ring closing 
metathesis was tested with addition of titanium isopropoxide148 or lithium bromide 
(Table 16, entries 3 and 4). However, only a relative improvement was observed with 
lithium bromide (Table 16, entry 4). To avoid the need for a phenolic protecting group 
our strategy needed to be changed. 
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Scheme 130. Reagents and Conditions: i) 18, PhMe, 110 °C, 1 h; ii) Cs2CO3, MeOH, RT then 
HCl 1M, 78%; iii) see Table 16. 
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Entry Reagents and conditions Result* 
1 223 (10 mol%), PhMe (10-3 M), 110 °C, 5 h 8% of 366 
2 223 (10 mol%), PhMe (10-6 M), 110 °C, 5 h 12% of 366 
3 223 (10 mol%), PhMe (10-3 M), Ti(iPrO)4, 110 °C, 5 h Decomposition 
4 223 (10 mol%), PhMe (10-3 M), LiBr, 110 °C, 5 h 15% of 366 
 
 
Table 16. Different reaction conditions tested to synthesis deschloro-pochonin H (366). 
 
5.3.2.2 New strategy via an intramolecular trapping of the ketene 
Barrett and Miyatake-Ondozaba have recently developed a new biomimetic strategy to 
synthesise the natural product zearalenone (6) using an intramolecular ketene-trapping 
procedure (Scheme 131).149 
Reaction between dioxinone 8 and benzotriazole intermediate 367 with zinc chloride 
gave diketo-dioxinone 368 in 63% yield. The presence of the Lewis acid, zinc 
chloride, was reported essential to achieve a selective C-acylation in a good yield. 
Cross metathesis of diketo-dioxinone 368 and alcohol 13 (Chapter 2) using second 
generation Grubbs catalyst 227, proceeded in good yield with a E/Z ratio of 20/1. 
Subsequent thermolysis of 369 in toluene (4 x 10-2 M) generated ketene 370, which 
performed an intramolecular trapping reaction to give cyclic diketo-ester 371. Ketal 
deprotection then gave triketo-ester 7 which underwent aldol condensation under basic 
conditions followed by elimination of water under acidic conditions to afford (S)-
zearalenone (6) in 46% yield over four steps (Scheme 131). 
 
                                                 
*
 Isolated yields. 
 137 
 
 
Scheme 131. Synthesis of zearalenone by Barrett and Miyatake-Ondozaba. 
 
Inspired by this work, our new strategy was based on the formation of key 
intermediate 372. Cross-metathesis of diketo-dioxinone 312 with unprotected alcohol 
18 using the second generation Hoveyda-Grubbs catalyst (223) gave alcohol 372 with 
a good Z:E selectivity (1:9, Z:E) (Scheme 132). This step is, as far as we know, the 
first reported metathesis reaction performed on an unprotected diketo-ester. Upon 
heating, diketo-dioxinone 372 underwent a retro Diels–Alder reaction and generated a 
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triketo-ketene which was trapped intramolecularly by the unprotected alcohol to make 
the cyclic triketo-ester 373 (confirmed by 1H-NMR) (Scheme 132). Subsequent basic 
and acid treatments to perform the aromatization were unsuccessful and no desired 
product 366 was formed. It was thought that during the basic treatment, the ester and 
the adjacent ketone could have chelated the counter cation as they were aligned in the 
same plane. This conformation was similar to the one previously described, 
preventing the ring closing metathesis. Therefore under basic conditions, the 
conformation of the 17- membered macrocyclic lactone 373 was thought to prevent 
the aldol reaction from occuring. The presence of the furan might also rigidify the 
intermediate 373 backbone. Thus it was postulated that in its biosynthesis, synthesis of 
the furan might occur after the resorcylate formation.  
 
 
 
Scheme 132. Reagents and Conditions: i) 223, 18, CH2Cl2, 40 °C, 1 h, 61%; ii) PhMe (10-3), 
110 °C, 1 h; ii) Cs2CO3, MeOH, RT then HCl 1M. 
 
Treatment of diketo-dioxinone 372 with triethylamine gave benzodioxinone 374 in 
67% yield.86 However, attempted transesterification to form 366 under basic 
conditions failed (Scheme 133). 
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Scheme 133. Reagents and Conditions: i) Et3N, CH2Cl2, RT, 1 h, 64%; ii) NaH, THF, 60 °C, 
8 h. 
 
5.3.2.3 Improved synthesis of deschloro-pochonin H via a ring closing metathesis 
with a phenol protecting group 
All our attempts to generate product 366 via a protecting group free synthesis were not 
successful, therefore we decided to acetylate both phenols in resorcylate 365 and to 
hopefully suppress any undesired effects of the previously mentioned hydrogen bond. 
Treatment of intermediate 365 with acetic anhydride and DMAP gave acetylated 
compound 375 in good yield. Subsequent ring closing metathesis using the second 
generation Hoveyda-Grubbs catalyst 223 gave macrolactone 376 with a 1:3, Z:E ratio. 
The two diastereoisomeres were inseparable by column chromatography. 
Deprotection of the acetyl groups with sodium hydrogencarbonate afforded the (Z)-
descholoro-pochonin H (366) in a 68% isolated yield (scheme 134). 
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Scheme 134. Reagents and Conditions: i) Ac2O, DMAP, THF, RT, 70 min, 73%; ii) 223, 
PhMe, 90 °C, 2 h, 54%; iii) NaHCO3 aq., MeOH, RT, 14 h, 68%. 
 
The X-ray structure of compound 366 (Figure 20) confirmed the presence of a 
hydrogen bond between the sp3 oxygen of the ester and a phenolic proton. By NMR, 
the proton shift involved in the hydrogen bonding is 11.87 ppm for intermediate 365 
and 8.5 ppm for macrolactone 366 (scheme 134). We also notice that the aromatic ring 
and the ester of the resorcylate are not in the same plane. All those observations 
demonstrate that, even if compound 366 is a 13 membered ring, its macrolactone is 
strained and the conformation adopted does not place the ester group in the same 
plane as the aromatic ring, which was a necessary conformation to perform the 
intramolecular aldol reaction. A similar explanation can be made to interpret the 
unsuccessful ring closing metathesis with no phenol protecting group, indeed the 
hydrogen bond was locking the conformation of intermediate 365 in a position which 
was unable to adopt the deschloro-pochonin H (366) conformation (observed in the X-
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ray) and consequently was not able to perform the ring closure. To summarize, the X 
ray indicates the low probability of those reactions succeeding due to conformation 
restrictions. 
 
 
 
 
Figure 20. Crystal structure of deschloro-pochonin H (366). 
 
5.3.2.4 Towards the chlorination of deschloro-pochonin H 
Both natural products, pochonin G and H, contain a chlorine atom at the sixth position 
of the resorcylate ring. Introducing the chlorine atom in an early stage of the synthesis, 
even before the aromatization step, would have been a good idea since chlorination of 
resorcylates via electrophilic substitution is usually low yielding.150 Two strategies 
were tested. The first one was similar to the method previously described. First the 
Intramolecular hydrogen bond 
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known chloro keto-dioxinone 9053 was made from dioxinone 8 and chloroacetyl 
chloride (89). Treatment of 90 with lithium di-iso-propylamine at –78 °C followed by 
the addition of Weinreb amide 17 at –40 °C, failed to give the desired keto-dioxinone 
377 (Scheme 135).  
 
 
Scheme 135. Reagents and Conditions: i) LiHMDS, THF, -78 °C; ii) 89, THF, -78 °C to RT, 
8 h, 70%; iii) LDA (2eq.), THF, -78 °C to -40 °C; iv) 17, THF, -40 °C, 1 h. 
 
The second strategy was relying on the direct addition of chlorine to intermediate 312. 
Treatment of diketo-dioxinone 312 with sulfuryl chloride gave an unstable 
intermediate in low yield and any attempts at aromatization were unsuccessful 
(Scheme 136). Thus it was decided to introduce the chlorine atom later in the 
synthesis. 
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Scheme 136. Reagents and Conditions: i) SO2Cl2, CH2Cl2, -30 °C, 1 h; ii) isopropanol, sealed 
tube, 100 °C, 3 h. 
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Chlorination of the resorcylate ring was attempted on intermediates 365, 375 and 376 
using both sulfuryl chloride and NCS. However only decomposition was observed 
(Scheme 139). 
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Scheme 137. Reagents and Conditions: i) SO2Cl2, CH2Cl2, -30 °C, 1 h; ii) NCS, CH2Cl2, RT, 
1 h. 
 
 
Another attempt was performed using sulfuryl chloride in THF which led to 
intermediate 382 in 12% yield (Scheme 138, Table 17, entry 1). Adding a base such as 
sodium hydride (Table 17, entry 2) or 2-tert-butyl-1,1,3,3-tetramethylguanidine 
(Barton’s base) (Table 17, entry 3) or changing the chlorinating agent to N- 
chlorosuccinimide (Table 17, entries 4-5) did not change the selectivity. Addition of 
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m-CPBA to 366 gave resorcylate 382 in 72% yield (Table 17, entry 6). All treatments 
with chlorinating agents or peracids were leading to the opening of the furan to 
provide macrolactone 382 rather than effecting chlorination (Scheme 138). 
 
 
 
Scheme 138. Reagents and Conditions: i) conditions see Table 17. 
 
Entry Reagents and conditions Result 
1 SO2Cl2, THF, –30 °C to 0 °C, 90 min 12% of 382 
2 SO2Cl2, NaH, THF, –30 °C to 0 °C, 90 min S.M. 
3 
SO2Cl2, Barton’s base, THF, 
 –30 °C to 0 °C, 90 min 
S.M. 
4 NCS, THF, –30 °C to 0 °C, 90 min 6% of 382 
5 
NCS, Barton’s base, THF, 
 –30 °C to 0 °C, 90 min 
S.M. 
6 m-CPBA, CH2Cl2, RT, 1 h 72% of 366 
 
 
Table 17. Different chlorination conditions tested. 
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5.4 Conclusions 
In summary, we report the first synthesis of dechlor-pochonin H 366 in eleven steps 
with an overall yield of 4.5% (Scheme 138). Further applications of this strategy 
towards pochonin G are currently under investigation.  
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Scheme 139. Reagents and Conditions: i) NaI, acetone, RT, 8 h, 98%; ii) FeSO4, 7H2O, H2O2, 
DMSO, RT, 8 h, 98%; iii) NBS, CH2Cl2, -78 °C to 0 °C, 8 h, 79%; iv) Zn, AcOH, THF, RT, 1 
h, 63%; v) 318, Pd2dba3 (3 mol%), 360 (9 mol%), DMA, 90 °C, 8 h, 69%; vi) LDA (2eq), 
THF, -78 °C to -40 °C; vii) 350, THF, -40 °C, 1 h, 63%; viii) 18, PhMe, 110 °C, 1 h; then 
Cs2CO3, MeOH, RT then 1M HCl, 78%; ix) Ac2O, DMAP, THF, RT, 70 min, 73%; x) 223, 
PhMe, 90 °C, 2 h, 54%; xi) NaHCO3 aq., MeOH, RT, 14 h, 68%. 
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CHAPTER SIX:  
OVERALL CONCLUSIONS 
AND APPLICATIONS 
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To summarise, from the key building block diketo-dioxinone, we succeeded to 
synthesise a large variety of interesting compounds. We had access to the resorcylic 
acid lactones of which (S)-zearalenone (6) is a member. We performed the total 
synthesis of erythrin (4) and montagnetol (2) and assigned their absolute 
stereochemical configuration. We reported the construction of polysubstituted bicyclic 
frameworks (214 and 15) as well as heteroaromatic 20. Finally we synthesised 382 
and 366, derivates of a hair-growth stimulant pochonin G (3) (Figure 21). 
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Figure 21. Diketo-dioxinone, a key building block. 
 149 
In addition, we reported four efficient strategies to synthesise diketo-dioxinones. 
The first one using a Mukaiyama aldol reaction: 
 
 
 
The second one using allylester 156: 
 
 
 
The third one using Weinreb amide 178: 
 
 
 
And the fourth one using benzotriazole derivative 9: 
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In this thesis, we report a novel strategy to synthesise resorcylates from diketo-
dioxinones which underwent a retro-Diels-Alder reaction to generate triketo-ketenes. 
These highly reactive intermediates were trapped with alcohols to generate triketo-
esters. An aromatisation reaction was then performed under mild, optimised 
conditions in good yields. This methodology was then used within the Barrett group to 
synthesise natural products difficult to obtain via more conventional synthesis. 
 
Accordingly, Navarro reported the total synthesis of the marine antifungal agent 
15G256β (5) using this approach.77 Dioxinone 173 described in section 2.2.1.5, was 
heated in the presence of alcohol 383 to give triketo-ester 384. This intermediate 384 
was then aromatised to afford, after phenol group protection, resorcylate 385. A 
Yamaguchi esterification was then performed between the acid derived from ester 385 
via a deallylation and the alcohol derived from ester 385 via a selective desilylation to 
provide dimer 386. Subsequent deallylation-Yamaguchi esterification with alcohol 
383 gave the allyl ester 387 in 71% yield. Upon deallylation, desilylation followed by 
Yamaguchi lactonisation and debenzylation by hydrogenolysis gave the natural 
product 15G256β (5) (Scheme 140). 
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Scheme 140. Synthesis of 15G256β (5). 
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The intermolecular ketene generation, alcohol trapping and aromatisation process was 
also successfully utilised in the synthesis of ent-W1278A (177, n = 2), -B (n= 3), and -
C (n =4) by Poverlein and Navarro.83 For example, ent-W1278A (177) was obtained 
from the key resorcylate intermediate 389, which was achieved from diketo-dioxinone 
173 in 75% yield via an alcohol 388 trapping aromatisation. From intermediate 389, 
an iterative desilylation, mild ketene trapping followed by resorcylate formation was 
performed to obtain the oligo-ester 391 in 50% yield. Subsequent aromatisation-
hydrogenolysis gave carboxylic acid ent-W1278A (177, n = 2) in 60% (Scheme 141). 
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Scheme 141. Synthesis of ent-W1278A (177, n = 2).  
 
Within the Barrett group, Calo performed the total synthesis of aigialomycin D (38) 
using the intermolecular alcohol trapping-aromatisation strategy.151 He also compared 
two available syntheses to build diketo-dioxinone 393. Intermediate 393 was obtained 
in 81% yield using allyl ester 156 and acid chloride 392 whereas using keto-dioxinone 
16 and Weinreb amide 394 only gave 20% of diketone 393 due to the formation of 
1,4-addition products. Aigialomycin D (38) was obtained via a ring closing metathesis 
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followed by ketal deprotection in 79% yield over two steps from resorcylate 396 
(Scheme 142). 
 
 
 
Scheme 142. Synthesis of aigialomycin D (38). 
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CHAPTER SEVEN: 
EXPERIMENTAL  
 
 156 
General Procedures: 
All reactions were carried out in oven-dried glassware under N2 using solvents and 
reagents as commercially supplied, unless otherwise stated. Et2O, THF, PhMe, 
CH2Cl2, Et3N and MeOH were redistilled from Na-Ph2CO, Na-Ph2CO, Na, CaH2, 
CaH2 and Mg turnings–I2, respectively. Column chromatography was carried out on 
silica gel, particle size 40-63 µm, using flash techniques (eluants are given in 
parenthesis). Analytical thin layer chromatography was performed on pre-coated silica 
gel F254 glass plates with visualization under UV light or by staining using either 
acidic vanillin or anisaldehyde spray reagents.  
 
Melting points: obtained using a Reichert-Thermovar melting point apparatus and are 
uncorrected.  
Infrared spectra: obtained using a Mattson 5000 FTIR apparatus with automatic 
background subtraction. Indicative features of each spectrum are given with 
adsorptions reported in wavenumbers (cm-1).  
Proton magnetic resonance spectra (1H NMR): recorded at 400 MHz on Bruker 
DRX-400 spectrometers. All spectra are referenced to the residual solvent peak. 
Chemical shifts (δ) are quoted in parts per million (ppm) and coupling constants (J) 
recorded in Hertz (Hz).  
Carbon magnetic resonance spectra (13C NMR): recorded at 100 MHz on Brüker 
DRX-400 spectrometers, or at 125 MHz on an AM 500 spectrometer. Chemical shifts 
(δ) are quoted in ppm and referenced to the residual solvent peak. Spectra recorded at 
500 MHz (1H NMR) and 125 MHz (13C NMR) were carried out by the Imperial 
College Department of Chemistry NMR service or by the GSK NMR service.  
Gas chromatography mass spectrometry (GCMS): recorded on a Hewlett-Packard 
5890 series 2 gas chromatograph. Mass spectrometry: Low and high resolution mass 
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spectra (EI, CI) were recorded by Imperial College Mass Spectrometry Service using 
a Micromass Platform II and Micromass AutoSpec-Q spectrometer.  
Microanalysis: determined by the University of North London Analytical Service. 
Optical Rotations: recorded at 25 °C on a Perkin-Elmer 241 Polarimeter with a path 
length of 1 dm, using the 589.3 mn D-line of sodium. Concentrations (c) are quoted in 
g/100 mL. 
X-ray Diffraction: X-ray diffraction data were recorded by the Imperial College 
Department of Chemistry X-ray diffraction service. 
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Hydroxyundec-1-en-6-one (120)75  
 
 
 
To a suspension of magnesium powder (2.45 g, 101 mmol) in Et2O (100 mL) was 
added two crystals of iodine and the resultant mixture was sonnicated for 10 min and 
then heated to 60 °C at which point the reaction mixture turned from brown to 
colourless. 5-Bromo-1-pentene 118 (12.0 mL, 101 mmol) was added dropwise and 
after a further 1 h at 60 °C the reaction mixture was cooled to 25 °C. The resulting 
crude 4-pentenyl magnesium bromide 119 solution was transferred via canula to a 
solution of δ-hexanolactone 62 (13.3 g, 92.3 mmol) in THF (200 mL) at -78 °C, and 
the ensuing reaction mixture stirred for 2 h at that temperature before being quenched 
by addition of saturated aqueous NH4Cl (60 mL) and water (100 mL). The aqueous 
layer was extracted with Et2O (3 x 100 mL) and the combined organic extracts washed 
with H2O (2 x 50 mL) and dried (Na2SO4). Concentration in vacuo afforded alcohol 
120 (16.5 g) as a pale yellow oil which was used in the next step without purification: 
 
Rf  0.48 (EtOAc:hexanes, 1:1); IR (film) 3444, 1732, 1711, 1068 cm-1; 1H NMR (300 
MHz, CDCl3) δ 5.79−5.74 (m, 1H, H10), 5.04-4.96 (m, 2H, H11), 3.80−3.74 (m, 1H, 
H2), 2.48−2.39 (m, 4H, H5 and H7), 2.10−2.02 (m, 2H, H9), 1.99−1.39 (m, 6H, H3, H4 
and H5), 1.19 (d, J = 6.0 Hz, 3H, H1); 13C NMR (75 MHz, CDCl3) 
δ 211.3, 138.0, 115.2, 67.5, 42.6, 38.6, 33.1, 29.6, 23.4, 22.8, 19.7; MS (CI) m/z 185 
(M+H)+, 202 (M+NH4)+; HRMS (CI) calculated for C11H20O2: (M+H)+, 185.1542, 
found: 185.1546. 
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Acetic acid 1-methyl-5-oxodec-9-enyl ester (142) 
 
 
 
A mixture of alcohol 120 (5.0 g, 27.2 mmol), acetic anhydride (30 mL) and pyridine 
(30 mL) was heated to 60 °C. After 24 h the reaction mixture was cooled to 0 °C, 
quenched by addition of methanol (40 mL) and the solvent concentrated under 
vacuum. The residue was poured in water (30 mL) and extracted with CH2Cl2 (3 x 50 
mL). The combined organic layers were washed with brine (30 mL) and dried 
(Na2SO4). Concentration in vacuo was followed by flash column chromatography 
(SiO2, EtOAc:hexanes, 1:4) to afford ketone 142 (4.35 g, 71%) as a colorless oil:  
 
Rf  0.32 (EtOAc:hexanes, 1:3); IR (film) 2941, 1733, 1451, 1372, 1247, 1019 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 5.81-5.70 (m, 1H, H10), 5.02-4.85 (m, 2H, H11), 4.94-4.82 
(m, 1H, H2), 2.43−2.36 (m, 4H, H5 and H6), 2.01-1.97 (m, 2H, H9), 1.95 (s, 3H, H16), 
1.65-1.19 (m, 6H, H3, H4 and H8), 1.13 (d, J = 7.0 Hz, 3H, H1); 13C NMR (75 MHz, 
CDCl3) δ 210.6, 170.8, 137.9, 115.2, 70.5, 42.3, 41.9, 35.2, 33.1, 22.8, 21.3, 19.8, 
19.5; MS (CI) m/z 227 (M+H)+, 244 (M+NH4)+; HRMS (CI) calculated for C13H23O3: 
(M+H)+, 227.1647; found: (M+H)+, 227.1647. 
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Acetic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester 
(143) 
 
 
 
To a solution of compound 142 (5.0 g, 22.1 mmol) in benzene (150 mL) ethylene 
glycol was added (37.0 mL, 66.4 mmol), followed by PPTS (556 mg, 2.92 mmol). 
The reaction mixture was heated to 90 °C under Dean-Stark phase-separating 
apparatus. After 18 h the reaction mixture was allowed to cool to RT, diluted with 
EtOAc (100 mL) and washed with sat. aq. NaHCO3 (2 x 80 mL). The organic layer 
was dried (Na2SO4), concentrated under vacuum and purified by flash column 
chromatography (SiO2, EtOAc:hexanes, 1:9) to afford ketal 143 (4.36 g, 73%) as a 
clear oil:  
 
Rf  0.46 (EtOAc:hexanes, 1:9); IR (film) 1732, 1451, 1371, 1245, 1042 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 5.86-5.67 (m, 1H, H10), 4.98 (d, J = 16.3 Hz, 1H, H11), 4.93 (d, J 
= 10.4 Hz, 1H, H11), 4.91-4.85 (m, 1H, H2), 3.90 (s, 4H, H17 and H18),  2.06−2.01 (m, 
2H, H9), 2.01 (s, 3H, H15), 1.72-1.33 (m, 10H, H3, H5, H4, H7 and H8), 1.18 (d, 3H, J = 
6.0 Hz, H1); 13C NMR (75 MHz, CDCl3) δ 170.7; 138.6, 114.6, 111.5, 70.8, 64.9 (2C), 
36.8, 36.5, 36.0, 33.8, 23.1, 21.3, 19.9, 19.7; MS (CI) m/z 271 [M+H]+, 288 
[M+NH4]+; HRMS (CI) calculated for C15H27O4: [M+H]+ 271.1909, found: 271.1900. 
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5-(2-Pent-4-enyl-[1,3]dioxolan-2-yl)-pentan-2-ol (140) 
 
 
 
To a solution of ketal 143 (16.0 g, 59.3 mmol) in methanol (59 mL) was added aq. 
KOH (3M, 140 mL, 419 mmol). The mixture was stirred at 25 °C for 3 h after which 
time the reaction was concentrated under vacuum. The residue was dissolved in 
CH2Cl2 (350 mL) and successively washed with water (175 mL) and brine (175 mL). 
The organic layer was dried (Na2SO4) and concentrated under vacuum to give the 
racemic mixture of alcohols 140 (12.58 g, 93%) as a clear oil:  
 
Rf  0.55 (EtOAc:hexane 1:3); IR (film) 3422, 1456, 1147, 1044, 911 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 5.82 (tdd, J = 17.1, 10.2, 6.2 Hz, 1H, H10), 5.03 (dd, J = 17.1, 1.2 
Hz,1H, H11), 4.97 (dd, J = 10.2, 1.2 Hz, 1H, H11), 3.94 (s, 4H, H14 and 
H15), 3.83−3.76 (m, 1H, H2), 2.07 (q, J = 7.1 Hz, 2H, H3), 1.61-1.55 (m, 4H, H9 and 
H8), 1.47-1.35 (m, 6H, H4, H5 and H7), 1.18 (d, J = 6.0 Hz, 3H, H1); 13C NMR 
(75 MHz, CDCl3) δ 138.6, 114.6, 111.6, 67.9, 65.0 (2C), 39.4, 37.0, 36.5, 33.8, 23.4, 
23.1, 19.9; MS (CI) m/z 229 [M+H]+, 246 [M+NH4]+; HRMS (CI) calculated for 
C13H28O3N [M+NH4]+ 246.2069, found 246.2068. 
 162 
(S)-5-(2-Pent-4-enyl-[1,3]dioxolan-2-yl)-pentan-2-ol (13) 
 
 
 
To a solution of racemic alcohol 140 (12.58 g, 55 mmol) and vinyl acetate (10.2 mL, 
165 mmol) in hexane (262 mL), was added in one portion CAL-B (550 mg, 10 mol%) 
and the resultant mixture was stirred under air at 35 °C for 80 min. The reaction 
mixture was filtered and the solvent was evaporated under vacuum. The residue was 
purified by flash column chromatography (SiO2, gradient EtOAc:hexane 1:10 to 1:3) 
to yield acetate 141 (5.46 g, 51%) and the enantiomerically enriched mixture of 
alcohols 144 (6.04 g, 48%, [α]D 25 +5.77 (c 3.14, CH2Cl2) (the literature optical 
rotation for R-(–)-127 is αD25 = –6.8 (c 1.02 CH2Cl2))40 both as clear oils. 
 
To a solution of 144 (6.04 g, 26.4 mmol) and vinyl acetate (5.8 mL, 93.9 mmol) in 
hexane (148 mL) was added in one portion CAL-B (312 mg, 10 mol%) and the 
resultant mixture was stirred under air at 35 °C for 3 h. The reaction was filtered and 
the solvent evaporated under vacuum. The residue was purified by flash column 
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chromatography (SiO2, gradient EtOAc:hexane 1:10 to 1:3) to yield the enantiomeric 
pure S-(+)-alcohol 13 (4.79 g, 79%; 38% over 2 steps) as a clear oil: 
 
Spectroscopical data for (R)-Acetic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-
2-yl)butyl ester (141): Rf  0.46 (EtOAc:hexane 1:9); [α]D25 –1.0 (c 1.10, CH2Cl2); IR 
(film) 1732, 1451, 1371, 1245, 1042 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.86-5.67 
(m, 1H), 5.01-4.95 (m, 2H), 4.91-4.85 (m, 1H), 3.90 (s, 4H),  2.06−2.01 (m, 2H), 2.06 
(s, 3H), 1.72-1.33 (m, 10H), 1.18 (d, J = 6.0 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
170.8, 138.6, 114.5, 111.5, 70.8, 64.9 (2C), 42.3, 36.8, 36.5, 33.9, 23.1, 21.4, 19.9, 
19.7; MS (CI) m/z 271 [M+H]+, 288 [M+NH4]+; HRMS (CI) calculated for C15H27O4 
[M+H]+ 271.1909, found 271.1900. Anal. calcd. for C15H26O4: C, 66.64; H, 9.69. 
Found: C, 66.53; H, 9.59. 
 
Spectroscopical data for alcohol S-(+)-13: Rf 0.55 (EtOAc:hexanes 1:3) ; [α]D 25 
+6.7 (c 3.14, CH2Cl2); IR (neat) 3422, 1455, 1129, 1082, 911 cm-1; 1H NMR (CDCl3, 
400 MHz) δ 5.82 (tdd, J = 17.1, 10.2, 6.2 Hz, 1H), 5.03 (dd, J = 17.1, 1.2 Hz, 1H), 
4.94 (dd, J = 10.2, 1.2 Hz, 1H), 3.92 (s, 4H),  3.83-3.76 (m, 1H), 2.07 (q, J = 7.1 Hz, 
2H), 1.64-1.54 (m, 4H), 1.48-1.37 (m, 6H), 1.18 (d, J = 6.0 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δ 138.6, 114.6, 111.6, 67.9, 65.0 (2C), 39.4, 37.0, 36.5, 33.8, 23.4, 
23.1, 19.9; MS (CI) m/z 229 [M+H]+, 246 [M+NH4]+; HRMS (CI) calculated for 
C13H28O3N [M+NH4]+ 246.2069, found 246.2068. 
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5-(1-Hydroxyethyl)-2,2,6-trimethyl[1,3]dioxin-4-one (146) 
 
 
 
LiN(SiMe3)2 in THF (1 M; 0.23 mL, 0.23 mmol) was added dropwise with stirring to 
dioxinone 8 (30 mg, 0.21 mmol) in THF (2 mL) and the resulting pale yellow solution 
stirred at –70 °C for 50 min, when acetaldehyde (110) (0.03 mL, 0.52 mmol) was 
added. The reaction temperature was maintained at –70 °C for 30 min after which 
time the solution was poured onto aq. HCl (1 M; 5 mL) and Et2O (4 mL) was added. 
The organic phase was washed with brine (3 x 5 mL), dried (MgSO4), rotary 
evaporated and chromatographed (Et2O:hexanes 2:1) gave dioxinone 146 (16.3 g, 
42%) as a clear oil: 
 
Rf 0.2 (EtOAc:hexanes 1:1); IR (neat) 3449, 2974, 2930, 1717, 1636, 1392, 1270, 
1206cm-1; 1H NMR (CDCl3, 400 MHz) δ 4.56 (q, 1H, J = 6.6 Hz, H11), 3.38 (s broad, 
1H, -OH), 2.01 (s, 3H, H7), 1.65 (s, 3H, -CH3), 1.63 (s, 3H, -CH3), 1.45 (d, 3H, J = 6.6 
Hz, H12); 13C NMR (CDCl3, 100 MHz) 163.6, 162.1, 108.3, 105.5, 65.0, 25.3, 24.8, 
23.5, 17.2; MS (CI) m/z 187 [M + H]+. 
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Acetic acid 2-(2,2-dimethyl-6-oxo-6H-[1,3]dioxin-4-yl)-1-methyl-vinyl 
ester (149) 
 
 
 
To a solution of LiHMDS (1.06 M in THF, 3.11 mL, 3.3 mmol) in THF (20 mL) at –
40 ºC was added diketene-acetone adduct 8 (400 µL, 3 mmol) dropwise, and the 
solution stirred at –40 ºC for 45 min. A solution of acetyl chloride 148 (426 µL, 6 
mmol) in THF (5 mL) was added dropwise and the resultant solution was allowed to 
warm to RT over 1 h. 1 M HCl (20 mL) was added, and the mixture extracted with 
Et2O (3 x 30 mL), dried (MgSO4), rotary evaporated, and chromatographed 
(CH2Cl2:EtOAc, 9:1) to afford 149 as a yellow oil (275 mg, 50%): 
 
Rf  0.3 (EtOAc:hexanes, 1:1); IR (neat) 3096, 2998, 2945, 1764, 1730, 1669, 1385, 
1015 cm-1; 1H NMR (CDCl3, 300 MHz) δ 5.44 (s, 1H, H7), 5.29 (s, 1H, H3), 2.13 (s, 
3H, -CH3), 1.98 (s, 3H, -CH3), 1.60 (s, 6H, H9 and H10); 13C NMR (CDCl3, 75 MHz) 
δ 167.6, 161.7, 161.5, 155.4, 109.8, 106.1, 94.8, 24.9, 21.7, 20.8; MS (CI) m/z 227 
(M+H)+, 244 (M+NH4)+ 
 166 
2,2-Dimethyl-6-(2-oxopropyl)-4H-1,3-dioxin-4-one (16) 
 
 
 
LiN(SiMe3)2 in THF (1 M; 21 mL, 21 mmol) was added dropwise with stirring to 
dioxinone 8 (2.8 mL, 21 mmol) in THF (60 mL) and the resulting pale yellow solution 
stirred at –70 °C for 50 min, when AcCl (0.9 mL, 12.6 mmol) was added. The reaction 
temperature was maintained at –70 °C for 30 min after which time the solution was 
poured onto aq. HCl (1 M; 50 mL) and Et2O (40 mL) was added. The organic phase 
was washed with brine (3 x 50 mL), dried (MgSO4), rotary evaporated and 
chromatographed (Et2O:hexanes gradient 1:1 to 2:1) gave keto-dioxinone 16 (2.1 g, 
55%) as a white solid: 
 
Rf 0.13 (Et2O:hexanes 1:1); mp 47-50 °C (hexanes/CH2Cl2);IR: 1733, 1714, 1639, 
1379, 1317, 1270, 1253, 1197, 1160, 1011, 904, 862, 821, 794 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.31 (s, 1H, H3), 3.31 (s, 2H, H7), 2.21 (s, 3H, H12), 1.68 (s, 6H, H9 
and H10); 13C NMR (100 MHz, CDCl3) δ 201.0, 164.5, 160.8, 107.4, 96.9, 48.15, 
30.3, 25.2 (2C); HRMS (CI) calc. for C9H13O4: (M + H)+, 185.0814, found: (M + H)+, 
185.0812. Anal. calcd. for C9H12O4: C, 58.69; H, 6.57. Found: C, 58.75; H, 6.63. 
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Methyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate 
(151) 
 
 
 
Dioxinone 8 (0.5 mL, 3.8 mmol) in THF (5 mL) was added dropwise with stirring to a 
solution of LiN(SiMe3)2 (4.56 mL, 4.56 mmol, 1 M in THF)  in THF (70 mL) at –78 
°C for 30 min. Acid chloride 150 (0.14 mL, 1.3 mmol) in THF (2 mL) was slowly 
added at –78 °C. The mixture was stirred at RT overnight. The solution was 
sequentially quenched by addition of an aqueous solution of NH4Cl (50 mL), and a 
solution of HCl (1 M) until pH 4. After extraction with EtOAc (3 x 70 mL), the 
combined organic layers were washed with brine, dried (MgSO4), rotary evaporated 
and chromatographed (EtOAc:hexanes 1:4) to give ester 151 (186.1 mg, 61%) as a 
colorless oil:  
 
Rf 0.4 (EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ 5.36 (s, 1H, H3), 3.38 (s, 
3H, H15), 3.52 (s, 2H, -CH2-), 3.49 (s, 2H, -CH2-), 1.70 (s, 6H, H9 and H10); 13C NMR 
(CDCl3, 100 MHz) 195.5, 166.8, 163.4, 160.4, 107.4, 97.1, 52.6, 48.8, 47.0, 25.0 (2C); 
MS (ESI) m/z 243 [M + H]+. 
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3-(3-methylbut-2-enyloxy)-3-oxopropanoic acid (154) 
 
 
 
Prop-2-en-1-ol (153) (25.5 g, 30 ml, 438.48 mmol, 6.3 eq.) and 2, 2-dimethyl-1, 3-
dioxane-4, 6-dione (152) (10 g, 69.38 mmol, 1.0 eq.) were stirred at 80 oC for 12 h. 
The volatiles were removed in vacuo and the remaining liquid dissolved in ethanol (20 
mL). A solution of aqueous ammonia (50%, 5 mL) was added to the mixture, which 
was then allowed to stir for 30 minutes. The volatiles were removed in vacuo and the 
remaining residue washed with 1:1 diethyl ether:hexane (200 mL). The pale yellow 
residue was dissolved in water (30 mL), pH adjusted to pH 3 using 1 M HCl and 
extracted with diethyl ether (3 x 100 mL). The organics were combined, dried over 
MgSO4 and volatiles removed in vacuo to afford propanoic acid 154 as a pale yellow 
oil (2.9 g, 30%): 
 
Rf 0.43 (Petroleum ether: EtOAC). IR (neat) 3044, 1722, 1413, 1369, 1318, 1274, 
1157, 990, 929 cm-1. 1H (400MHz, CDCl3) 5.99-5.90 (m, 1H), 5.41-5.36 (m, 1H), 
5.33-5.29 (m, 1H), 4.71 (dt, J= 5.6 and 1.2Hz), 3.50 (s, 2H). 13C NMR (400MHz, 
CDCl3): 40.6, 65.9, 119.2, 131.2, 166.7, 170.6. HRMS (CI) m/z C6H8O4+ [M + NH4]+ 
Anal. calcd. 161.0423, found [M + H]+ found 161.0764. 
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Allyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate (156) 
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Monoallyl malonate 154 (21.1 g, 146.8 mmol) was stirred in anhydrous CH2Cl2 (250 
mL) at 0 oC. Oxalyl chloride (14.6 mL, 179.1 mmol) and DMF (2 mL) were added 
and the reaction mixture stirred for 1 h at 0 oC followed by 2 h at RT. The volatiles 
were removed in vacuo, to afford acid chloride 155 as a brown oil.  
To a solution of  HMDS (1.9 mL, 9.12 mmol) in of THF (140 mL) at –78 ºC,  BuLi 
(3.8 mL, 9.5 mmol, 2.5 M in hexanes) was added dropwise and the resultant solution 
was stirred at this temperature over 30 min. After this period, dioxinone 8 (1 mL, 7.6 
mmol) was added dropwise and the solution stirred at –78 ºC for 1.5 h. After this time, 
acid chloride 155 (374 mg, 2.3 mmol) was added in one portion and the temperature 
was raised up to RT overnight. The reaction was quenched by addition of a saturated 
solution of ammonium chloride (3 mL). The pH was adjusted to pH=3 with aq. HCl (1 
M). The mixture was extracted with EtOAc (2 x 40 mL) and the combined organic 
layers were washed with brine and dried (MgSO4). The solvent was removed under 
vacuum and the crude residue purified by chromatography (hexane:EtOAc, 8:2) to 
yield compound 156 (327 mg, 61 %) as a yellow oil: 
 
Rf 0.30 (hexane:EtOAc 7:3); IR (KBr) 2999, 2945, 1727, 1639, 1391, 1274, 1204, 
1010, 903, 809. 1H NMR (CDCl3, 300 MHz) δ 5.90 (ddd, J = 16.4, 11.1, 5.8 Hz, 1H, 
 170 
H18), 5.37 (s, 1H, H3), 5.33 (d, J = 17.2 Hz, 1 H, H19), 5.27 (d, J = 10.4 Hz, 1H, H19), 
4.63 (dd, J = 5.9, 1.8 Hz, 2H, H14), 3.54 (s, 2H, -CH2-), 3.50 (s, 2H, -CH2-), 1.71 (s, 
6H, H16 and H17).13C NMR (75 MHz, CDCl3) 195.4, 165.9, 163.4, 160.4, 131.1, 
119.2, 107.3, 97.0, 66.2, 48.9, 46.9, 24.9 (2C). MS (ESI) m/z 269 [M+H]+; HRMS 
(ESI) calcd. C13H17O6: [M+H]+, 269.1025; found: [M+H]+, 269.1030. Anal. calcd for 
C13H16O6: C, 58.20; H, 6.01. Found: C, 58.29; H, 5.99. 
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6-methyl-2,2-diphenyl-4H-1,3-dioxin-4-one (165) 
 
 
 
t-Butylacetoacetate 166 (1 mL, 6 mmol) was cooled under nitrogen to -10 ºC, and 
acetophenone 167 (1.44 g, 12 mmol) dissolved in acetic anhydride (2 mL) was added. 
After 10 min, sulphuric acid was added dropwise (0.326 mL, 6 mmol) and the mixture 
washed up to 0 ºC and stirred for 15 h. After this period, the mixture was poured in a 
cooled saturated solution of potassium carbonate to neutralize the acid and was 
extracted with ethyl acetate (2 x 30 mL). The combined organic layers were washed 
with brine and dried (MgSO4), rotary evaporated and chromatographed (SiO2, hexane: 
ethyl acetate; 8:2) to afford the compound 165 (650 mg, 53 %): 
 
1H NMR (CDCl3, 400 MHz) δ 7.58-7.21 (m, 10H, ArH), 4.93 (s, 1H, H3), 2.00 (s, 3H, 
H7); 13C NMR (CDCl3, 100 MHz) 168.5, 158.5, 149.4, 147.4, 129.8, 127.7, 125.8, 
102.7, 98.1, 20.0; MS (CI) m/z 267 [M + H]+. 
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(E)-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-methylbut-3-enoic 
acid (170) 
 
 
 
n-BuLi (0.93 mL, 0.58 mmol) was added dropwise to (i-Pr)2NH (0.09 mL, 0.7 mmol) 
in THF (4 mL) at –78 °C and stirred for 20 min. Dioxinone 149 (60 mg, 0.27 mmol) 
in THF (2 mL) was added dropwise with stirring to the solution at –78 °C and stirred 
for 30 min and the mixture stirred at RT for 5 h and poured into aq. HCl (1 M; 5 mL). 
EtOAc was added (8 mL), the layers separated and the aqueous phase extracted with 
EtOAc (8 mL). The combined organic phases were washed with brine (3 mL), dried 
(MgSO4), rotary evaporated and chromatographed (EtOAc:hexanes 6:1) to give 
dioxinone 170 (7.3 g, 12%) as a white solid:  
 
Rf 0.1 (EtOAc); IR (neat) 3100, 1745, 1685, 1630, 1353, 1045, 986, 816 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 5.72 (s, 1H, H7), 5.37 (s, 1H, H3), 3.21 (s, 2H, H12), 2.07 
(s, 3H, H24), 1.70 (s, 6H, H9 and H10); 13C NMR (CDCl3, 100 MHz) δ 178.8, 164.0, 
1601.3, 141.5, 114.4, 107.4, 100.6, 46.5, 24.8 (2C), 18.2; MS (CI) m/z 227 [M + H]+. 
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Allyl 2-acetyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-
oxobutanoate (174) 
 
 
 
Pyridine (0.36 mL, 4.8 mmol) was added with stirring to keto-ester 156 (500 mg, 1.96 
mmol) and MgCl2 (214 mg, 2.2 mmol) in CH2Cl2 (35 mL) at 0 ºC giving a bright 
yellow solution. After 20 min, acid chloride 148 (237 mg, 2.6 mmol) in CH2Cl2 (5 
mL) was added in one portion and the mixture was allowed to warm to RT over 15 
min. After 30 min stirring, the reaction was quenched by addition of saturated aqueous 
NH4Cl (10 mL) and the pH was adjusted to 4 with aq. HCl (1 M). The mixture was 
extracted with EtOAc (2 x 35 mL) and the combined organic layers were washed with 
brine and dried (MgSO4). Rotary evaporation and chromatography (EtOAc:hexanes 
1:4) gave diketo-ester 174 (245 mg, 43%) as a yellow oil: 
 
Rf 0.21 (EtOAc:hexanes 1:2); IR (KBr) 3421, 2924, 2852, 1726, 1596 cm-1; 1H NMR 
(CDCl3, 300 MHz) δ 6.02–5.91 (m, 1H, H21), 5.40–5.30 (m, 3H, H22 and H3), 4.70 (d, 
J = 6.0 Hz, 2H, H20), 3.72 (s, 2H, H7), 2.42 (s, 3H, H15), 1.69 (s, 6H, H13 and H14).; 
13C NMR (75 MHz, CDCl3) δ 196.1, 193.8, 165.9, 165.1, 160.7, 131.5, 119.7, 108.2, 
107.2, 96.5, 65.9, 43.2, 25.6, 24.9 (2C), MS (ESI) m/z 311 [M + H]+. 
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1-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)pentane-2,4-dione (10) 
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To a 0 ºC cooled solution of compound 174 (616.3 mg, 1.9 mmol) in THF (3 mL), 
was added morpholine (0.4 mL, 4.6 mmol) (the solution turned to bright yellow) and a 
solution of Pd(PPh3)4 (90.5 mg, 0.07 mmol) in of THF (15 mL). The temperature was 
raised to RT and after 30 min the reaction was quenched by addition of a saturated 
solution of ammonium chloride (20 mL). The pH was adjusted to pH=4 with aq. HCl 
(1 M). The mixture was extracted with Et2O (3 x 80 mL) and the combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed 
(cyclohexane:EtOAc, 4:1) to give compound 10 (178.8 mg, 40%)* as a yellow oil: 
 
Rf 0.30 (hexanes:EtOAc 2:1); IR (neat) 1732, 1637, 1377, 1273, 1204, 1015, 967, 810 
cm-1; 1H NMR (CDCl3, 400 MHz, keto:enol = 1:9 ) enol: δ 15.05 (s, 1H, -OH), 5.55 
(s, 1H, H3), 5.39 (s, 1H, H7), 3.20 (s, 2H, H5), 2.08 (s, 3H, H1), 1.70 (s, 6H, H15 and 
H16); 13C NMR (CDCl3, 100 MHz) δ 189.8, 188.3, 165.0, 160.7, 107.1, 100.2, 96.3, 
43.5, 24.9 (2C), 24.2; MS (CI, NH3) m/z 227 [M + H]+; HRMS (CI, NH3) calc. for 
C11H15O5 [M + H]+: 227.0841, found 227.0889. Anal.calcd. for C11H14O5: C, 58.40; 
H, 6.24. Found: C, 58.48; H, 6.29. 
                                                 
*
 All the di- and tri-keto-esters exist as a mixture of keto and enol tautomers. However, for 
convenience, they are drawn as single entities. The assigned signals in the magnetic resonance spectra 
are those which correspond to the main tautomeric form observed. 
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1-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)pentane-2,4-dione (10) 
 
 
 
n-BuLi (11.9 mL, 19.11mmol) was added dropwise to (i-Pr)2NH (2.97 mL, 21.0 
mmol) in THF (26 mL) at –78 °C and stirred for 20 min. Keto-dioxinone 16 (1.76 g, 
9.56 mmol) in THF (9.5 mL) was added dropwise with stirring to the solution at –78 
°C and the resulting cloudy yellow solution was slowly allowed to warm up to –40 °C 
and stirred for 30 min. Weinreb amide 178 (0.5 mL, 4.78 mmol) in THF (4.8 mL) was 
slowly added and the mixture stirred at –40 °C for 1 h and poured into aq. HCl (1 M; 
60 mL). Et2O was added (60 mL), the layers separated and the aqueous phase 
extracted with Et2O (60 mL). The combined organic phases were washed with brine 
(80 mL), dried (MgSO4), rotary evaporated and chromatographed (Et2O:hexanes 1:1) 
to give diketo-dioxinone 10 (745.1 mg, 69%) as a yellowish solid: 
 
Rf 0.30 (hexanes:EtOAc 2:1); IR (neat) 1732, 1637, 1377, 1273, 1204, 1015, 967, 810 
cm-1; 1H NMR (CDCl3, 400 MHz, keto:enol = 1:9 ) enol: δ 15.05 (s, 1H, -OH), 5.55 
(s, 1H, H3), 5.39 (s, 1H, H7), 3.20 (s, 2H, H5), 2.08 (s, 3H, H1), 1.70 (s, 6H, H15 and 
H16); 13C NMR (CDCl3, 100 MHz) δ 189.8, 188.3, 165.0, 160.7, 107.1, 100.2, 96.3, 
43.5, 24.9 (2C), 24.2; MS (CI, NH3) m/z 227 [M + H]+; HRMS (CI, NH3) calc. for 
C11H15O5 [M + H]+: 227.0841, found 227.0889. Anal.calcd. for C11H14O5: C, 58.40; 
H, 6.24. Found: C, 58.48; H, 6.29. 
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1-(1H-Benzo[d][1,2,3]triazol-1-yl)butane-1,3-dione (9) 
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Commercially available dioxinone 8 (3 mL, 22.5 mmol) and benzotriazole 179 (2.68 
g, 22.5 mmol) in dry PhMe (80 mL) were heated for 11 h at 90 °C. The solution was 
rotary evaporated and provided 9 (4.5g) as an unstable pale yellow solid and as a 1:1 
mixture of tautomers: 
 
1H NMR (d8-THF, 400 MHz) δ13.07 (br s, 0.5H, H9), 8.29 (dd, J = 16.5, 8.0 Hz, 1H, 
ArH), 8.11 (d, J = 8.0 Hz, 1H, ArH), 7.67 (q, J = 8.0 Hz, 1H, ArH), 7.52 (q, J = 8.0 
Hz, 1H, ArH), 6.69 (s, 0.5H, H7), 4.57 (s, 1H, H3), 2.34 (s, 1.5H, -CH3), 2.20 (s, 1.5H, 
-CH3); 13C NMR (d8-THF, 100 MHz) δ 200.5, 183.5, 170.4, 167.5, 147.7, 147.5, 
132.2, 132.0, 131.4, 131.1, 127.2, 126.9, 121.1 (2C), 115.4, 115.1, 90.9, 51.7, 30.4, 
22.3. 
 177 
1-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)pentane-2,4-dione (10) 
 
 
 
Dioxinone 8 (9 mL, 67.5 mmol) was added dropwise to LiN(SiMe3)2 in THF (1 M; 70 
mL, 69.7 mmol) in THF (750 mL) at –78 ºC and the mixture stirred at that 
temperature. After 1.5 h, amide 9 (4.5 g, 22.5 mmol) was added in one portion and the 
mixture was allowed to warm up to RT. After stirring overnight, the reaction mixture 
was quenched by addition of 1 M aq. HCl to pH 4. The mixture was extracted with 
EtOAc (3 x 250 mL) and the combined organic layers were washed with brine, dried 
(MgSO4) and rotary evaporated. The mixture was dissolved in CH2Cl2 (250 mL) and 
washed with a buffer solution (pH = 9)* (5 x 50 mL). The organic layer was dried 
(MgSO4), rotary evaporated and chromatographed (hexanes:EtOAc 8:1 to 2:1) to give 
10 (2.70 g, 53%) as a clear oil:  
 
Rf 0.30 (hexanes:EtOAc 2:1); IR (neat) 1732, 1637, 1377, 1273, 1204, 1015, 967, 810 
cm-1; 1H NMR (CDCl3, 400 MHz, keto:enol = 1:9 ) enol: δ 15.05 (s, 1H, -OH), 5.55 
(s, 1H, H3), 5.39 (s, 1H, H7), 3.20 (s, 2H, H5), 2.08 (s, 3H, H1), 1.70 (s, 6H, H15 and 
H16); 13C NMR (CDCl3, 100 MHz) δ 189.8, 188.3, 165.0, 160.7, 107.1, 100.2, 96.3, 
43.5, 24.9 (2C), 24.2; MS (CI, NH3) m/z 227 [M + H]+; HRMS (CI, NH3) calc. for 
C11H15O5 [M + H]+: 227.0841, found 227.0889. Anal.calcd. for C11H14O5: C, 58.40; 
H, 6.24. Found: C, 58.48; H, 6.29. 
                                                 
*
  Buffer solution from Sigma-Aldrich pH 9.00 reference number 456101. It was observed that the yield decreases 
if benzotriazole was not removed before chromatography, due to competitive aromatization to benzodioxinone 
15. To avoid this side product, the mixture was washed with a buffer solution (pH 9) to remove benzotriazole 
and suppress the rate of the aromatization reaction. 
 
 178 
(5R)-allyl 2-(2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetyl)-3-oxo-5-
(triisopropylsilyloxy)hexanoate (172) 
 
 
To a suspension of compound 156 (100 mg, 0.37 mmol) and MgCl2 (33 mg, 0.37 
mmol) in CH2Cl2 (0.9 mL) at 0 ºC, was added pyridine (0.060 mL, 0.72 mmol). The 
solution (turned bright yellow) was stirred at this temperature for 20 min. After this 
period, acid chloride 171 (137 mg, 0.49 mmol) dissolved in of CH2Cl2 (0.8 mL) was 
added in one portion and the temperature was raised to RT over 15 min. After 30 min 
of continuous stirring, the reaction was quenched by addition of a saturated solution of 
ammonium chloride (2 mL) and the pH was adjusted to pH=4 with aq. HCl (1 M). The 
mixture was extracted with EtOAc (2 x 15 mL) and the combined organic layers were 
washed with brine and dried (MgSO4). The solvent was removed under vacuum and 
the residue was purified by chromatography (hexane:EtOAc, 9:1) to afford the 
compound 172 (157 mg, 83 %) as a yellow oil: 
 
Rf 0.75 (hexane:EtOAc 7:3); [α]D –14.0 (c 0.005, CHCl3); IR (KBr) 2944, 2855, 1733, 
1640, 1376, 172, 1204, 1126, 1015, 882. 1H NMR (CDCl3, 300 MHz)  δ 17.53 (s, 1H, 
-OH), 5.97 (ddd, J = 17.1, 11.1, 5.8 Hz, 1H, H4), 5.39 (d, J =17.1 Hz, 1H, H4), 5.34 
(s, 1H, H12), 5.32 (d, J = 10.4 Hz, 2H, H2), 4.55-4.30 (m, 1H, H23), 3.67 (s, 2H, H9), 
2.99 (dd, J = 14.1, 8.2 Hz, 1H, H22), 2.80 (dd, J = 14.1, 4.7 Hz, 1H, H22), 1.69 (s, 6H, 
H18 and H19), 1.23 (d, J = 6.2 Hz, 1H, H25), 1.03 (s, 15 H).13C NMR (75 MHz, CDCl3) 
195.5, 193.2, 165.9, 164.9, 160.6, 131.3, 119.8, 109.3, 107.1, 96.5, 66.4, 66.0, 47.1, 
43.0, 24.9, 24.8, 24.3, 18.0 (6C), 12.4 (3C). MS (ESI) m/z 511 [M+H]+; HRMS (ESI) 
calcd. C26H43O8Si: [M+H]+, 511.2727; found: [M+H]+, 511.2715. Anal. calcd for 
C26H42O8
 179 
(R)-1-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-6-
(triisopropylsilyloxy)heptane-2,4-dione (173) 
 
 
 
To a 0 ºC cooled solution of compound 172 (200 mg, 0.39 mmol) in THF (3 mL), was 
added morpholine (0.07 mL, 0.8 mmol) (the solution turned to bright yellow) and a 
solution of Pd(PPh3)4 (46 mg, 0.04 mmol) in of THF (0.8 mL). The temperature was 
raised to RT and after 30 min the reaction was quenched by addition of a saturated 
solution of ammonium chloride (4 mL). The pH was adjusted to pH=4 with aq. HCl (1 
M). The mixture was extracted with Et2O (3 x 15 mL) and the combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed 
(cyclohexane:EtOAc, 4:1) to give compound 173 (148mg, 89 %) as a yellow oil: 
 
Rf 0.45 (Hexane:EtOAc, 7:3); [α]D –27.0 (c 0.017, CHCl3);  IR (KBr) 2944, 2866, 
2539, 2344, 1734, 1615, 1377, 1272, 1205, 1125, 1014, 882. 1H NMR (CDCl3, 400 
MHz)  δ 15.03 (bs, 1H, -OH), 5.58 (s, 1H, H3), 5.38 (s, 1H, H9), 4.44-4.34 (m, 1H, 
H17), 3.21 (s, 2H, H6), 2.50 (dd, J = 13.7, 6.5 Hz, 1H, H1), 2.36 (dd, J = 13.7, 6.0 Hz,  
1H, H1), 1.69 (s, 6H, H15 and H16), 1.22 (d, J =  6.4 Hz, 3H, H19), 1.04 (s, 15 H). 13C 
NMR (75 MHz, CDCl3) 189.3 (2C), 164.9, 160.6, 107.0, 101.2, 96.3, 66.2, 47.9, 43.7, 
24.9, 24.8, 24.0, 18.0 (6C), 12.3 (3C). MS (ESI) m/z 427 [M+H]+; HRMS (ESI) calcd. 
C22H39O6Si: [M+H]+, 427.5216; found: [M+H]+, 427.2516. Anal. calcd for 
C22H38O6Si: C, 61.94; H, 8.98. Found: C, 62.12; H, 9.04. 
 180 
(R,Z)-6-(2,6-dihydroxy-4-oxohept-1-enyl)-2,2-dimethyl-4H-1,3-dioxin-
4-one (182) 
 
 
 
To a 0 ºC cooled solution of compound 173 (52 mg, 0.13 mmol) in THF (3 mL) in a 
plastic vessel, 0.6 mL of HF in pyridine was added. The temperature was raised up to 
RT in 45 min and the solution was maintained with continuous stirring for 6 h. After 
this period, the reaction was quenched by adding carefully 3 mL of saturated sodium 
bicarbonate solution. The mixture was extracted with AcOEt (2 x 10 mL) and the 
combined organic layers were dried (MgSO4). The solvent was removed under 
vacuum and the residue was chromatographed (CH2Cl2 :MeOH, 95:5) to afford the 
compound 182 (31 mg, 92 %) as a yellow oil: 
 
Rf 0.30 (CH2Cl2 :MeOH, 95:5); 1H NMR (CDCl3, 300 MHz) δ5.40 (s, 1H, H3), 5.36 
(s, 1H, H9), 4.55 (m, 1H, H17), 3.16 (s, 2H, H6), 2.45 (s, 1H, H1), 2.43 (d, J 2.1, 1H, 
H1), 1.69 (s, 6H, H15 and H16), 1.46 (d, J 6.2, 3H, H19); 13C NMR (75 MHz, CDCl3) 
192.39, 169.28, 165.19, 160.54, 107.09, 106.32, 95.77, 76.55, 42.58, 39.20, 25.05, 
24.80, 20.31. MS (ESI) m/z 271 [M + H]+. 
 181 
(E)-5-(1-hydroxybut-2-enylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
(185) 
 
 
 
Crotonoyl chloride (180) (3.99 g, 38.2 mmol) was added to a solution of Meldrum’s 
acid (152) (5.0 g, 34.7 mmol) and pyridine (5.49 g, 69.4 mmol) in CH2Cl2 (25 mL) at 
0 ºC over a period of 10 min. The resulting mixture was stirred for 1 h at 0 ºC and then 
1 h at RT. The reaction mixture was poured into an ice-cold solution of 2 M aq. HCl 
(30 mL), diluted with CH2Cl2 (55 mL) and the phases were separated. The organic 
layer was washed with 2 M aq. HCl (30 mL), water (2 x 30 mL), dried (MgSO4) 
rotary evaporated and chromatographed (EtOAc:hexanes 1:4) to provide the alkylated 
product 185 (3.5 g, 48%) as a white solid:  
 
Rf 0.35 (EtOAc:hexanes 1:3); mp 81-83 °C (EtOAc/hexanes); IR (neat) 2989, 1730, 
1636, 1529, 1389, 1159, 907, 789 cm-1; 1H NMR (CDCl3, 400 MHz) δ 14.89 (s, 1H, 
H12), 7.58 (d, J = 16.0Hz, 1H, H14), 7.40 (dq, J = 16.0, 8.2Hz, 1H, H13), 2.08 (dd, J = 
8.2, 1.4Hz, 3H, H15), 1.75 (s, 6H, H9 and H10); 13C NMR (CDCl3, 100 MHz) 182.7, 
171.9, 160.5, 149.0, 124.4, 104.6, 89.2, 26.8 (2C), 19.4; MS (ESI) m/z 213 [M + H]+. 
 182 
(E)-2,2-dimethyl-6-(prop-1-enyl)-4H-1,3-dioxin-4-one (184) 
 
 
 
Dry acetone (57) (4 µL, 0.05 mmol) was added to the alkylated product 185 (22.4 mg, 
0.106 mmol) in PhMe (0.1 mL), and the mixture was refluxed for 5 h. After the dark 
yellow solution was cooled to RT the solvent was evaporated under reduced pressure. 
The resulting yellow oil was chromatographed (EtOAc:hexanes 1:3) to afford the 
dioxinone 184 (11 mg, 62%) as a yellow oil:  
 
Rf 0.42 (EtOAc:hexanes 1:3); IR (neat) 1430, 1392, 1252, 943 cm-1; 1H NMR (CDCl3, 
400 MHz) δ 6.59 (dq, J = 16.0, 8.2Hz, 1H, H11), 5.94 (dd, J = 16.0, 1.4Hz, 1H, H7), 
5.24 (s, 1H, H3), 1.91 (dd, J = 8.2, 1.4Hz, 3H, H12), 1.72 (s, 6H, H9 and H10); 13C 
NMR (CDCl3, 100 MHz) 171.6, 171.2, 147.4, 128.5, 122.1, 60.4, 22.3, 18.1, 14.0; MS 
(ESI) m/z 169 [M + H]+. 
 183 
6-((3Z,5E)-4-hydroxy-2-oxohepta-3,5-dienyl)-2,2-dimethyl-4H-1,3-
dioxin-4-one (12) 
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Unsaturated dioxinone 184 (38.0 mg, 0.23 mmol) and benzotriazole 179 (26.8 mg, 
0.23 mmol) in dry PhMe (8 mL) were heated for 11 h at 90 °C. The solution was 
rotary evaporated and provided 183 (51.5 mg) as an unstable pale yellow solid. 
 
Dioxinone 8 (0.09 mL, 0.68 mmol) was added dropwise to LiN(SiMe3)2 in THF (1 M, 
0.7 mL, 0.7 mmol) in THF (8 mL) at –78 ºC and the mixture stirred at that 
temperature. After 1.5 h, amide 183 (51.5 mg, 0.23 mmol) was added in one portion 
and the mixture was allowed to warm up to RT. After stirring overnight, the reaction 
mixture was quenched by addition of 1 M aq. HCl to pH 4. The mixture was extracted 
with EtOAc (3 x 5 mL) and the combined organic layers were washed with brine, 
dried (MgSO4) and rotary evaporated. The mixture was dissolved in CH2Cl2 (5 mL) 
and washed with a buffer solution (pH = 9)* (5 x 5 mL). The organic layer was dried 
                                                 
*
 Buffer solution from Sigma-Aldrich pH 9.00 reference number 456101. 
 184 
(MgSO4), rotary evaporated and chromatographed (hexanes:EtOAc 8:1 to 2:1) to give 
12 (8.1 mg, 14%) as a clear oil:  
 
Rf 0.61 (EtOAc:hexane 1:2); IR (neat) 2996, 2363, 1732, 1637, 1377, 1273, 1204, 
1015, 967, 810 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.92 (qd, J = 14.6, 7.0 Hz, 1H, 
H2), 5.8 (qd, J = 14.6, 1.5 Hz, 1H, H3), 5.49 (s, 1H, H5), 5.38 (s, 1H, H11), 3.25 (s, 2H, 
H9), 1.92 (dd, J = 7.0, 1.5 Hz, 3H, H1), 1.72 (s, 6H, H17 and H18);  13C NMR (CDCl3, 
100 MHz) δ 192.8, 177.7, 165.1, 160.7, 141.4, 126.3, 107.1, 98.8, 96.3, 44.8, 24.9 
(2C), 18.5; MS (CI, NH3) m/z 253 [M+H]+,calculated for C13H16O5 [M+H]+ 253.10. 
 
 
 185 
1-chloro-pent-4-en-2-ol (190)90  
 
 
 
To a stirring solution of chloroacetaldehyde (50% wt in H2O) 188 (7.8 mL, 61.5 
mmol) in water (1.2 L) were added allyl bromide 189 (8.0 mL, 92.5 mmol) and 
indium (7.1 g, 61.5 mmol). The mixture was stirred for 10 h at RT. The aqueous 
mixture was extracted with ether (3 x 250 mL), the combined organic phases were 
dried and concentrated in vacuo. The crude product was distilled (bp 65-70°C / 16-17 
Torr) to yield 190 (6.9 g, 94%) as a colorless oil: 
 
Rf 0,47 (EtOAc 100%) ; IR (neat) 3399 (br), 3079, 2912, 1642, 1432, 921 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 5.89-5.75 (m, 1H, H2), 5.20-5.14 (m, 2H, H1), 3.93-3.82 
(m, 1H, H4), 3.63 (dd, J = 4.0 Hz, 10.9 Hz, 1H, H5), 3.51 (dd, J = 6.5 Hz, 10.9 Hz, 1H, 
H5), 2.39 (br. s, 1H, OH), 2.37−2.33 (m, 2H, H3); 13C NMR (CDCl3, 100 MHz) 
δ 133.2, 118,7, 70.6, 49.4, 38.7; MS (CI, NH3) m/z 120[M+H]+. 
  
 186 
3-Hydroxy-hex-5-enenitrile (191) 
 
 
 
To a solution of 190 (6.9 g) in DMSO–H2O (10:1, 6.6 mL) was added KCN (0.43 g, 
6.65 mmol) and NaI (1.98 g, 13.3 mmol). The mixture was stirred for 5 h at 80 °C, 
then diluted with EtOAc (38 mL) and washed with saturated brine. The combined 
aqueous layers were extracted with EtOAc. The combined organic layers were dried 
and concentrated in vacuo to give crude mixture of 191 (5.1 mg), which was used in 
the next step without further purification. An analyticaly pure sample was obtained by 
column chromatography on silica gel (EtOAc:hexane, 1:15 to 1:3) as a colorless oil: 
 
Rf 0.6 (EtOAc:hexanes 1:2); IR (neat) 3445, 2930, 2360, 2253, 1644, 1418, 1073    
cm-1 ; 1H NMR (CDCl3, 400 MHz) δ  5.87-5.77 (m,1H, H2), 5.27-5.24 (m, 2H, H1), 
4.07-4.01 (m, 1H, H4), 2.60 (dd, J = 5.0 Hz, 16.7 Hz, 1H, H5), 2.55 (dd, J = 5.0, 16.7 
Hz, 1H, H5), 2.48-2.34 (m, 2H, H3), 2.09 (br. s, 1H, -OH); 13C NMR (CDCl3, 100 
MHz) δ 132.5, 120.0, 117.4, 66.7, 40.9, 25.2;   MS (CI, NH3) m/z 112 [M+H]+, 129 
[M+NH4]+; HRMS (NH3) calculated. for C6H9NO [M+NH4]+ 129.1069, found 
129.1028. 
 187 
3-(tert-butyl-dimethyl-silanyloxy)-hex-5-enenitrile (192) 
 
 
 
Imidazole (1.2 g, 17.7 mmol) and TBSCl (1.33 g, 8.9 mmol) were added to a cooled 
(0 °C) and stirred solution of crude 191 (550 mg) in DMF (3.8 mL). The mixture was 
stirred for 13 h and then diluted with H2O (45 mL). The reaction mixture was 
extracted with CH2Cl2 and the combined organic layers were dried and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel 
(EtOAc:hexane, 1:40) to provide 192 (821.7 mg, 81%) of  as a colorless oil: 
 
Rf 0.7 (EtOAc: hexane 1:4); IR (neat) 2931, 2858, 2251, 1642, 1464, 1101 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 5.84-5.73 (m, 1H, H2), 5.19 (d, J = 5.4 Hz; 1H, H1), 5.15 
(s,1H, H1), 4.03 (quint, J = 5.7 Hz, 1H, H4), 2.50 (dd, J = 5.7, 16.6 Hz, 1H, H5), 2.45 
(dd, J = 5.7, 16.6 Hz, 1H, H5), 2.38 (t, J=5.7 Hz, 2H, H3), 0.93 (s, 9H, -0-Si-C-
(CH3)3), 0.148 (s, 3H, -0-Si-CH3), 0.12 (s, 3H, -0-Si-CH3); 13C NMR (CDCl3, 100 
MHz) δ 132.8, 119.0, 117.8, 68.0, 41.5, 25.7 (3C), 25.5, 18.0, −4.6, −4.8;  MS (CI, 
NH3) m/z 226 [M+H]+,243 [M+NH4]+; HRMS (CI, NH3) calculated for C12H23NOSi 
[M+NH4]+ 243.1934, found 243,1894. 
 
 
 188 
3-(ter-butyl-dimethyl-silanyloxy)-hex-5-enal (193) 
 
 
 
To a cooled (-52 °C), stirred solution of the nitrile 192 (100 mg, 0.44 mmol) in 
toluene (1.8 mL) under argon was added DIBAL-H (0.6 mL of 1.04 mol/L solution in 
toluene, 0.66 mmol). The mixture was stirred at -52 °C for 2 h and then quenched with 
EtOH. The resulting solution was diluted with 0.2 mol/L aq. HCl (4 mL), and 
extracted with hexane (3 x 25 mL). The combined organic layers were washed with 
saturated brine-saturated aqueous NaHCO3 (1:1) and then dried and concentrated in 
vacuo to give 193 (97.3 mg, 96%) as a brown oil and was used in the next step 
without further purification. An analyticaly pure sample was obtained by column 
chromatography on silica gel (EtOAc:hexane, 1:3) as a colorless oil: 
 
Rf 0.88 (EtOAc: hexane 1:2); IR (neat) 2955, 2930, 2857, 1726, 1255, 1100, 836, 776 
cm-1; 1H NMR (CDCl3, 400 MHz) δ 9.82 (t, J = 2.3 Hz, 1H, H7), 5.84-5.75 (m, 1H, 
H2), 5.12 (m, 1H, H1), 5.09 (d, J = 5.4 Hz; 1H, H1), 4.28 (quint, J = 5,7 Hz, 1H, H4), 
2.56-2.54 (m, 2H, H5), 2.33 (t, J = 5.7 Hz, 2H, H3), 0.89 (s, 9H, -0-Si-C-(CH3)3), 0.10 
(s, 3H, -0-Si-CH3), 0.08 (s, 3H, -0-Si-CH3); 13C NMR (CDCl3, 100 MHz) 
δ 202.1, 133.8, 118.1, 67.7, 50.4, 42.3, 25.7 (3C), 18.0, −4.4, −4.8; MS (CI) m/z 229 
[M+H]+; HRMS (CI) calculated. for C12H24O2Si [M+H]+ 229,1546, found 229,1630. 
 189 
Tert-Butyl-(2,2-dimethyl-6-methylene-6H[1,3]dioxin-4-
yloxy)dimethylsilane (64)91  
 
 
 
To a solution of diisopropylamine (2.3 mL, 16.6 mmol) in THF (26 mL) at 0 °C was 
added n-BuLi (2.5 M in hexanes, 6.6 mL, 16.6 mmol). The resulting solution was 
stirred for 30 min prior to cooling to -78 °C in a dry ice/acetone bath. To this solution 
was added HMPA (3.14 mL, 18 mmol). The solution was stirred for 30 min at -78 °C, 
and then dioxinone 8 (2 mL, 15 mmol) was added slowly. The resulting solution was 
stirred 30 min at -78 °C prior to slow addition of TBSCl (2.7g, 18 mmol) in THF (10 
mL). The dry ice/acetone was removed and the solution was allowed to stir for 6 h at 
25 °C. The yellow solution was diluted with cold pentane and washed with water. The 
organic layer was dried over Na2SO4, filtered through a pad of Celite® and the filtrate 
was concentrated in vacuo. The residue was purified by distillation (bp = 68 °C, 0.44 
mbar) to yield 64 (2.9g, 76%) as a yellow oil: 
 
Rf 0.25 (EtOAc:hexanes, 1:1); IR (neat) 3417, 2933 1741, 1671, 1639, 1344, 1226 cm-
1; 1H NMR (CDCl3, 400 MHz) δ 4.64 (s, 1H, H3), 4.04 (s, 1H, H9), 3.85 (s, 1H, H9), 
1.52 (s, 6H, H7 and H8), 0.92 (s, 12H), 0.19 (s, 6H); 13C (CDCl3, 100 MHz) δ 153.6, 
152.0, 102.5, 93.9, 84.7, 25.0 (2C), 24.5 (3C), 18.0, -4.3 (2C); MS (CI, NH3) m/z 257 
[M + H]+; HRMS (CI) m/z calc for C13H25O3Si: [M+NH4]+, 257.1573; found: 
[M+NH4]+, 257.1575. 
 190 
6-[4-(tert-butyl-dimethyl-silanyloxy)-2-hydroxy-hept-6-enyl]-2,2-
dimethyl-[1,3]dioxin-4-one (194) 
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To a cooled (-78 °C), stirred solution of 193 (1.0 g, 4.38 mmol) in CH2Cl2 (18 mL) 
under argon were added BF3·Et2O (0.59 mL, 4.62 mmol) and 64 (1.23 g, 5.7 mmol). 
The mixture was stirred at -78 °C for 45 min and then quenched with saturated 
aqueous NaHCO3. This was diluted with saturated aqueous NaHCO3 (36 mL), and 
extracted with CH2Cl2. The combined organic layers were dried and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel 
(EtOAc:hexane, 1:4) to provide a 1:1 diastereoisomere mixture of 194 (726.5 mg, 
45%) as a colorless oil: 
 
Rf 0.5 (EtOAc: hexane 1:2); IR (neat) 3475, 2930, 2857, 2360, 2341, 1724, 1632, 
1390, 1255 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.79-5.71 (m, 1H, H2), 5.34 (s, 1H, 
H9), 4.09-4.05 (m, 2H, H1), 4.28-4.27 (m, 0.5H, H6), 4.09-4.05 (m, 1H, H4), 4.02-3.98 
(m, 0.5H, H6), 3.39 (s, 0.5H disappear with D2O, -OH), 2.31 (s, 0.5H disappear with 
D2O, -OH), 2.46-2.39 (m, 2H, -CH2-), 2.38-2.29 (m, 2H, -CH2-), 1.70 (s, 6H, H16 and 
H17), 1.67-1.61 (m, 2H, H3), 0.92 (s, 9H, -0-Si-C-(CH3)3), 0.15 (s, 3H, -0-Si-CH3), 
0.12 (s, 3H, -0-Si-CH3); MS (CI) m/z 370,22; HRMS (CI) calculated for C19H34O5Si 
[M+H]+
 
370.2176, found 370.2230 
 
 
 191 
6-[4-(ter-butyl-dimethyl-silanyloxy)-2-oxo-hept-6-enyl]-2,2-dimethyl-
[1,3]dioxin-4-one (195) 
 
 
 
To a cooled (0 °C), stirred solution of 194 (229 mg, 0.61 mmol) in CH2Cl2 (4.5 mL) 
was added Dess-Martin periodinane (524 mg, 1.2 mmol). The mixture was stirred for 
5 h and then diluted with saturated aqueous NaHCO3:20% aq. Na2S2O3 (1:1, 7 mL) 
and CH2Cl2 (4 mL) at 0 °C. The mixture was stirred for 20 min and then the organic 
layer was separated. The aqueous layer was extracted with CH2Cl2. The combined 
organic layers were dried and concentrated in vacuo to give the crude ketone 195, 
which was used in the next step without purification. In a small-scale experiment, the 
pure ketone was obtained by column chromatography on silica gel (EtOAc/hexane, 
1:4) as a colorless oil: 
 
Rf 0.58 (EtOAc:hexane 1:2); IR (neat) 2953, 2930, 2857, 1730, 1640 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 5.82-5.73 (m, 1H, H2), 5.33 (s, 1H, H9), 5.12-5.07 (m, 2H, H1), 
4.27-4.24 (m, 1H, H4), 3.39 (d, J = 16.8 Hz, 1H, H7), 3.34 (d, J = 16.8 Hz, 1H, H7), 
2.65 (dd, J = 7.7 Hz, J=15.5 Hz, 1H, H5), 2.53 (dd, J = 7.7 Hz, J=15.5 Hz, 1H, H5), 
2.27 (t, J = 6.0 Hz, 2H, H3), 1.73 (s, 6H, H17 and H18), 0.89 (s, 9H, -0-Si-C-(CH3)3), 
0.10 (s, 3H, -0-Si-CH3), 0.05 (s, 3H, -0-Si-CH3); 13C NMR (CDCl3, 100 
MHz)δ 202.4, 164.4, 160.8, 133.7, 118.1, 107.2, 96.7, 68.5, 49.4, 48.8, 42.1, 25.8 (3C)
, 25.1, 25.0, 18.0,−4.5, −4.9; MS (CI, NH3) 386 [M+NH4]+; HRMS (CI) calculated for 
C19H32O5Si [M+H]+  369,2019, found 369,2102. 
 192 
6-(4-hydroxy-2-oxo-hept-6-enyl)-2,2-dimethyl-[1,3] dioxin-4-one (196)
 
 
 
 
48% aq. HF (0.28 mL) was added to a cooled (0 °C), stirred solution of the crude 
ketone 195 in MeCN (5,8 mL). The mixture was stirred at RT for 8 h and then 
quenched with saturated aq. NaHCO3. The solution was diluted with saturated 
aqueous NaHCO3 (9 mL), and extracted with CH2Cl2. The combined organic layers 
were dried and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (EtOAc/hexane, 1:2) to provide 196 (80.1 mg, 51%, 2 
steps) as a colorless oil: 
 
Rf 0.28 (EtOAc:hexane 1:1); IR (neat) 3446, 2924, 2854, 1726, 1637 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 5.84-5.77 (m, 1H, H2) 5.37 (s, 1H, H9), 5.18 (s, 1H, H1), 5.15 (d, 
J = 5.6 Hz, 1H, H1), 4.18-4.15 (m, 1H, H4), 3.39 (s, 2H, H7),  2.68-2.66 (m, 2H, H5), 
2.28.(t, J = 6.5 Hz, 2H, H3), 2.05 (br, 1H,-OH), 1.73 (s, 6H, H17 and H18);  13C NMR 
(CDCl3, 100 MHz) δ 203.6, 163.9, 160.6, 133.7, 118.7, 107.3, 96.9, 66.7, 48.9, 47.9,  
41.0, 29.7, 25.1; MS (CI, NH3) m/z 255 [M+H]+, 272 [M+NH4]+; HRMS (CI, NH3) 
calculated. for C13H19O5 [M+H]+ 255.1232, found 255.1236. 
 
 
 193 
6-(2,4-Dihydroxy-hept-6-enyl)-2,2-dimethyl-[1,3]dioxin-4-one (396) 
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48% aq. HF (1.5 mL) was added to a cooled (0 °C), stirred solution of 194 (1.53 g, 
4.11 mmol) in MeCN (30.4 mL). The mixture was stirred at RT for 8 h and then 
quenched with saturated aq. NaHCO3. This was diluted with saturated aq. NaHCO3 
(49 mL), and extracted with ethyl acetate. The combined organic layers were dried 
and concentrated in vacuo. The residue was purified by column chromatography on 
silica gel (EtOAc:hexane, 1:1) to provide 396 (801 mg, 78%) as a colorless oil:
 
 
Rf 0.15 (EtOAc: hexane 1:1); 1H NMR (CDCl3, 400 MHz) δ 5.86-5.76 (m, 1H, H2), 
5.37 (s, 1H, H9), 5.23-5.18 (m, 2H, H1), 4.28-4.18 (m, 1H, H4), 4.04-3.95 (m, 1H, H6), 
2.48-2.27 (m, 4H, H3 and H7), 2.07 (br, 2H, -OH), 1.73 (s, 6H, H17 and H18), 1.68 (m, 
2H, H5); 13C NMR (CDCl3, 100 MHz) 169.6, 169.2, 161.6, 161.5, 134.3, 133.9, 118.5, 
118.3, 106.7 (2C), 95.0, 94.8, 71.4, 69.2, 67.7, 65.9, 42.5 (2C), 42.0 (3C), 41.9. 41.6, 
25.2, 25.2, 24.8; MS (CI) 257 [M+H]+. 
 194 
6-(2-Hydroxy-4-oxo-hepta-2,6-dienyl)-2,2-dimethyl-[1,3]dioxin-4-one 
(197) 
 
 
 
To a cooled (0 °C), stirred solution of 196 (29.6 mg, 0.116 mmol) in CH2Cl2 (3 mL) 
was added Dess-Martin periodinane (100 mg, 0.23 mmol). The mixture was stirred for 
5 h and then diluted with saturated aq. NaHCO3:20% aq. Na2S2O3 (1:1, 2 mL) and 
CH2Cl2 (1 mL) at 0 °C. The mixture was stirred for 20 min and then the organic layer 
was separated. The aqueous layer was extracted with CH2Cl2. The combined organic 
layers were dried and concentrated in vacuo. The ketone 197 (10 mg, 32%) was 
obtained colourless oil: 
 
Rf 0.41 (EtOAc:hexane 1:1); 1H NMR (CDCl3, 400 MHz) δ 5.93-5.86 (m, 1H, H2), 
5.59 (s, 1H, H5), 5.42 (s, 1H, H9), 5.26-5.21 (m, 2H, H1), 3.26 (s, 2H, H7), 3.11 (d, J = 
6.8Hz, 2H, H3), 1.72 (s, 6H, H17 and H18); 13C NMR (CDCl3, 100 MHz) 198.9, 190.1, 
168.9, 137.3, 134.8, 117.2, 108.5, 100.3, 91.4, 48.5, 47.1, 24.8 (2C); MS (CI, NH3) 
m/z 255 [M+NH4]+ 270; HRMS (CI, NH3) calculated. for C13H16O5 [M+NH4]+ 
270,1383, found 270.1355. 
 
 195 
6-(2-Hydroxy-4-oxo-hepta-2,6-dienyl)-2,2-dimethyl-[1,3]dioxin-4-one 
(198) 
 
 
 
To 197 (317mg, 1.2 mmol) in THF (0.8 mL), was added Et3N (0.1 mL) and heated at 
reflux overnight. Evaporation in vacuo gave 198 (247.1 mg, 82%) as a yellowish oil: 
 
Rf 0.48 (EtOAc:hexane 1:2); 1H NMR (CDCl3, 400 MHz) δ 6.47 (s, 1H, ArH), 6.32 (s, 
1H, ArH), 5.79 (m, 1H, H16), 5.12 (m, 2H, H17), 3.87 (d, J = 6.8Hz, 2H, H14), 1.72 (s, 
6H, H12 and H13); 13C NMR (CDCl3, 100 MHz) 169.2, 161.9, 159.2, 141.7, 136.5 , 
115.9, 111.6, 105.8, 104.4, 99.0, 38.8, 24.7 (2C); MS (CI) m/z 235 [M+H]+. 
 196 
6-(2,4-Dihydroxy-hepta-1,3,5-trienyl)-2,2-dimethyl-[1,3]dioxin-4-one 
(198) 
 
 
 
To 197 (300mg) in THF (0.8 mL), was added triethylamine (0.7 mL) and heated under 
refluxed for 2 days. Evaporation in vacuo gave a mixture of 199 and 198 (203 mg), 
64%:36% respectively: 
 
Rf 0.48 (EtOAc:hexane 1:2); 1H NMR (CDCl3, 400 MHz) δ 6.47 (s, 1H, ArH), 6.32 (s, 
1H, ArH), 5.79 (m, 1H, H16), 5.12 (m, 2H, H17), 3.87 (d, J = 6.8Hz, 2H, H14), 1.72 (s, 
6H, H12 and H13); 13C NMR (CDCl3, 100 MHz) 169.2, 161.9, 159.2, 141.7, 136.5 , 
115.9, 111.6, 105.8, 104.4, 99.0, 38.8, 24.7 (2C); MS (CI) m/z 235 [M+H]+. 
 197 
Ethyl (4E)-3-hydroxyhex-4-enoate (201)99 
 
 
 
A solution of butyl lithium in hexane (1.6 M, 62.5 mL, 100 mmol) was added 
dropwise at 10 °C to a stirred solution of dry diisopropylamine (14 mL, 100 mmol) in 
dry tetrahydrofuran (120 mL) under nitrogen. After being stirred for 30 min at 0 °C, 
the reaction mixture was cooled to -70 °C, and dry ethyl acetate (397) (9.8 mL, 100 
mmol) was added dropwise. The resulting solution was stirred for 1 h at -70 °C, 
becoming very pale yellow. Dry crotonaldehyde (200) (8.3 mL, 100 mmol) was added 
dropwise to it, and the reaction mixture was stirred at -70 °C for 1 h. The reaction was 
quenched at -70 °C by addition of glacial acetic acid (8.6 L, 150 mmol) and the 
resulting gel was diluted with saturated aq. NaHCO3 (100 mL) and warmed to RT. 
The resulting suspension was filtered through Celite®, and the filtrate was washed 
with ether (100 mL). The aqueous and organic phases were separated, and the aqueous 
layer was saturated with NaCl, prior to extraction with ether (3 x 100 mL). The 
combined organic layers were dried (MgSO4), and solvent was removed by 
evaporation to give a yellow liquid. Flash column chromatography on silica gel, 
eluting with 10% ethyl acetate dichloromethane, gave the title compound 201 (14.5 g, 
92%) as a mobile yellow liquid: 
 
Rf 0.33 (10% EtOAc:CH2Cl2); IR (neat) 3620, 3550, 1720, 970 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 5.69 (1 H, dqd, J = 15.3, 6.4, 1.0 Hz, H2), 5.46 (1 H, ddq, J = 
15.3, 6.5, 1.5 Hz, H3), 4.43 (1 H, dt, J = 6.0, 6.0 Hz, H4), 4.12 (2 H, q, J = 7.1 Hz), 
3.07-2.77 (1 H, br, exchanges in D2O, OH), 2.47 (2 H, d, J = 6.0 Hz, H5), 1.65 (3 H, 
dd, J = 6.4, 1.0 Hz, H1), 1.22 (3 H, t, J = 7.1 Hz); 13C NMR (CDCl3, 100 MHz) 
δ 172.3, 131.8, 127.3, 66.8, 60.6, 41.5, 17.5, 14.1; MS (CI, NH3) m/z 158 [M+H]+, 
272 [M+NH4]+; HRMS (CI, NH3) calculated. for C8H14O3 [M+NH4]+ 158.0943, found 
158.0938. 
 198 
Ethyl (4E)-3-(tert-Butyldimethylsiloxy)hex-4-enoate (202)99 
 
 
 
A solution of imidazole (8.3 g, 122 mmol) in dry CH2Cl2 (70 mL) was added at RT to 
a stirred solution of freshly distilled tert-butyldimethylsilyl chloride (6.6 g, 44 mmol) 
in dry CH2Cl2 (30 mL). To the resulting white suspension was added a solution of the 
β-hydroxy ester 201 (5.7 g, 36 mmol) in dry CH2Cl2 (40 mL). The suspension was 
stirred at RTunder nitrogen for 4 h, then quenched by addition of saturated aq. 
NaHCO3 (100 mL). The two phases were separated, and the aqueous layer was 
saturated with NaCl prior to extraction with CH2Cl2 (2 x 40 mL). The combined 
organic layers were dried (MgSO4), and solvent was removed by evaporation to give a 
pale yellow liquid. Flash column chromatography on silica gel, eluting with CH2Cl2, 
gave the title compound 202 (9.72 g, 99%) as a clear, colourless liquid: 
 
Rf 0.42 (hexane:Et2O, 9:1); IR (neat) 3030, 1735, 1670, 955 cm-1; 1H NMR (CDCl3, 
400 MHz) δ 5.61 (1 H, dqd, J = 15.3, 6.6, 0.6 Hz, H2), 5.41 (1 H, ddq, J = 15.2, 6.9, 
1.4 Hz, H3), 4.52-4.46 (1 H, m, H4), 4.09 (2 H, qd, J = 7.2, 2.2 Hz, CH3CH2-), 2.49 (l 
H,dd, J = 14.3, 8.0 Hz, H5), 2.37 (1 H,dd, J = 14.3, 5.3 Hz, H5), 1.64 (3H, ddd, J = 6.6, 
1.4, 0.8, H1), 1.23 (3 H, t, J =  7.2, CH3CH2-), 0.83 (9 H, s, SiCCH3), 0.01 (3 H, s, 
SiCH3), 0.00 (3 H, s, SiCH3), 13C NMR (CDCl3, 100 MHz) δ 171.3, 133.4, 126.0, 
70.7, 60.2, 44.1, 25.7 (3C), 18.0, 17.5, 14.2, -4.3, -5.1; MS (CI, NH3) m/z 273 
[M+H]+,HRMS (CI, NH3) calculated. for C14H32NO3Si [M+NH4]+ 290.1573, found 
290.1571. 
 
 199 
(4E)-3-(tert -Butyldimethylsiloxy)hex-4-enal (203)99 
 
 
 
A solution of diisobutylaluminium hydride in toluene (1.5 M, 35 mL, 52 mmol) was 
added dropwise at -85 °C to a stirred solution of the protected ester 202 (8.13 g, 29.8 
mmol) in dry THF (1.50 mL) under nitrogen. The solution was stirred at -90 °C for 
2.5 h, then quenched by dropwise addition of saturated aqueous ammonium chloride 
(15 mL) (T< -75 °C). The reaction mixture was allowed to warm to RT, and saturated 
aq. Rochelle salt (potassium sodium tartrate) solution (50 mL) was added. The 
solution was poured into brine (100 mL) and then ethyl acetate (150 mL) was added. 
Agitation of the mixture led to formation of a gel. Further Rochelle salt solution (50 
mL) and ethyl acetate (50 mL) were added to the gel, which was left overnight to 
break down. The resulting two liquid phases were separated, and the aqueous layer 
was saturated with sodium chloride prior to extraction with ethyl acetate (3 x 150 
mL). The combined organic layers were dried (MgS04) and then the solvent was 
removed by evaporation to give a yellow liquid. Flash column chromatography on 
silica gel, eluting with 9: 1 hexane-ether to 100% ether, gave 203 (6.1 1 g, 90%) as a 
colourless liquid: 
 
Rf 0.33 (9:1, hexane:Et2O); IR (neat) 3035, 2710, 1725, 1670, 960 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 9.74 (1 H, t, J = 2.5 Hz, H6), 5.65 (1 H, dqd, J = 15.3, 6.2, 0.7 
Hz, H2), 5.38 (1 H, ddq, J = 15.3, 6.5, 1.4 Hz, H3), 4.57 (1 H, dt, J = 6.0, 6.0 Hz, H4), 
2.58 (1 H, ddd, J = 16.0, 7.0, 2.9 Hz, H5), 2.46 (1 H, ddd, J = 16.0, 5.0, 2.2 Hz, H5), 
1.66 (3 H, dd, J = 6.2, 0.7 Hz, H1), 0.84 (9 H, s), 0.03 (3 H, s, SiCH3), 0.01 (3 H, s, 
SiCH3); 13C NMR (CDCl3, 100 MHz) δ 202.1, 133.1, 126.3, 69.4, 51.6, 25.7 (3C), 
18.0, 17.5, -5.0; -4.2; MS (CI) m/z 229 [M+H]+,HRMS (CI) calculated. for 
C12H25O2Si [M+H]+ 228.1511, found 228.1518. 
 200 
(E)-6-(4-(tert-butyldimethylsilyloxy)-2-hydroxyhept-5-enyl)-2,2-
dimethyl-4H-1,3-dioxin-4-one (204) 
 
TBSO O
2
3
TBSO HO
11
O
OO
1718
OTBS
O O
BF3
.Et2O
203
64
204
H
 
 
To a –78 °C cooled solution of compound 203 (1.0 g, 4.38 mmol) in CH2Cl2 (18 mL), 
was added BF3·Et2O (0.59 mL, 4.62 mmol) followed by 64 (1.23 g, 4.8 mmol). The 
mixture was stirred at –78 °C for 1.5 h and then quenched with saturated aqueous 
NaHCO3 (36 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic 
layers were washed with brine and dried (MgSO4). The solvent was rotary evaporated 
and the residue was purified by chromatography (SiO2, hexane:DCM 5:1 to CH2Cl2 
100% to CH2Cl2:methanol 1%) to provide the diastereoisomeric mixture of alcohols 
204 (989 mg, 61%) as a colourless oil:  
 
Rf 0.3 (EtOAc: hexane 1:3); IR (film) 3474 (br), 2954, 2931, 2857, 1727, 1634, 1390, 
1254, 1204 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.62-5.57 (m, 2H, H2 and H3), 5.33 
(S, 1H, H11), 4.48-4.42 (m, 0.5H, -CH-OH), 4.33-4.27 (m, 0.5 H, -CH-OH), 4.23-4.09 
(m, 0.5H, -CH-OH), 4.08-3.50 (m, 0.5H, -CH-OH), 3.70 (s, 0.5H, -OH), 3.62 (s, 0.5H, 
-OH), 2.41-2.23 (m, 2H), 1.70 (s, 6H, H17 and H18), 1.70-1.60 (m, 2H), 0.87 (s, 9H), 
0.08 (s, 1.5H), 0.07 (s, 1.5H), 0.04 (s, 3H); 13C NMR (100 MHz, CDCl3) δ  169.1. 
(2C), 161.1 (2C), 134.0, 132.5, 126.7, 126.4, 106.5 (2C), 95.1, 95.0, 75.0, 72.4, 68.1, 
65.8, 44.1, 43.0, 41.7, 41.6, 25.8, 25.4 (6C), 25.2, 24.9, 24.6, 18.0, 17.9, 17.6, 17.4, 
3.6, -4.4, -4.8, -5.1; MS (CI) m/z 370.22 [M]+; HRMS (CI) calculated for C19H34O5Si: 
[M]+, 370.2176; found: [M]+, 370.2230. Anal. Calcd for C19H34O5Si: C, 61.58; H, 
9.25; Found: C, 61.48; H, 9.19. 
 201 
(E)-6-(4-(tert-butyldimethylsilyloxy)-2-oxohept-5-enyl)-2,2-dimethyl-
4H-1,3-dioxin-4-one (205) 
 
 
 
To a 0 °C cooled solution of 204 (229 mg, 0.62 mmol) in CH2Cl2 (4.5 mL) was added 
in one portion Dess-Martin periodinane (509 mg, 1.2 mmol). The mixture was stirred 
for 5 h at this temperature and then diluted with saturated aq. NaHCO3 (3.5 mL), 
aqueous Na2S2O3 (2%, 3.5 mL) and CH2Cl2 (4 mL). After 20 min of continuous 
stirring the temperature was raised to RT and the organic layer was separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 20 mL) and the combined organic 
layers were dried (MgSO4) and concentrated under vacuum to give ketone 205, which 
was used in the next step without further purification. In a separate experiment, ketone 
205 was chromatographed (SiO2, EtOAc:hexane, 1:4) and obtained as a colourless oil: 
 
Rf 0.58 (EtOAc:hexane 1:2) ; IR (neat) 3448, 2999, 2925, 2856, 1724, 1633 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 5.66-5.58 (m, 1H, H2), 5.43-5.37 (m, 1H, H3), 5.28 (s, 1H, 
H11), 4.53 (dd, J = 11.9, 7.6 Hz, 1H, H4), 3.37 (s, 2H, H9), 2.70 (dd, J = 15.5, 7.6 Hz, 
1H, H5), 2.46 (dd, J = 15.5, 7.6 Hz, 1H, H5), 1.71 (s, 3H, -CH3), 1.70 (s, 3H, -CH3), 
1.66 (d, J = 7.6Hz, 3H, H1), 0.85 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H); 13C NMR (CDCl3, 
100 MHz) δ  201.9, 164.5, 160.7, 133.0, 126.6, 107.2, 96.7, 70.6, 51.3, 48.8, 25.8 
(3C), 25.1, 25.0, 18.1, 17.5, -4.2, -5.0; MS (CI, NH3) 369 [M+H]+ , 386 [M+NH4]+ 
 
 
 202 
(E)-6-(4-hydroxy-2-oxohept-5-enyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 
(206) 
 
 
 
To a 0 ºC cooled solution of the crude ketone 205 in MeCN (5.8 mL), was added aq. 
HF (48 %, 0.28 mL). The temperature was raised to RT and after 30 min of 
continuous stirring the reaction was quenched with saturated aq. NaHCO3 (9 mL) and 
extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were dried (MgSO4) 
and concentrated under vacuum. The residue was purified by column chromatography 
(SiO2, EtOAc:hexane, 1:2) to provide 206 (127 mg, 81%, overall yield from 204) as a 
colourless oil: 
 
Rf 0.3 (EtOAc: hexane 1:2); IR (neat) 3475, 2999, 1723, 1637, 1377, 1274, 1204, 
1015, 967, 903 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.79-5.62 (m, 1H, H2), 5.47 (dd, 
1H, J = 13.6, 6.8 Hz, H3), 5.34 (s, 1H, H11), 4.57-4.43 (m, 1H, H4), 3.37 (s, 2H, H9),  
2.72 (dd, J = 16.8, 8.3 Hz, 1H, H5), 2.66 (dd, J = 16.8, 3.9 Hz, 1H, H5), 2.51 (bs, 1H, -
OH), 1.70 (s, 6H, H17 and H18), 1.68 (d, J = 0.9 Hz, 3H, H1); 13C NMR (CDCl3, 100 
MHz) 203.1, 164.0, 160.6, 131.6, 127.8, 107.2, 96.8, 68.5, 49.7, 47.9, 25.0 (2C), 17.6; 
MS (CI, NH3) m/z 255 [M+H]+; HRMS (CI, NH3) calculated for C13H19O5 [M+H]+ 
255.2790, found 255.2741. Anal. Calcd for C13H18O5: C, 61.40; H, 7.14; O, 31.46 
Found: C, 61.48; H, 7.17. 
 
 
 203 
6-((3Z,5E)-4-hydroxy-2-oxohepta-3,5-dienyl)-2,2-dimethyl-4H-1,3-
dioxin-4-one (12) 
 
 
 
To a 0 °C cooled solution of 206 (262 mg, 1.03 mmol) in CH2Cl2 (26 mL) was added 
in one portion Dess-Martin periodinane (876.7 mg, 2.1 mmol). The mixture was 
stirred for 5 h at this temperature and then diluted with saturated aq. NaHCO3 (6 mL), 
aq. Na2S2O3 (2%, 6 mL) and CH2Cl2 (4 mL). After 20 min of continuous stirring the 
temperature was raised to RT and the organic layer was separated. The aqueous layer 
was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were dried 
and concentrated in vacuo. The residue was purified by chromatography (SiO2, 
EtOAc:hexane, 1:2) to provide 12 (146 mg, 56%,) as a yellow oil:  
 
Rf 0.61 (EtOAc:hexane 1:2); IR (neat) 2996, 2363, 1732, 1637, 1377, 1273, 1204, 
1015, 967, 810 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.92 (qd, J = 14.6, 7.0 Hz, 1H, 
H2), 5.8 (qd, J = 14.6, 1.5 Hz, 1H, H3), 5.49 (s, 1H, H5), 5.38 (s, 1H, H11), 3.25 (s, 2H, 
H9), 1.92 (dd, J = 7.0, 1.5 Hz, 3H, H1), 1.72 (s, 6H, H17 and H18);  13C NMR (CDCl3, 
100 MHz) δ 192.8, 177.7, 165.1, 160.7, 141.4, 126.3, 107.1, 98.8, 96.3, 44.8, 24.9 
(2C), 18.5; MS (CI, NH3) m/z 253 [M+H]+,calculated for C13H16O5 [M+H]+ 253.10. 
 204 
1-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)pentane-2,4-dione (12) 
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n-BuLi (11.9 mL, 19.11 mmol) was added dropwise to (i-Pr)2NH (2.97 mL, 21.0 
mmol) in THF (26 mL) at –78 °C and stirred for 20 min. Keto-dioxinone 16 (1.76 g, 
9.56 mmol) in THF (9.5 mL) was added dropwise with stirring to the solution at –78 
°C and the resulting cloudy yellow solution was slowly allowed to warm up to –40 °C 
and stirred for 30 min. Weinreb amide 207 (616.6 mg, 4.78 mmol) in THF (4.8 mL) 
was slowly added and the mixture stirred at –40 °C for 1 h and poured into aq. HCl (1 
M; 60 mL). Et2O was added (60 mL), the layers separated and the aqueous phase 
extracted with Et2O (60 mL). The combined organic phases were washed with brine 
(80 mL), dried (MgSO4), rotary evaporated and chromatographed (Et2O:hexanes 1:1) 
to give diketo-dioxinone 12 (313.3 mg, 26%) as a yellowish solid: 
 
Rf 0.61 (EtOAc:hexane 1:2); IR (neat) 2996, 2363, 1732, 1637, 1377, 1273, 1204, 
1015, 967, 810 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.92 (qd, J = 14.6, 7.0 Hz, 1H, 
H2), 5.8 (qd, J = 14.6, 1.5 Hz, 1H, H3), 5.49 (s, 1H, H5), 5.38 (s, 1H, H11), 3.25 (s, 2H, 
H9), 1.92 (dd, J = 7.0, 1.5 Hz, 3H, H1), 1.72 (s, 6H, H17 and H18); 13C NMR (CDCl3, 
100 MHz) δ 192.8, 177.7, 165.1, 160.7, 141.4, 126.3, 107.1, 98.8, 96.3, 44.8, 24.9 
(2C), 18.5; MS (CI, NH3) m/z 253 [M+H]+,calculated for C13H16O5 [M+H]+ 253.10. 
 205 
1-(2,4,6-trihydroxyphenyl)ethanone (45) 
 
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and MeOH (2 mL) in PhMe (10 mL) 
were heated at reflux for 5 h. The solution was rotary evaporated, dissolved in MeOH 
(10 mL) and added to a well-stirred 2 M KOH solution in MeOH (5 mL) at -20 °C. 
The solution was stirred for 70 min before being poured into ice cooled 5 M HCl (15 
mL). The precipitate was extracted with ether (3 x 20 mL). The combined organic 
phases were washed with a saturated NaCl solution (10 mL), dried, filtered and 
concentrated to give acetophenone 45 (38.9 mg, 52%) as a white solid besides a 
mixture of 45 and resorcylate 11 (11.4 mg, 12%): 
 
Product 45: Rf 0.54 (hexanes:EtOAc 1:2); 1H NMR (CDCl3, 400 MHz) δ 5.69 (s, 2H), 
2.63 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 203.8, 165.7, 165.4 (2C), 104.8, 95.1 
(2C), 32.1; MS (ESI) m/z 169 [M + H]+. This data is in accordance with the 
literature.25 
 
 206 
Methyl 2,4-dihydroxy-6-methylbenzoate (11) 
 
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and MeOH (2 mL) in PhMe (15 mL) 
were heated at reflux for 5 h. The solution was rotary evaporated and dissolved in 
MeOH (20 mL), then Cs2CO3 (716 mg, 2.2 mmol) was added in one portion and the 
mixture stirred at RT for 1 h. The mixture was quenched by addition of an aqueous 
solution of HCl (1 M) until pH 4 and the solution was stirred vigorously for 15 min. 
Brine (20 mL) was added and the mixture extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(EtOAc:hexanes 1:3) to provide methyl orsellinate 11 (70.3 mg, 87%) as a white 
solid: 
 
Rf 0.54 (hexanes:EtOAc 1:2); mp 138 °C (EtOAc/Petroleum ether); IR (neat) 3370, 
2969, 1640 cm-1; 1H NMR (CDCl3, 400 MHz) δ 11.75 (s, 1H), 6.23 (s, 1H), 6.28 (s, 
1H), 3.92 (s, 3H), 2.49 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 172.1, 165.3, 160.3, 
144.0, 111.3, 104.5, 100.9, 51.9, 24.2; MS (ESI) m/z 182 [M + H]+. This data is in 
accordance with the literature152. 
 
 207 
Methyl 2-allyl-4,6-dihydroxybenzoate (211) 
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Diketo-1,3-dioxinone 12 (100 mg, 0.4 mmol) and MeOH (0.08 mL, 2.0 mmol) were 
heated in PhMe (10 mL) at reflux for 5 h. The solution was rotary evaporated and 
dissolved in MeOH (10 mL) when Cs2CO3 (650 mg, 2.0 mmol) was added in one 
portion and the mixture was stirred at RT for 1 h. The mixture was quenched by 
addition of an aqueous solution of HCl (1 M) until pH 4 and the solution was stirred 
vigorously for 15 min. Brine (10 mL) was added and the mixture extracted with 
EtOAc (3 x 10 mL). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc:hexanes 1:4) to provide resorcylate 13 
(111.4 mg, 92%) as a clear oil:  
 
Rf 0.2 (EtOAc:hexanes 1:4); IR (neat) 3182, 3144, 2069, 1814, 1533, 1432, 1415, 
1374, 1281, 1269, 1051, 936, 916 cm-1; 1H NMR (CDCl3, 400 MHz) δ 11.67 (s, 1H, 
H7), 6.31 (d, J = 1.1Hz, 1H, ArH), 6.27 (d, J = 1.1Hz, 1H, ArH), 5.91 (ddt, J = 16.8, 
10.3, 6.4Hz, 1H, H13), 5.02-4.95 (m, 2H, H14), 3.89 (s, 3H, H11), 3.60 (d, J = 6.4Hz, 
1H, H12); 13C NMR (CDCl3, 100 MHz) 171.8, 165.2, 161.2, 143.4, 137.2, 115.5, 
111.0, 104.8, 101.7, 51.8, 40.5; MS (CI) m/z 209 [M + H]+. 
 
 208 
1-(2,4,6-trihydroxyphenyl)ethanone (214) 
 
 
 
Diketo-1,3-dioxinone 12 (50 mg, 0.22 mmol) and MeOH (2 mL) in PhMe (7 mL) 
were heated at reflux for 5 h. The solution was rotary evaporated, dissolved in MeOH 
(7 mL) and added to a well-stirred 2 M KOH solution in MeOH (5 mL) at -20 °C. The 
solution was stirred for 70 min before being poured into ice cooled 5 M HCl (15 mL). 
The precipitate was extracted with Et2O (3 x 20 mL). The combined organic phases 
were washed with a saturated NaCl solution (10 mL), dried, filtered and concentrated. 
The residue was then dissolved in AcOH (2 mL) and stirred at reflux for 2 h. The 
solution was evaporated and chromatographed (hexane:Et2O 1:2) to give product 214 
(16.8 mg, 43%) as a white solid besides a mixture of products 214 and 398 (3.1 mg, 
8%): 
 
Product 214: Rf 0.54 (hexanes:EtOAc 1:2); mp 181 °C (EtOAc/Petroleum ether); 1H 
NMR (CDCl3, 400 MHz) δ 6.47 (s, 1H), 6.02 (s, 1H), 4.54-4.49 (m, 1H), 2.77-2.63 
(m, 2H), 1.49 (d; J = 6.5 Hz, 3H) 13C NMR (CDCl3, 100 MHz) δ 195.1, 166.3, 163.8, 
163.2, 101.8, 96.6, 94.6, 74.3, 43.1, 20.9; MS (ESI) m/z 195 [M + H]+. 
 
 209 
Methyl 2,4-dihydroxy-6-methylbenzoate (11) (one step) 
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Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and MeOH (2 mL) in CH2Cl2 (15 mL) 
with 4Å molecular sieves were heated at 100 °C in a sealed tube for 10 h. The solution 
was filtered through Celite® and washed with excess CH2Cl2. The mixture was rotary 
evaporated to provide methyl orsellinate 11 (66 mg, 82%) as a white solid: 
 
Rf 0.54 (hexanes:EtOAc 1:2); mp 138 °C (EtOAc/Petroleum ether); IR (neat) 3370, 
2969, 1640 cm-1; 1H NMR (CDCl3, 400 MHz) δ 11.75 (s, 1H), 6.28 (s, 1H), 6.23 (s, 
1H), 3.92 (s, 3H), 2.49 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 172.1, 165.3, 160.3, 
144.0, 111.3, 104.5, 100.9, 51.9, 24.2; MS (ESI) m/z 182 [M + H]+. This data is in 
accordance with the literature152. 
 
 210 
Isopropyl 2,4-dihydroxy-6-methylbenzoate (218) (one step) 
 
isopropanol
sealed tube, 100 °CO
O O O O
10
O
O
OH
HO
218
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) in isopropanol (5 mL) were heated at 
100 °C in a sealed tube for 10 h. The mixture was rotary evaporated to provide 
orsellinate 218 (78 mg, 98%) as a white solid: 
 
Rf 0.54 (hexanes:EtOAc 1:3); IR (neat) 3385, 2942, 1630 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 11.85 (s, 1H), 6.41 (s, 1H), 6.38 (s, 1H), 5.25 (s, 1H), 3.42 (s, 3H), 1.32 (s, 
6H); 13C NMR (CDCl3, 100 MHz) δ 171.1, 164.3, 159.3, 144.0, 112.3, 105.5, 100.7, 
67.3, 21.6 (2C); MS (ESI) m/z 211 [M + H]+. 
 211 
Isopropyl 2,4-dihydroxy-6-methylbenzoate (218) (one step) 
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Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and isopropanol (2 mL) in CH2Cl2 (5 
mL) with 4Å molecular sieves were heated at 100 °C in a sealed tube for 10 h. The 
solution was filtered through Celite® and washed with excess CH2Cl2. The mixture 
was rotary evaporated to provide orsellinate 218 (77 mg, 98%) as a white solid: 
 
Rf 0.54 (hexanes:EtOAc 1:3); IR (neat) 3385, 2942, 1630 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 11.85 (s, 1H), 6.41 (s, 1H), 6.38 (s, 1H), 5.25 (s, 1H), 3.42 (s, 3H), 1.32 (s, 
6H); 13C NMR (CDCl3, 100 MHz) δ 171.1, 164.3, 159.3, 144.0, 112.3, 105.5, 100.7, 
67.3, 21.6 (2C); MS (ESI) m/z 211 [M + H]+. 
 212 
Pent-4-en-2-yl 2,4-dihydroxy-6-methylbenzoate (220) (one step) 
 
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and alcohol 219 (0.2 mL) in PhMe (8 
mL) with were heated at 100 °C for 5 h. The mixture was rotary evaporated, dissolved 
in isopropanol (5 mL) and heated at 100 °C in a sealed tube for 8 h to provide 
orsellinate 220 (75.2 mg, 72%) as a clear oil: 
 
Rf 0.25 (hexanes:EtOAc 1:3); IR (neat) 3375, 2932, 1653, 1602, 923 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 11.00 (s, 1H), 6.31 (s, 1H), 6.26 (s, 1H), 5.90-5.79 (m, 1H), 5.30-
5.26 (m, 1H), 5.18-5.13 (m, 2H), 2.52 (s, 3H), 2.55-2.43 (m, 2H), 1.40 (d, J = 6.4 Hz, 
3H); 13C NMR (CDCl3, 100 MHz) δ 170.5, 162.7, 160.9, 144.8, 131.1, 119.8, 111.5, 
103.7, 101.5, 71.2, 40.3, 24.9, 20.3; MS (ESI) m/z 237 [M + H]+. 
 213 
Pent-4-en-2-yl 2,4-dihydroxy-6-methylbenzoate (220) (one step) 
 
 
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) and alcohol 17 (2 mL) in CH2Cl2 (5 
mL) with 4Å molecular sieves were heated at 100 °C in a sealed tube for 10 h. The 
solution was filtered through Celite® and washed with excess CH2Cl2. The mixture 
was rotary evaporated to provide orsellinate 220 (74 mg, 72%) as a clear oil: 
 
Rf 0.25 (hexanes:EtOAc 1:3); IR (neat) 3375, 2932, 1653, 1602, 923 cm-1; 1H NMR 
(CDCl3, 400 MHz) δ 11.00 (s, 1H), 6.31 (s, 1H), 6.26 (s, 1H), 5.90-5.79 (m, 1H), 5.30-
5.26 (m, 1H), 5.18-5.13 (m, 2H), 2.52 (s, 3H), 2.55-2.43 (m, 2H), 1.40 (d, J = 6.4 Hz, 
3H); 13C NMR (CDCl3, 100 MHz) δ 170.5, 162.7, 160.9, 144.8, 131.1, 119.8, 111.5, 
103.7, 101.5, 71.2, 40.3, 24.9, 20.3; MS (ESI) m/z 237 [M + H]+. 
 
 
 
 
 214 
(6Z,8E)-((S)-5-(2-(pent-4-enyl)-1,3-dioxolan-2-yl)pentan-2-yl)7-
hydroxy-3,5-dioxodeca-6,8-dienoate (14) 
 
 
 
A mixture of alcohol 13 (33.8 mg, 0.15 mmol) and dioxolenone 12 (37.3 mg, 0.15 
mmol) in xylenes (50 µL) was heated for 8 min at 150 °C, then stirred at RT for 15 
min. The solution was concentrated in vacuo and provided 14 (62.5 mg, 99%) as a 
colourless oil: 
 
Rf 0.43 (EtOAc: hexane 1:3); 1H NMR (400 MHz, CDCl3) δ 6.94 (m, 1H), 6.77 (qd, 
1H, J = 7.0, 14.0Hz), 5.89-5.69 (m, 4H), 5.53 (s, 0.5H), 5.34 (s, 1H), 5.17 (s, 1H), 
5.03-4.94 (m, 6H), 4.94-5.03 (m, 6H), 3.92 (d, 8H, J = 3.1 Hz), 3.62 (s, 1H), 3.57 (s, 
1H), 3.22 (s, 2H), 2.05 (m, 4H), 1.91 (dt, 4H, J = 1.6, 7.2 Hz), 1.70-1.36 (m, 20H), 
1.23 (dd, 6H, J = 0.8, 6.3 Hz). 
 
 215 
(S,E)-5-(2-(pent-4-enyl)-1,3-dioxolan-2-yl)pentan-2-yl 2,4-dihydroxy-
6-(prop-1-enyl)benzoate (222) 
 
 
 
To keto ester 14 (60.3 mg, 0.148 mmol) in 2 mL of methanol was added KOH (40 mg, 
0.71 mmol). The resulting mixture was stirred for 12 h at 23 °C. The reaction mixture 
was acidified with HCl aq. to pH = 1 and extracted with 3 x 2 mL with EtOAc. The 
organic layers were dried and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (EtOAc: hexane 1:3) to provide 222 (52.5 mg, 
0.13 mmol, 91%) as a colourless oil: 
 
Rf 0.43 (EtOAc: hexane 1:3); [α]D 25 +28.6 (c 3.7, CH2Cl2); IR (film) 3338 (br), 2948, 
2360, 1644, 1259 cm-1 1H NMR (400 MHz, CDCl3) δ 11.74 (s, 1H, H14), 6.94 (dd, 1H, 
J = 1.6, 15.4 Hz, H7), 6.35 (d, 1H, J = 2.6 Hz, ArH), 6.30 (d, 1H, J = 2.6 Hz, ArH), 
5.90-5.71 (m, 2H, H8), 5.20-5.16 (m, 2H, H13), 5.10-4.92 (m, 2H, H17), 3.91 (s, 4H, 
H26 and H27), 2.03 (q, 2H, J = 7.2 Hz, H21), 1.85 (dd, 3H, J = 1.6, 6.6 Hz, H11), 1.64-
1.41 (m, 10H, H12, H19, H20, H22 and H23), 1.36 (d, 3H, J=6.3 Hz, H29); 13C NMR (100 
MHz, CDCl3) δ 170.9, 164.7, 160.2, 144.4, 138.5, 132.4, 127.0, 114.7, 111.5, 108.2, 
104.4, 102.0, 72.6, 64.9 (2C), 36.8, 36.5, 36.1, 33.8, 23.1, 20.1, 19.7, 18.4; MS (CI) 
m/z 405; HRMS (CI) calculated for C23H32O6: [M+H]+, 405,2199; found: [M+H]+, 
405.2280. Anal. Calcd for C23H32O5: C, 68.29; H, 7.97; O, 23.73 Found: C, 68.37; H, 
8.03. 
 
 216 
(S,E)-6-oxoundec-10-en-2-yl 2,4-dihydroxy-6-(prop-1-enyl)benzoate 
(226) 
 
 
 
To keto ester 14 (60 mg, 0.15 mmol) in methanol (2 mL), was added KOH (39.8 mg, 
0.71 mmol). The resulting mixture was stirred for 12 h at 23 °C. The reaction mixture 
was acidified with HCl in methanol to pH = 1 and stir for 30 min and extracted 3 x 2 
mL with EtOAc. The organic layers were dried and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (EtOAc: hexane 1:3) to 
provide 226 (43.5 mg, 82%) as a colourless oil: 
 
Rf 0.43 (EtOAc:hexane 1:3); [α]D 25 +16.1 (c 15.3, CH2Cl2); IR (film) 3371 (br), 2933, 
1644, 1260 cm-1; 1H NMR (400 MHz, CDCl3) δ 11.71 (s, 1H, H14), 6.93 (dd, J = 1.6, 
15.4 Hz, 1H, H7), 6.36 (d, J = 2.6 Hz, 1H, ArH), 6.33 (d, J = 2.6 Hz, 1H, ArH), 5.91-
5.70 (m, 3H, H8 and H18), 5.19-5.12 (m, 1H, H13), 5.00 (d, J = 17.2 Hz, 1H, H17), 4.81 
(d, J = 10.3 Hz, 1H, H17), 2.47-2.41 (m, 4H, H19 and H23), 2.06 (q, J = 7.2 Hz, 2H, 
H21), 1.85 (dd, J = 6.6, 1.6 Hz, 3H, H11), 1.71-1.65 (m, 6H, H12, H20 and H22), 1.38 (d, 
J = 6.3 Hz, 3H, H25); 13C NMR (100 MHz, CDCl3) δ  210.9, 170.8, 164.7, 160.5, 
144.4, 137.8, 132.4, 127.0, 115.3, 108.4, 104.2, 102.1, 72.2, 42.3, 41.9, 35.3, 33.0, 
22.8, 19.9, 19.3, 18.4; MS (CI) m/z 360 [M+H]+; HRMS (CI) calculated for C21H29O5: 
[M+H]+, 361.1937; found: [M+H]+, 361.1956. Anal. Calcd for C21H28O5: C, 69.98; H, 
7.83, Found: C, 69.96; H, 7.92. 
 217 
(S,E)- Zearalenone (6) 
 
 
 
To a solution of diene 226 (33.8 mg, 0.09 mmol) in PhMe (58 mL) at 80 ºC, was 
added in one portion second generation Hoyveda-Grubbs catalyst 223 (5.8 mg, 9.3 
µmol). The resultant solution was stirred for 24 h whilst argon was bubbled through 
the reaction mixture. After this period, the mixture was cooled to RT and the solvent 
was evaporated under vacuum. The residue was purified by column chromatography 
(EtOAc:hexane 1:2) to provide 6 (21.2 mg, 0.06 mmol, 71%) as a white solid whose 
analytical properties were identical with an authentic sample purchased from Sigma-
Aldrich Chemical Co. (Cat. # Z125): 
 
Rf 0.45 (EtOAc:hexane, 1:1); [α]D 25 –123.1 (c 1.0, CH2Cl2); IR (film) 3355 (br), 
2933,1694, 1674, 1611, 1581, 1446, 1354 ,1314, 1258, 1199, 1170, 1120 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 12.01 (s, 1H, H19), 7.01 (dd, J = 15.5, 1.5 Hz, 1H, H7), 
6.41 (d, J =2.5 Hz, 1H, ArH), 6.34 (d, J =2.5 Hz, 1H, ArH), 5.67 (ddd, J = 15.5, 10.5, 
3.5 Hz, 1H, H8), 5.57 (s, 1H, -OH), 5.01-4.98 (m, 1H, H14), 2.85 (ddd, J =18.5, 12.0, 
1.0 Hz, 1H, -CH2-), 2.63-2.57 (m, 1H, -CH2-), 2.41-2.33 (m, 1H, -CH2-), 2.22-2.10 
(m, 4H, -CH2-), 1.80-1.70 (m, 2H, -CH2-), 1.67-1.61 (m, 2H, -CH2-), 1.49 (m, 1H, -
CH2-), 1.38 (d, J =6.5 Hz, 3H, H22); 13C NMR (100 MHz, CDCl3) δ 211.7, 171.3, 
160.6, 165.4, 144.0, 133.1, 132.4, 108.4, 103.8, 102.4, 73.4, 42.9, 36.7, 34.7, 31.0, 
22.3, 21.0, 20.8; MS (CI) m/z 319; HRMS (CI) calculated for C18H23O5: [M+H]+, 
319.1467; found: [M+H]+, 319.1470. 
 218 
Synthesis of S-(–)-zearalenone (6), single vessel procedure 
 
 
 
A solution of compound 13 (11 mg, 0.05 mmol) and alcohol 12 (12.4 mg, 0.05 mmol) 
in toluene (0.2 mL) was heated at reflux for 2 h. After this time, the mixture was 
cooled to RT diluted with MeOH (0.3 mL) and cesium carbonate (55.9 mg, 1 mmol) 
added in one portion. The mixture was stirred at this temperature for 12 h. After this 
period the solution was acidified by the addition of Dowex resin 50WX8-400 (200 
mg) and stirred for 24 h. The resin was removed by filtration and the solution was 
diluted in PhMe (35 mL). Second generation Hoveyda-Grubbs catalyst 223 (3.2 mg, 
5.2 µmol) was added in one portion and the resultant solution was heated to 80 ºC for 
8 h whilst argon was bubbled through the reaction mixture. After this period the 
mixture was cooled to RT and the solvent was evaporated under vacuum. The residue 
was purified by column chromatography (EtOAc:hexane 1:2) to provide 6 (11 mg, 
0.03 mmol, 63%) as a white solid whose analytical properties were identical with an 
authentic sample purchased from Sigma-Aldrich Chemical Co. (Cat. # Z125).* 
 
 
 
 
                                                 
*
  When the reaction was carried out following exactly the same experimental procedure but without 
filtering off the Dowex 50WX8-400 resin, S-(–)-Zearalenone was obtained in 42 % yield.  
 219 
(3R,4R)-3,4-dihydroxydihydrofuran-2(3H)-one (250a)119 
 
 
 
D-isoascorbic acid 249 (70.0 g) in water (5 L, 4 °C) was sequentially treated with 
sodium carbonate (85.0 g) over 30 min, hydrogen peroxide 30% (88 mL) over 1 h, and 
charcoal (16.0 g in portions).The mixture was filtered through Celite® (200 mL 
boiling water wash), treated with 6 M HCl (200 mL, pH 1.5), and concentrated to 
dryness under vacuum (45-50 °C). The solid was extracted with boiling ethyl acetate 
(5 x 300 mL portions). These combined extracts were concentrated in vacuo, treated 
with diethyl ether(200 mL), filtered, affording D-erythronolactone 250a (43.6g, 94%), 
which was suitable for further use: 
 
Rf 0.5 (hexanes:EtOAc 2:1); [α]D -73 (c 1.00, H2O); mp 101-103 °C*; 1H NMR 
(DMSO-d6, 400 MHz) δ 5.81 (s, 1H), 5.41(s, 1H), 6.29 (d, J = 2.4 Hz, 1H), 4.53-4.56 
(m, 1H), 4.37-4.31 (m, 1H), 4.11-4.01 (m, 2H); 13C NMR (CDCl3, 100 MHz) 177.0, 
73.4, 71.9, 69.9; MS (ESI) m/z 119 [M + H]+. 
 
                                                 
*
 lit. mp 104-105 °C 
 220 
(2R,3R)-Benzyl 2,3,4-tri-(benzyloxy)butanoate (251a)153 
 
 
 
Ag2O (39.2 g, 169.2 mmol) was added with stirring to D-erythronolactone (250a) (5.0 
g, 42.3 mmol) and benzyl bromide (40.2 ml, 338.4 mmol) in Et2O (270 mL). The 
mixture was stirred in the dark for 3 days at RT and then filtered through Celite®. The 
filtrate was rotary evaporated and chromatographed (EtOAc:hexanes gradient 1:99 to 
3:7) affording the titled benzyl ester 251a (11.14 g, 53%) as a white solid: 
 
Rf 0.35 (hexanes:EtOAc 10:1); [α]D +25.5 (c 2.30, CH2Cl2); mp 52 °C 
(EtOAc/hexane); IR (neat) 3064, 3031, 2869, 1745, 1496, 1454, 1265, 1110, 1027, 
910, 738, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34-7.31 (m, 20H, ArH), 5.16 (d, 
J = 2.0 Hz, 2H, -CH2-), 4.68, 4.46, 4.60, 4.57 (AB2q, J = 11.5 Hz, 4H, -CH2-), 4.49 (s, 
2H, -CH2-), 4.29 (d, J = 5.2 Hz, 1H, H3), 4.04 (dd, J = 10.2, 4.8 Hz, 1H, H4), 3.75 (dd, 
J = 10.2, 4.8 Hz, 1H, H5), 3.69 (dd, J = 10.4, 5.2 Hz, 1H, H5); 13C NMR (100 MHz, 
CDCl3) 170.7, 138.1, 138.0, 137.2, 135.5, 128.5 (2C), 128.3 (3C), 128.2 (3C), 128.2 
(2C), 128.0 (2C), 127.8 (2C), 127.7 (2C), 127.6 (2C), 127.5 (2C), 78.9, 77.9, 73.3, 
72.7, 72.6, 69.0, 66.6; MS (ESI) m/z 514 [M + NH4]+; HRMS (ESI) calcd. C32H36NO5: 
[M + NH4]+, 514.2593; found: [M + NH4]+, 514.2607. Anal. calcd for C32H32O5: C, 
77.40; H, 6.50. Found: C, 77.37; H, 6.45. 
 221 
(2S,3S)-Benzyl 2,3,4-tri-(benzyloxy)butanoate (251b) 
 
 
 
This reaction followed the same procedure as for 251a starting from L-
erythronolactone 250b (1.0 g, 8.46 mmol) giving benzyl ester 251b (2.18 g, 52%) as a 
white solid:  
 
[α]D -27.1 (c 2.50, CH2Cl2); m.p. 49 °C (EtOAc/hexane); Rf, IR, 1H NMR, 13C NMR 
and MS were identical to those of (2R,3R)-benzyl 2,3,4-tris(benzyloxy)butanoate 
250a. Anal. calcd for C32H32O5: C, 77.40; H, 6.50. Found: C, 77.41; H, 6.52. 
 222 
(2S,3R)-2,3,4-Tri-(benzyloxy)butan-1-ol (252a)120 
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Benzyl ester 251a (11.0 g, 22.1 mmol) in THF (14 mL) was added dropwise with 
stirring over 10 min to LiAlH4 in THF (2.4 M; 18.4 mL, 44.3 mmol) in THF (14 mL) 
at 0 °C. After 10 min, the mixture was warmed to RT and quenched by the sequential 
addition of water (22 mL), 1 M aq. NaOH (44 mL) and water (60 mL) The suspension 
was filtered through Celite®, washed with EtOAc (2 x 50 mL) and the resulting 
solution was rotary evaporated and chromatographed (EtOAc:hexanes gradient 1:9 to 
35:65) to give alcohol 252a (10.83 g, 78%) as a clear oil:  
 
Rf 0.25 (hexanes:EtOAc 10:1); [α]D -4.4 (c 1.46, CH2Cl2); IR (KBr) 3436, 3062, 
3029, 2869, 1496, 1454, 1394, 1365, 1326, 1207, 1099, 1027, 736, 698, 597 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 7.40 -7.32 (m, 15H, ArH), 4.78 - 4.58 (m, 7H, -CH2-), 
3.82 - 3.67 (m, 6H, H2, H3 and H5); 13C NMR (CDCl3, 100 MHz) 138.1, 138.1 (2C), 
128.5, 128.4 (2C), 128.4 (3C), 127.9 (2C), 127.9 (2C), 127.8, 127.7 (2C), 127.7 (2C), 
78.6, 78.2, 73.4, 72.7, 72.3, 69.3, 61.4 ; MS (ESI) m/z 410 [M + NH4]+; HRMS (ESI) 
calcd. C25H32NO4: [M + NH4]+, 410.2331; found: [M + NH4]+, 410.2330. Anal. calcd 
for C25H28O4: C, 76.50; H, 7.19. Found: C, 76.41; H, 7.13. 
 223 
(2R,3S)-2,3,4-Tri-(benzyloxy)butan-1-ol (252b) 
 
 
 
This reaction followed the same procedure as for 252a starting from ester 251b (1.0 g, 
2.0 mmol) giving alcohol 252b (1.0 g, 79%): 
 
[α]D +3.8 (c 2.30, CH2Cl2); Rf, IR, 1H NMR, 13C NMR and MS were identical with 
those of 252a. Anal. calcd for C25H28O4: C, 76.50; H, 7.19. Found: C, 76.48; H, 7.15. 
 224 
(2S,3R)-2,3,4-Tri-(benzyloxy)butyl 2,4-dihydroxy-6-methylbenzoate 
(254a) 
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Diketo-1,3-dioxinone 10 (2.1 g, 9.3 mmol) and alcohol 252a (2.8 g, 7.1 mmol) in 
PhMe (50 mL) were heated at 110 °C for 5 h. The solution was rotary evaporated to 
give triketo-ester 253a which was dissolved in MeOH (100 mL). Cs2CO3 (7.0 g, 21.5 
mmol) was added in one portion, the mixture was stirred at RT for 1 h and quenched 
with aqueous HCl (1 M) to pH 4. The solution was stirred vigorously for 15 min, then 
brine (200 mL) was added and the mixture was extracted with EtOAc (3 x 100 mL). 
The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (hexanes:EtOAc 5:1) to provide ester 254a (2.97 g, 77%) as a clear 
oil:  
 
Rf 0.5 (hexanes:EtOAc 2:1); [α]D -15.1 (c 1.24, CH2Cl2); IR (KBr) 3330, 1649, 1620, 
1453, 1314, 1258, 1103, 845, 801, 738, 697 cm-1; 1H NMR (CDCl3, 400 MHz) δ 
11.73 (s, 1H, -OH), 7.37 - 7.27 (m, 15H, ArH), 6.29 (d, J = 2.4 Hz, 1H, ArH), 6.20 (d, 
J = 2.4 Hz, 1H, ArH), 4.77 - 4.54 (m, 8H, H10 and H18), 3.98 (m, 1H, H12), 3.88 - 3.74 
(m, 3H, H11 and –CH2-), 2.42 (s, 3H, H7); 13C NMR (CDCl3, 100 MHz) 171.4, 165.4, 
160.3, 144.0, 138.0, 137.8, 137.8, 128.4 (3C), 128.3 (3C), 128.0 (2C), 127.9, 127.8 
(3C), 127.8 (3C), 111.2, 105.7, 101.2, 76.8, 76.3, 73.4, 72.3, 68.5, 63.3, 24.5; MS 
(ESI) m/z 543 [M + H]+; HRMS (ESI) calcd. C33H35O7: [M + H]+, 543.2383; found: 
[M + H]+, 543.2389. Anal. calcd for C33H34O7: C, 73.04; H, 6.32. Found: C, 73.04; H, 
6.29. 
 225 
(2R,3S)-2,3,4-Tri-(benzyloxy)butyl 2,4-dihydroxy-6-methylbenzoate 
(254b) 
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This reaction followed the same procedure as for 254a, starting from diketo-1,3-
dioxinone 10 (500 mg, 1.3 mmol) and alcohol 252b (374.7 mg, 1.7 mmol), giving 
ester 254b (281 mg, 78%):  
 
[α]D +19.1 (c 0.80, CH2Cl2); Rf, IR, 1H NMR, 13C NMR and MS were identical with 
those of 254a. Anal. calcd for C33H34O7: C, 73.04; H, 6.32. Found: C, 73.07; H, 6.28. 
 226 
(2S,3R)-(_)-Montagnetol (244) 
 
 
 
 
Pd/C (10%, 50 mg) was added to ester 254a (246 mg, 0.45 mmol) in EtOAc (20 mL). 
After 6 h of stirring under an atmosphere of H2, the mixture was filtered through 
Celite®, and rotary evaporated to give (2S,3R)-(_)-montagnetol (244) (100 mg, 81%) 
as a white solid:  
 
Rf 0.24 (EtOAc); [α]D -10.1 (c 0.50, (CH3)2CO); mp 138-139 °C (acetone/benzene); 
IR (neat) 3379, 1646, 1455, 1316, 1263, 1205, 1167, 1078 cm-1; 1H NMR (CD3OD, 
400 MHz) δ 6.20 (d, J = 2.4 Hz, 1H, ArH), 6.15 (d, J = 2.4 Hz, 1H, ArH), 4.59 (dd, J 
= 11.6, 2.8 Hz, 1H, H11), 4.39 (dd, J = 11.6, 6.8 Hz, 1H, H11), 3.89 (td, J = 6.8, 2.8 Hz, 
1H, H10), 3.79 (dd, J = 13.6, 6.0 Hz, 1H, H18), 3.66 - 3.62 (m, 2H, H12 and H18), 2.52 
(s, 3H, H7); 13C NMR (CD3OD, 100 MHz) 173.0, 166.1, 163.8, 144.9, 112.5, 106.0, 
101.7, 73.8, 71.2, 67.9, 64.6, 24.6; MS (CI) m/z 273 [M + H]+; HRMS (CI) calcd. 
C12H17O7: [M + H]+, 273.0974; found: [M + H]+, 273.0982. Anal. calcd for C12H16O7: 
C, 52.94; H, 5.92. Found: C, 52.92; H, 5.91. 
 227 
(2R,3S)-(+)-Montagnetol (2) 
 
 
 
This reaction followed the same procedure as for 244 starting from ester 254b (123 
mg, 0.23 mmol) giving of the desired (2R,3S)-(+)-montagnetol (2) (50 mg, 81%):  
 
[α]D +11 (c 0.40, (CH3)2CO); mp 135-136 °C (acetone/benzene); Rf, IR, 1H NMR, 13C 
NMR and MS were identical with those of (2S,3R)-(_)-montagnetol (2). Anal. calcd 
for C12H16O7: C, 52.94; H, 5.92. Found: C, 52.93; H, 5.90. 
 
 228 
4-Hydroxy-6-(2-oxopropyl)-2H-pyran-2-one (256) 
 
 
 
Diketo-1,3-dioxinone 10 (100 mg, 0.44 mmol) in PhMe (30 mL) was heated for 8 h at 
110 °C. The solution was rotary evaporated and chromatographed (hexanes:EtOAc 
2:1) to provide 256 (50.3 mg, 68%) as a yellowish oil: 
 
Rf 0.20 (hexanes:EtOAc 1:1); 1H NMR (d8-THF, 400 MHz) δ 10.1 (1H, s), 5.89 (d, J 
= 2.0 Hz, 1H), 1.19 (d, J = 2.0 Hz, 1H), 3.53 (s, 2H), 2.15 (s, 3H); 13C NMR (d8-THF,
 
100 MHz) δ 200.1, 169.3, 162.5, 159.7, 101.6, 89.3, 47.2, 28.6; MS (ESI) m/z 168 [M 
+ H]+. This data is in accordance with the literature.154 
 
 
 229 
3-hydroxy-5-methyl-4-(((2S,3R)-2,3,4-tris(benzyloxy)butoxy) 
carbonyl)phenyl 2,4-dihydroxy-6-methylbenzoate (258) 
 
 
 
Sodium hydride (2.8 mg, 0.11 mmol) was added with stirring to resorcylate 254a (30 
mg, 0.06 mmol) in DMF (8 mL) at 0 °C. After 30 min at 100 °C, a solution of 
resorcylate 15 (11.5 mg, 0.06 mmol) in DMF (3 mL) was added slowly. The mixture 
was stirred for 24 h, then brine (10 mL) was added and the mixture was extracted with 
Et2O (5 x 10 mL). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (hexanes:EtOAc 5:1) to provide ester 258 (14.5 mg, 
38%) as a clear oil:  
 
Rf 0.6 (hexanes:EtOAc 4:1); [α]D -9.4 (c 0.1, CH2Cl2); IR (neat) 1745, 1653, 1600, 
1251, 1150, 1145, 721 cm-1; 1H NMR (CDCl3, 400 MHz) δ 7.42 - 7.24 (m, 15H, 
ArH), 6.65 (d, J = 2.4 Hz, 1H, ArH), 6.51 (d, J = 2.4 Hz, 1H, ArH), 6.48 (d, J = 2.4 
Hz, 1H, ArH), 6.41 (d, J = 2.4 Hz, 1H, ArH), 4.71 - 4.55 (m, 8H, H11 and -CH2-), 3.95 
- 3.94 (m, 1H, H10), 3.78 - 3.68 (m, 3H, H12 and H18), 2.42 (s, 3H, -CH3), 2.36 (s, 3H, -
CH3); 13C NMR (CDCl3, 100 MHz) 171.1, 165.9, 164.3, 161.0, 157.8, 155.1, 143.3, 
139.2, 138.1, 137.8, 137.7, 128.7 (2C), 128.6 (2C), 128.2, 128.1, 128.0, 128.0 (2C), 
127.8 (2C), 127.8 (2C), 127.8, 127.7, 116.6, 115.7, 110.2, 108.7, 108.2, 98.3, 76.3, 
73.5, 72.3, 72.2, 68.4, 68.4, 63.7, 24.3, 20.1; MS (CI) m/z 693 [M + H]+. 
 230 
3-Hydroxy-5-methyl-4-(((2S,3R)-2,3,4-tris(benzyloxy)butoxy) 
carbonyl)phenyl 2,4-bis(benzyloxy)-6-methylbenzoate (259a) 
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Trifluoroacetic anhydride (29 µL, 0.20 mmol) was added with stirring to acid 240 
(65.5 mg, 0. 19 mmol)113 in PhMe (4 mL) at 0 °C. After 2 h at RT the solution was 
rotary evaporated and the residue dissolved in PhMe (4 mL) and added slowly to ester 
254a (85 mg, 0.16 mmol) in PhMe (2 mL) at 0 °C. The mixture was stirred for 1 h at 
RT after which rotary evaporation gave the crude diester 259a (130 mg) as an oil, 
which was used directly in the next step. A small sample was purified by 
chromatography (hexanes:EtOAc 8:1) for characterization purposes: 
 
Rf 0.7 (hexanes:EtOAc 4:1); [α]D -10.1 (c 0.1, CH2Cl2); IR (neat) 1746, 1658, 1603, 
1250, 1160, 1135, 738 cm-1; 1H NMR (CDCl3, 400 MHz) δ 11.40 (s, 1H, -OH), 7.42 - 
7.26 (m, 25H, ArH), 6.64 (d, J = 2.4 Hz, 1H, ArH), 6.51 (d, J = 2.4 Hz, 1H, ArH), 
6.49 (d, J = 2.4 Hz, 1H, ArH), 6.40 (d, J = 2.4 Hz, 1H, ArH), 5.09 (s, 2H, -CH2-), 5.07 
(s, 2H, -CH2-), 4.72 - 4.56 (m, 8H, H11 and -CH2-), 3.96 - 3.95 (m, 1H, H10), 3.78 - 
3.69 (m, 3H, H12 and H18), 2.43 (s, 3H, H7), 2.37 (s, 3H, H27); 13C NMR (CDCl3, 100 
MHz) 171.1, 165.9, 164.3, 161.0, 157.8, 155.1, 143.3, 139.2, 138.1, 137.8, 137.7, 
136.4, 136.3, 128.7 (2C), 128.6 (2C), 128.4 (2C), 128.4 (3C), 128.2, 128.1, 128.0, 
128.0 (2C), 127.8 (2C), 127.8 (2C), 127.8 (2C), 127.7, 127.5 (2C), 127.4 (2C), 116.6, 
115.7, 110.2, 108.7, 108.2, 98.3, 76.3, 73.5, 72.3, 72.2, 70.7, 70.1, 68.4, 68.4, 63.7, 
24.3, 20.1; HRMS (EI) calcd. C55H53O10: [M+H]+, 873.3639; found: [M+H]+, 
873.3646. Anal. calcd for C55H52O10: C, 75.67; H, 6.00. Found: C, 75.65; H, 5.98. 
 231 
3-Hydroxy-5-methyl-4-(((2R,3S)-2,3,4-tris(benzyloxy)butoxy) 
carbonyl)phenyl 2,4-bis(benzyloxy)-6-methylbenzoate (259b) 
 
 
 
This reaction followed the same procedure as for 259a. Starting from ester 254b (70 
mg, 0.13 mmol) giving of the desired diester 259b (126 mg):  
 
[α]D +11 (c 0.1, CH2Cl2); Rf, IR, 1H NMR, 13C NMR and MS were identical with 
those of diester 259a. Anal. calcd for C55H52O10: C, 75.67; H, 6.00. Found: C, 75.65; 
H, 5.98. 
 232 
(2S,3R)-(_)-Erythrin (248) 
 
 
 
Pd/C (10%, 20 mg) was added to diester 259a (130 mg) in EtOAc (5 mL). After 6 h of 
stirring under an atmosphere of H2, the mixture was filtered through Celite®, rotary 
evaporated and chromatographed (Et2O; MeOH:EtOAc gradient 0:1 to 1:99) gave 
(2S,3R)-(_)-erythrin (248) (42 mg, 63% over 2 steps) as a white solid:  
 
Rf 0.48 (EtOAc); [α]D -8.2 (c 0.2, MeOH); mp 166 °C (EtOAc/hexane); IR (neat) 
3448, 1639. 1625, 1504, 1462, 1399, 1250, 1245, 1075, 909 cm-1; 1H NMR (CD3OD, 
400 MHz) δ 6.67 (s, 1H, ArH), 6.65 (s, 1H, ArH), 6.29 (d, J = 2.4 Hz, 1H, ArH), 6.21 
(d, J = 2.4 Hz, 1H, ArH), 4.64 (dd, J = 11.6, 2.8 Hz, 1H, H11), 4.45 (dd, J = 11.2, 6.4 
Hz, 1H, H11), 3.91 (td, J = 6.8, 2.8 Hz, 1H, H10), 3.79 (dd, J = 13.6, 6.0 Hz, 1H, H18), 
3.75-3.64 (m, 2H, H12 and H18), 2.56 (s, 6H, H7 and H27); 13C NMR (CD3OD, 100 
MHz) 171.7, 170.8, 166.6, 164.7, 162.9, 154.9, 144.8, 143.6, 117.2, 114.4, 113.0, 
109.3, 105.4, 101.9, 73.8, 71.1, 68.4, 64.6, 24.3, 23.2; HRMS (EI) calcd. 
C20H22O10Na: [M + Na]+, 445.1111; found: [M + Na]+, 445.1103. Anal. calcd for 
C20H22O10: C, 56.87; H, 5.25. Found: C, 56.86; H, 5.27. 
 
 233 
(2R,3S)-(+)-Erythrin (4) 
 
 
 
This reaction followed the same procedure as for 248. Starting from ester 259b (81 
mg) giving (2R,3S)-(+)-erythrin (4) (33.2 mg, 61% over 2 steps):  
 
[α]D +9.0 (c 0.2, MeOH); mp 168 °C (EtOAc/hexane); Rf, IR, 1H NMR, 13C NMR and 
MS were identical with those of (2S,3R)-(_)-erythrin (248). Anal. calcd for C20H22O10: 
C, 56.87; H, 5.25. Found: C, 56.89; H, 5.26. 
 
 234 
7-Hydroxy-2,2,5-trimethyl-4H-benzo[d][1,3]dioxin-4-one (15) 
 
 
 
Diketo-1,3-dioxinone 10 (1 g, 4.42 mmol) was stirred with Et3N (10 mL) overnight in 
CH2Cl2 (80 mL). The solution was evaporated and chromatographed (hexane:EtOAc 
4:1) to give benzodioxinone 15 (883 mg, 96%) as a white solid:  
 
Rf 0.20 (hexanes:EtOAc 3:1); mp 198 °C (EtOAc/hexane); IR (nujol) 1689, 1290 cm-
1; 1H NMR (CD3OD, 400 MHz) δ 6.40 (d, J = 2.4 Hz, 1H, ArH), 6.21 (d, J = 2.4 Hz, 
1H, ArH), 2.54 (s, 3H, H14), 1.66 (s, 6H, H12 and H13); 13C NMR (CD3OD, 100 MHz) 
δ 165.7, 162.8, 160.5, 146.7, 115.00, 106.2, 104.9, 102.2, 25.7 (2C), 22.3; MS (CI, 
NH3) m/z 209 [M + H]+. This data is in accordance with the literature.155 
 
 235 
Allyl 7-hydroxy-2,2,5-trimethyl-4-oxo-4H-benzo[d][1,3]dioxine-6-
carboxylate (263) 
 
 
 
Diketo-1,3-dioxinone 174 (30 mg, 0.1 mmol) was stirred with  Et3N (1.5 mL) 90 min 
in CH2Cl2 (3 mL). The solution was evaporated and chromatographed 
(EtOAc:hexanes gradient 1:4 to 1:3) to give resorcylate 263 (27.6 mg, 98%) as a clear 
oil:  
 
Rf 0.39 (EtOAc:hexanes 1:3); IR (neat) 2996, 2929 2360, 1731, 1662, 1600, 1228, 
1033, 919 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.40 (s, 1H, H1), 6.04 (ddt, J = 17.1, 
10.6, 5.9Hz, 1H, H20), 5.44 (d, J = 17.1Hz, 1H, H21), 5.34 (d, J = 10.6Hz, 1H, H21), 
4.89 (d, J = 5.9Hz, 2H, H19), 2.94 (s, 3H, H14), 1.70 (s, 3H, H12 and H13); 13C NMR 
(CDCl3, 100 MHz) 170.71, 167.09, 160.88, 159.74, 150.23, 130.98, 119.78, 111.00, 
106.62, 104.93, 103.12, 66.80, 25.71 (2C), 20.48; MS (ESI) m/z 293 [M + NH4]+; 
HRMS (ESI) calcd. C15H17O6: [M + H]+, 293.1025; found: [M + H]+, 293.1036. 
 
 
 236 
5-hydroxy-2,2,7-trimethyl-4H-benzo[d][1,3]dioxin-4-one (266) 
 
 
 
DCC (10 mg, 0.05 mmol) was added to a solution of acid 170 (10 mg, 0.04 mmol) in 
CH2Cl2 (2 mL), followed by the addition of DMAP (5.9 mg, 0.05 mmol). The mixture 
was stirred for 5 h at 40 °C. The reaction mixture was filtered through Celite® and 
rotary evaporated and chromatographed (EtOAc:hexanes 1:3) to give aromatic 266 
(8.0 g, 86%) as a clear oil: 
 
Rf 0.35 (hexanes:EtOAc 2:1); IR (nujol) 3034, 1567, 1267, 1017, 978, 856 cm-1; 1H 
NMR (CD3OD, 400 MHz) δ 6.39 (d, J = 2.1 Hz, 1H, ArH), 6.26 (d, J = 2.1 Hz, 1H, 
ArH), 2.34 (s, 3H, H27), 1.65 (s, 6H, H12 and H13); 13C NMR (CD3OD, 100 MHz) 
δ 164.2, 161.4, 159.6, 147.5, 113.3, 104.1, 103.2, 101.1, 24.3 (2C), 21.1; MS (CI) m/z 
209 [M + H]+. 
 
 
 
 237 
1,3-dioxoisoindolin-2-yl 3-oxobutanoate (275) 
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A mixture of dioxinone 8 (1 mL, 7.5 mmol) and hydroxylphthalimide (274) (1.2 g, 7.5 
mmol) in toluene (15 mL) was heated for 90 min at 90 °C. The solution was 
concentrated in vacuo and provided ester 275 (780 mg, 43%) as a yellowish solid: 
 
1H NMR (CDCl3, 400 MHz) δ 7.95 -7.62 (m, 4H), 3.42 (s, 2H), 2.28 (s, 3H); MS (CI) 
m/z 248 [M + H]+. 
 
 
 238 
N-methoxy-N-methyl-3-oxobutanamide (277) 
 
 
 
N,O-dimethylhydroxylamine 276 (731.5 mg, 7.5 mmol), dioxinone 8 (1 mL, 7.5 
mmol) and Et3N (2 mL) in toluene (10 mL) was heated for 7 h at 90 °C. The solution 
was concentrated in vacuo and provided 277 (1.1 g, 99%) as a yellowish solid: 
 
IR (neat) 3484, 2977, 2943, 1718, 1655, 1430, 1389, 1362, 1313, 1163, 1119, 1027, 
988, 937, 747 cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.68 (s, 3H), 3.57 (s, 2H), 3.19 (s, 
3H), 2.26 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 201.3, 171.9, 60.9, 48.0, 31.2, 29.7; 
MS (ESI) m/z 146 [M + H]+. Those data are in accordance with the literature.126 
 239 
5-methyl-1H-pyrazol-3(2H)-one (279) 
 
 
 
A mixture of a solution of hydrazine 1 M in THF 278 (37.5 mL, 7.5 mmol) and 
dioxinone 8 (1 mL, 7.5 mmol) in toluene (10 mL) was heated for 8 h at 110 °C. The 
solution was concentrated in vacuo and provided 279 (1.3g, 62%) as a yellowish solid: 
 
1H NMR (DMSO-d6, 400 MHz) δ 10.61 (s, 1H), 5.12 (s, 1H), 2.19 (s, 3H); 13C NMR 
(DMSO-d6, 100 MHz) δ 161.8, 139.9, 89.6, 12.9; MS (ESI) m/z 99 [M + H]+. Those 
data are in accordance with the literature.127 
 
 
 240 
2-(diethylamino)-6-methyl-4H-1,3-oxazin-4-one (289) 
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A mixture of nitrile 287 (0.87 mL, 7.5 mmol) and dioxinone 8 (1 mL, 7.5 mmol) in 
toluene (10 mL) was heated for 12 h at 90 °C. The solution was concentrated in vacuo 
and provided 289 (1.7g, 99%) as a yellowish solid: 
 
mp 83-85 °C; IR (neat) 1670, 1650 cm-1; 1H NMR (CDCl3, 400 MHz) δ 5.28 (s, 1H), 
3.37 (q, J = 6.9, 4H), 2.12 (s, 3H), 1.19 (t, J = 6.9, 6H); 13C NMR (CDCl3, 100 MHz) 
δ 172.6, 162.6, 154.2, 90.0, 41.7, 19.7, 13.6; MS (CI) m/z 183 [M + H]+. Those data 
are in accordance with the literature.128 
 
 
 
 241 
2-amino-6-methyl-4H-1,3-oxazin-4-one (288) 
 
 
 
A mixture of cyanamide 286 (315 mg, 7.5 mmol) and dioxinone 8 (1 mL, 7.5 mmol) 
in toluene (10 mL) was heated for 12 h at 110 °C. The solution was concentrated in 
vacuo and provided 288 (1.3g, 99%) as a yellowish solid: 
 
IR (neat) 1678, 1657 cm-1; 1H NMR (CDCl3, 400 MHz) δ  5.62 (s, 2H), 2.18 (s, 1H); 
13C NMR (CDCl3, 100 MHz) δ 172.6, 160.6, 151.2, 92.0, 19.7; MS (CI) m/z 127 [M + 
H]+. 
 242 
3-benzyl-6-methyl-2-phenyl-2H-1,3-oxazin-4(3H)-one (291) 
 
 
 
A mixture of compound 290 (1.41 mL, 7.5 mmol) and dioxinone 8 (1 mL, 7.5 mmol) 
in toluene (10 mL) was heated for 5 h at 90 °C. The solution was concentrated in 
vacuo and provided 291 (0.7g, 41%) as a yellowish solid: 
 
IR (neat) 2112, 1618, 1560, 1414, 1367, 1178, 910, 817 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.72-6.98 (m, 10H), 6.03 (s, 1H), 5.32 (s, 1H), 4.78 (d, J = 13.3Hz, 1H), 
4.42 (d, J = 13.3Hz, 1H), 1.89 (s, 3H); MS (CI) m/z 127 [M + H]+. Those data are in 
accordance with the literature.129 
 243 
6-((5-Hydroxy-3-methyl-4,5-dihydroisoxazol-5-yl)methyl)-2,2-
dimethyl-4H-1,3-dioxin-4-one (296) 
 
 
 
Hydroxylamine hydrochloride (125.2 mg, 1.51 mmol) was added to a solution of 
diketo-1,3-dioxinone 10 (370.4 mg, 1.63 mmol) in pyridine (4 mL) and stirred for 5 h 
at RT. The reaction mixture was poured into H2O, acidified with a solution of 6 M aq. 
HCl (9 mL) and extracted with EtOAc (3 x 15 mL). The organic layers were dried 
(MgSO4) and rotary evaporated to provide without further purification the 
dihydroisoxazol 296 (351.0 mg, 89%) as a colorless oil:  
 
Rf 0.2 (EtOAc:hexanes 1:3); 1H NMR (CDCl3, 400 MHz) δ 5.43 (s, 1H, H3), 3.08 (d, J 
= 17.9Hz, 1H, -CH2-), 2.89 (d, J = 17.9Hz, 1H, -CH2-), 3.89 (d, J = 14.8Hz, 1H, -
CH2-), 3.82 (d, J = 14.8Hz, 1H, -CH2-), 2.03 (s, 3H, H15), 1.70 (s, 3H, -CH3), 1.69 (s, 
3H, -CH3); 13C NMR (CDCl3, 100 MHz) 166.0, 160.9, 156.9, 106.9, 105.2, 49.2, 42.3, 
25.3, 24.7 (2C), 13.3; MS (ESI) m/z 242 [M + H]+. 
 
 244 
2,2-Dimethyl-6-((3-methylisoxazol-5-yl)methyl)-4H-1,3-dioxin-4-one 
(297) 
 
 
 
TFA (2 mL) was added to a solution of dihydroisoxazol 296 (351 mg, 1.45 mmol) in 
CH2Cl2 (3 mL) and stirred overnight. The mixture was dilute with H2O (6 mL) and 
extracted with EtOAc (3 x 10 mL). The organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc:hexanes 1:4) to give isoxazol 297 (249.6 
mg, 77%) as a colourless oil: 
 
Rf 0.5 (EtOAc:hexanes 1:3); IR (neat) 2109, 1640 1530, 1498, 1455, 1359, 1305, 
1020, 701 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.02 (s, 1H, H12), 5.34 (s, 1H, H3), 
3.67 (s, 2H, H7), 2.30 (s, 3H, H15), 1.67 (s, 6H, H9 and H10); 13C NMR (CDCl3, 100 
MHz) 165.2, 165.00, 160.73, 160.18, 107.30, 104.05, 95.25, 31.34, 24.87 (2C), 11.40; 
MS (ESI) m/z 224 [M + H]+. 
 
 245 
2,2-Dimethyl-6-((5-methyl-1H-pyrazol-3-yl)methyl)-4H-1,3-dioxin-4-
one (301) 
 
 
 
Hydrazine (0.2 mL, 0.2 mmol, 1M in THF) was added to a solution of diketo-1,3-
dioxinone 10 (37.0 mg, 0.16 mmol) in THF (1 mL) and stirred for 5 h at RT. The 
reaction mixture was rotary evaporated and chromatographed (EtOAc:hexanes 1:4) to 
provide pyrazol 301 (351.0 mg, 89%) as a colourless oil:  
 
Rf 0.65 (EtOAc:hexanes 1:3); IR (neat) 1862, 1639, 1389, 1360, 1307, 1017, 802 cm-
1; 1H NMR (CDCl3, 400 MHz) δ 5.95 (s, 1H, H12), 5.25 (s, 1H, H3), 3.54 (s, 2H, H7), 
2.31 (s, 3H, H15), 1.66 (s, 6H, H9 and H10); 13C NMR (CDCl3, 100 MHz) 169.05, 
161.26, 144.77, 141.48, 106.75, 104.53, 94.14, 32.61, 24.94, 11.23 (2C); MS (ESI) 
m/z 223 [M + H]+. 
 
 246 
Methyl 4-(5-methyl-1H-pyrazol-3-yl)-3-oxobutanoate (309) 
 
 
 
Pyrazol 301 (100 mg, 0.45 mmol) and MeOH (0.09 mL, 2.3 mmol) were heated in 
PhMe (10 mL) at reflux for 5 h. The solution was rotary evaporated to provide ester 
309 (64.3 mg, 73%) as yellow oil:  
 
Rf 0.2 (EtOAc:hexanes 1:4); IR (neat) 3270, 2942, 1925, 1889, 1345, 1048 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 5.96 (s, 1H, H9), 3.85 (s, 2H, H6), 3.73 (s, 3H, H7), 3.54 (s, 
2H, H3), 2.30 (s, 3H, H12); MS (ESI) m/z 197 [M + H]+. 
 247 
2-Methylpyrazolo[1,5-a]pyridine-5,7-diol (20) 
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Dioxinone 301 (52 mg, 0.23 mmol) was heated in PhMe (500 mL) in a sealed tube at 
90 ºC for 5 h. The solution was rotary evaporated to provide without further 
purification, pyrazolopyridine 20a and tautomers 20b, 20c and 20d (35.7 mg, 93%) as 
a yellowish solid:  
 
Rf 0.1 (EtOAc); IR (neat) 3421, 3235, 1868, 1648, 1497, 1455, 1422, 1204, 923, 886 
cm-1; 1H NMR (MeOD, 400 MHz) after 15 min in the solvent (ratio 20a:20c, 2:3) δ 
6.28 (s, 1H, H10) (tautomer 20c), 6.10 (s, 1H, H2) (tautomer 20a), 6.06 (s, 1H, H3) 
(tautomer 20a), 6.05 (s, 1H, H4) (tautomer 20a), 5.28 (s, 1H, H12) (tautomer 20c), 3.59 
(s, 2H, H11) (tautomer 20c), 2.43 (s, 3H, H9) (tautomer 20c), 1.67 (s, 3H, H1) 
(tautomer 20a); 1H NMR (d6-DMSO, 400 MHz) (ratio 20a:20b:20c:20d, 15:5:60:20) 
δ 12.91 (s, 1H), 9.71 (s, 1H), 6.21 (s, 1H, H10) (tautomer 20c), 6.01 (s, 1H, H14) 
(tautomer 20d), 5.90 (s, 1H, H7) (tautomer 20b), 5.88 (d, J = 1.9Hz, 1H, H3) (tautomer 
20a), 5.86 (s, 1H, H2) (tautomer 20a), 5.85 (s, 1H, H8) (tautomer 20b), 5.38 (d, J = 
1.9Hz, 1H, H4) (tautomer 20a), 5.36 (s, 1H, H12) (tautomer 20c), 5.29 (s, 1H, H6) 
(tautomer 20b), 3.73 (s, 2H, H11) (tautomer 20c), 3.65 (s, 2H, H15) (tautomer 16), 3.61 
(s, 2H, H16) (tautomer 20d), 2.30 (s, 3H, H9) (tautomer 20c), 2.22 (s, 3H, H13) 
(tautomer 20d), 2.19 (s, 3H, H5) (tautomer 20b), 2.18 (s, 3H, H1) (tautomer 20a); 13C 
NMR (d6-DMSO,
 
100 MHz) 203.2, 169.6, 164.8, 161.1, 158.1, 156.3, 156.2, 155.0, 
153.1, 142.7, 140.9, 132.7, 106.9, 106.1, 104.3, 102.4, 91.5, 89.1, 48.6, 38.9, 33.2, 
15.3, 14.6 (2C); MS (ESI) m/z 165 [M + H]+. 
 248 
2-Methylpyrazolo[1,5-a]pyridine-5,7-diol (20) 
 
 
 
Dioxinone 309 (20 mg, 0.10 mmol) was heated in THF (10 mL) and AcOH (5 mL) at 
80 ºC for 5 h. The solution was rotary evaporated to provide without further 
purification, pyrazolopyridine 20 and its tautomers (12.1 mg, 72%) as a yellowish 
solid:  
 
Rf, IR, 1H NMR, 13C NMR and MS were identical to the product obtained in the 
previous experiment. 
 
 
 249 
Methyl 5-bromofuran-2-carboxylate (317) 
 
 
 
TMSCHN2 (5.1 mL, ~2 M in Et2O) was added dropwise to acid 315 (1.9 g, 10 mmol) 
in a mixture of benzene (12 mL) and methanol (6 mL) at 0 °C until gas evolution 
ceased. The solution was filtrated and rotary evaporated to give methyl ester 317 (2.0 
g, 99%) as a white solid:  
 
Rf 0.35 (EtOAc:hexanes 1:3); IR (neat) 1703, 1580, 1462, 1295, 1110, 921, 799, 753 
cm-1; 1H NMR (MeOD, 400 MHz) δ 7.20 (d, J = 3.5Hz, 1H, H2), 6.62 (d, J = 3.5Hz, 
1H, H3), 3.87 (s, 3H, H8); 13C NMR (MeOD, 100 MHz) 159.5, 147.6, 128.9, 121.4, 
115.3, 52.6; MS (CI) m/z 206 [M + H]+; HRMS (ESI) calcd. C6H6BrO3: [M + H]+, 
206.0130; found: [M + H]+, 206.0128. 
 
 
 250 
Methyl 5-allylfuran-2-carboxylate (319) 
 
 
 
Pd(PPh3)4 (70.5 mg, 0.06 mmol, 5 mol%), furan 317 (250 mg, 1.22 mmol) and 
allyltributylstannane (318) (0.57 mL, 1.83 mmol) were heated at 90 °C in DMA (6 
mL) overnight under argon. The mixture was cooled to RT and subsequently 
quenched with a saturated aqueous NH4Cl solution (5 mL). After extraction with Et2O 
(3 x 8 mL), the combined organic layers were washed with brine, dried (MgSO4), 
rotary evaporated and chromatographed* (EtOAc:hexanes 1:10) to give 319 (129.5 g, 
64%) as a colourless oil:  
 
Rf 0.52 (EtOAc:hexanes 1:5); IR (neat) 1721, 1519, 1437, 1300, 1206, 1136, 762 cm-
1; 1H NMR (CDCl3, 400 MHz) δ 7.11 (d, J = 3.4Hz, 1H, H2), 6.16 (d, J = 3.4Hz, 1H, 
H3), 5.92 (ddt, J = 17.1, 10.2, 6.5Hz, 1H, H10), 5.20-5.15 (m, 2H, H11), 3.87 (s, 3H, 
H8), 3.47 (d, J = 6.5Hz, 2H, H6); 13C NMR (CDCl3, 100 MHz) 162.4, 159.2, 158.9, 
132.4, 119.3, 118.0, 108.2, 51.7, 32.8; MS (ESI) m/z 167 [M + H]+. 
                                                 
*
 5% of KF can be incorporated into silica to facilitate the purification. 
 251 
(5-Allylfuran-2-yl)methanol (321) 
 
 
 
 
Methyl ester 319 (233 mg, 1.4 mmol) in THF (0.5 mL) was added dropwise with 
stirring over 10 min to LiAlH4 in THF (2.4 M; 1.16 mL, 2.8 mmol) in THF (2 mL) at 
0 °C. After 10 min, the mixture was warmed to RT and quenched by the sequential 
addition of water (0.9 mL), 1 M aq. NaOH (3.2 mL) and water (2.3 mL) The 
suspension was filtered through Celite®, washed with EtOAc (2 x 3 mL) and the 
resulting solution was rotary evaporated and chromatographed (EtOAc:hexanes 
gradient 1:2) to give alcohol 321 (100.3 mg, 91%) as a clear oil:  
 
Rf 0.45 (EtOAc:hexanes 1:1); IR (neat) 3442, 1723, 1063 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 6.20 (d, J = 3.0Hz, 1H, H2), 5.96 (d, J = 3.0Hz, 1H, H3),  5.91 (ddt, J = 17.0, 
10.3, 6.5Hz, 1H, H7), 5.17-5.10 (m, 2H, H8), 4.56 (s, 2H, H9), 3.38 (d, J = 6.5Hz, 2H, 
H6); 13C NMR (CDCl3, 100 MHz) 154.2, 152.7, 133.7, 117.0, 108.7, 106.3, 57.5, 32.7; 
MS (CI) m/z 139 [M + H]+; HRMS (ESI) calcd. C8H10O2: [M + H]+, 139.1630; found: 
[M + H]+, 139.1628. 
 
 252 
2-(5-allylfuran-2-yl)acetic acid (322) 
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Et3N (0.5 mL, 3.6 mmol) and methanesulfonyl chloride (0.14 mL, 1.8 mmol) was 
added to a solution of furan 321 (100 mg, 0.72 mmol) in CH2Cl2 (35 mL) at RT. After 
30 min, the reaction was poured into water (30 mL) and acidified with 1 M HCl until 
pH 3. The aqueous layer was extracted twice with CH2Cl2 (2 x 10 mL), and the 
combined organic layers were washed with brine (25 mL), dried (MgSO4) and 
concentrated under reduced pressure. Sodium cyanide (105 mg, 2.1 mmol) was added 
to a solution of the crude mesylate (570 mg) in DMF (35 mL) at RT, and the mixture 
was heated to 85 °C for 6 h. After cooling to RT, the mixture was concentrated under 
reduced pressure until to obtain a residual volume of 3 mL. Addition of water (10 mL) 
to this residue was followed by extraction with EtOAc (3 x 7 mL). The combined 
organic layers were washed with brine (10 mL), dried (MgSO4) and concentrated 
under reduced pressure. NaOH solution 25% (2.3 mL, 14.2 mmol) was added to a 
solution of the crude nitrile (48 mg) in 95% ethanol (28 mL). The reaction mixture 
was heated at 85 °C for 7 h. After cooling to RT, the mixture was neutralized with 1 
M HCl (14 mL) until pH 3. After stirring for 10 min at RT, the mixture was poured 
into EtOAc (50 mL) and water (20 mL). The aqueous layer was extracted with EtOAc 
(2 x 30 mL), and then was washed with brine (30 mL), dried (MgSO4) and rotary 
evaporated and chromatographed (EtOAc:hexanes 1:1) to give furan 322 (9.4 mg, 8%) 
as a white solid:  
 
Rf 0.1 (EtOAc:hexanes 1:1); 1H NMR (CDCl3, 400 MHz) δ 6.11 (d, J = 3.0Hz, 1H, 
ArH), 5.94 (d, J = 3.0Hz, 1H, ArH), 5.89 (ddt, J = 17.0, 10.4, 6.5Hz, 1H, H7), 5.15-
5.07 (m, 2H, H8), 3.89 (s, 2H, H9), 3.36 (d, J = 6.5Hz, 2H, H6); MS (CI) m/z 167 [M + 
H]+. 
 253 
2-Bromo-1-(furan-2-yl)ethanone (326) 
 
 
 
n-BuLi (4.7 mL, 7.4 mmol) was added dropwise to (i-Pr)2NH (1.1 mL, 8.1 mmol) in 
THF (26 mL) at –78 °C and stirred for 20 min. Furan (324) (0.49 mL, 6.8 mmol) in 
THF (9.5 mL) was added dropwise with stirring to the solution at –78 °C and stirred 
for 20 min. Ester 325 (1 mL, 6.8 mmol) in THF (4.8 mL) was slowly added at –78 °C. 
The mixture was stirred at RT for 1 h and poured into aq. HCl (1 M; 60 mL). Et2O 
was added (60 mL), the layers separated and the aqueous phase extracted with Et2O 
(60 mL). The combined organic phases were washed with brine (80 mL), dried 
(MgSO4), rotary evaporated and chromatographed (Et2O:hexanes 1:1) to give diketo-
dioxinone 326 (1 g, 63%) as a yellowish solid:  
 
Rf 0.25 (EtOAc:hexanes 1:5); 1H NMR (CDCl3, 400 MHz) δ 7.53 (d J = 1.5Hz, 1H), 
7.21 (d, J = 3.7Hz, 1H), 6.46 (dd, J = 3.7, 1.5Hz, 1H), 4.20 (s, 2H); 13C NMR (CDCl3, 
100 MHz) 189.2, 150.1, 147.6, 119.4, 112.9, 30.5; MS (ESI) m/z 188 [M + H]+. This 
data is in accordance with the literature.123 
 
 254 
Ethyl 2-(furan-2-yl)acetate (328)137 
 
 
 
The alkyl iodide 327 (7 mL, 59.0 mmol ), furan (324) (77 mL, 1061.3 mmol), and 
FeSO4,7H2O (8.2 g, 29.5 mmol) were stirred in 1 L of DMSO for 10 min. H2O2 (35% 
in H2O, 10.9 g, 112.0 mmol) were then added dropwise, while the solution was kept at 
RT with a H2O bath and stirred overnight. The mixture was then slowly diluted with 
brine and extracted with diethyl ether. The combined organic layers were washed with 
brine (200 mL), dried (Na2SO4), rotary evaporated and chromatographed 
(EtOAc:hexanes 1:3) to provide 328 (17.0 g, 98%) as a clear oil: 
 
Rf 0.41 (CH2Cl2); IR (neat) 2984, 2940, 2908, 1741, 1603, 1507, 1478, 1466, 1448, 
1392, 1369, 1338, 1301, 1272, 1229, 1185, 1157, 1097, 1075, 1031, 1013, 951, 737, 
601cm-1; 1H NMR (CDCl3, 400 MHz) δ 7.37 (dd, J = 1.8, 0.9Hz, 1H), 6.35 (dd, J = 
3.2, 1.8Hz, 1H), 6.23 (dd, J = 3.2, 0.9Hz, 1H), 4.20 (q, J = 7.1Hz, 2H), 3.69 (s, 2H), 
1.28 (t, J = 7.1Hz, 3H); 13C NMR (CDCl3, 100 MHz) 169.4, 147.7, 142.0, 110.5, 
107.9, 61.1, 34.1, 14.1; MS (CI) m/z 154 [M + H]+. 
 255 
2-(Furan-2-yl)ethanol (345)144 
  
 
 
Ester 328 (4.18 g, 27.13 mmol) stirred in THF (160 mL) was reacted at 0 °C with 
LiAlH4 (2.08 g, 58.55 mmol) added by portions. The mixture was heated to reflux for 
1.5 h, cooled, and hydrolysed with brine (90 mL). The salts were filtered off and 
washed with AcOEt. The aqueous layer was extracted AcOEt (3 x 90 mL) and the 
combined organic layers were washed with brine (90 mL) and dried over MgSO4. 
Evaporation of the solvents in vacuo provided 345 as a malodorous yellow oil (2.86 g, 
93%): 
 
Rf 0.28 (n-hexane:AcOEt 95:5); IR (neat) 3368, 3118, 2956, 2928, 2079, 1736, 1598, 
1507, 1469, 1422, 1374, 1341, 1241, 1210, 1146, 1079, 1047, 1002, 731cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 7.32 (dd, J = 1.9, 0.8Hz, 1H, H4), 6.29 (ddt, J = 3.1, 1.9, 
0.3Hz, 1H, H3), 6.08 (dq, J = 3.1, 0.8Hz, 1H, H2), 3.82 (t, J = 6.5Hz, 2H, H7), 2.86 (t, 
J = 6.5Hz, 2H, H6), 1.76 (s, 1H, -OH); 13C NMR (CDCl3, 100 MHz) 153.4, 141.8, 
110.7, 106.72, 61.2, 31.9; MS (CI) m/z 113 [M + H]+. 
 
 256 
Ethyl 2-(5-(2-hydroxyethyl)furan-2-yl)acetate (346)144 
 
 
 
The alkyl iodide 327 (0.7 mL, 5.9 mmol), furan 345 (1.32 g, 11.8 mmol), and 
FeSO4,7H2O (820 mg, 2.95 mmol) were stirred in 100 mL of DMSO for 10 min. H2O2 
(35% in H2O, 1.1 g, 11.2 mmol) were then added dropwise, while the solution was 
kept at RT with a H2O bath and stirred overnight. The mixture was then slowly diluted 
with brine and extracted with diethyl ether. The combined organic layers were washed 
with brine (20 mL), dried (Na2SO4), rotary evaporated and chromatographed 
(EtOAc:hexanes 1:3) to provide 346 (1.7 g, 75%) as a clear oil: 
 
Rf 0.28 (n-hexane:AcOEt 75:25); IR (neat) 3457, 2960, 2983, 2934, 1738, 1640, 1615, 
1566, 1466, 1447, 1370, 1323, 1268, 1226, 1184, 1162, 1030, 971, 915, 855, 791, 
686cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.14 (d, J = 3.1Hz, 1H, ArH), 6.06 (d, J = 
3.1Hz, 1H, ArH), 4.19 (q, J = 7.1Hz, 2H, H13), 3.86 (t, J = 6.2Hz, 2H, H10), 3.65 (s, 
2H, H6), 2.88 (t, J = 6.2Hz, 2H, H9), 1.83 (br, 1H,-OH), 1.28 (t, J = 7.1Hz, 3H, H14); 
13C NMR (CDCl3, 100 MHz) 170.0, 152.8, 147.1, 109.1, 107.9, 61.6, 61.5, 34.6, 32.0, 
14.5; MS (ESI) m/z 199 [M + H]+. 
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Ethyl 2-(5-(2-oxoethyl)furan-2-yl)acetate (347) 
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Dess-Martin periodinane (214 mg, 0.5 mmol) was added in one portion with stirring 
to alcohol 346 (50 mg, 0.25 mmol) in CH2Cl2 (6 mL) at 0 °C. The mixture was stirred 
for 5 h at this temperature and diluted with saturated aq. NaHCO3 (3 mL), aq. Na2S2O3 
(2%, 3 mL) and CH2Cl2 (2 mL). After 20 min stirring, the mixture was allowed to 
warm to RT and the organic layer was separated. The aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc:hexanes 1:2) to provide aldehyde 347 (48 
mg, 98%) as a yellow oil:  
 
Rf 0.32 (EtOAc:hexanes 1:2); IR (neat) 1733, 1371, 1317, 1219, 1023, 791 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 9.71 (t, J = 2.1Hz, 1H, H10), 6.21 (d, J = 3.4Hz, 1H, ArH), 
6.20 (d, J = 3.4Hz, 1H, ArH), 4.18 (q, J = 7.2Hz, 2H, H12), 3.69 (d, J = 2.1Hz, 2H, 
H9), 3.66 (s, 2H, H6), 1.27 (t, J = 7.2Hz, 3H, H13); 13C NMR (CDCl3, 100 MHz) 196.7, 
171.0, 147.8, 145.6, 109.5, 109.0, 60.18, 42.6, 33.9, 13.9; MS (ESI) m/z 197 [M + 
H]+. 
 
 258 
(E)-ethyl 4-(5-(2-ethoxy-2-oxoethyl)furan-2-yl)but-2-enoate (349) 
 
 
 
Aldehyde 347 (50 mg, 0.25 mmol) in THF (5 mL) was slowly added at –78 °C to a 
solution of ylide 348 (133 mg, 0.38 mmol) in THF (20 mL). After 30 min at –78 °C 
and 1 h at RT, the mixture was quenched with aq. NH4Cl sat. (50 mL). The aqueous 
layer was extracted with Et2O (2 × 30 mL) and the combined organic extracts were 
washed with brine (50 mL), dried (MgSO4) and rotary evaporated. Chromatography 
(Hexanes:Et2O 4:1) gave alkene 349 (35.0 mg, 52%) as a colorless oil: 
 
Rf  0.48 (EtOAc:hexanes, 1:2); IR (film) 1630, 1389, 1354, 1218, 1027, 898 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 6.13 (d, J = 3.0 Hz, 1H, ArH),  6.02 (d, J = 3.0 Hz, 1H, 
ArH),  5.86 (d, J = 15.6 Hz, 1H, H14),  5.01 (dt, J = 15.6, 6.6 Hz, 1H, H10), 
4.21−4.16 (m, 4H, -CH2-), 3.63 (s, 2H, H6),  3.50 (d, J = 6.6 Hz, 2H, H9), 
1.27−1.24 (m, 6H, -CH3); MS (CI) m/z 267 (M+H)+. 
 
 259 
2-iodo-N-methoxy-N-methylacetamide (352) 
 
 
 
2-chloro-N-methoxy-N-methylacetamide (351) (25 g, 181.8 mmol) and NaI (32.7 g, 
218.2 mmol) in 450 mL acetone were stirred at RT overnight, in the dark. Acetone 
was removed by evaporation in vacuo. H2O (150 mL) were added to the residue and 
the product was extracted with CH2Cl2 (3 x 100 mL). The combined organic layers 
were washed with brine (150 mL), dried (Na2SO4), and rotary evaporated to give 352 
(40.8 g, 98%) as clear oil:  
 
IR (neat) 1652, 1421, 1380, 1154, 995, 936, 840 cm-1; 1H NMR (CDCl3, 400 MHz) δ 
3.86 (s, 2H, H1), 3.79 (s, 3H, H8), 3.19 (s, 3H, H6); 13C NMR (CDCl3, 100 MHz) 
169.3, 61.3, 32.7, -5.9; MS (EI) m/z 230 [M + H]+; HRMS (EI) calcd. C4H8INO2: [M 
+ H]+, 229.9678; found: [M + H]+, 229.9683. Anal. calcd. for C4H8INO2: C, 20.98; H, 
3.52; N, 6.12. Found: C, 20.94; H, 3.52; N, 6.11. 
 
 
 260 
(Furan-2-yl)-N-methoxy-N-methylacetamide (353) 
 
 
 
The alkyl iodide 352 (13.5 g, 59.0 mmol ), furan (324) (77 mL, 1061.3 mmol), and 
FeSO4,7H2O (8.2 g, 29.5 mmol) were stirred in  1 L of DMSO for 10 min. H2O2 (35% 
in H2O, 10.9 g, 112.0 mmol) were then added dropwise, while the solution was kept at 
RT with a H2O bath and stirred overnight. The mixture was then slowly diluted with 
brine and extracted with diethyl ether. The combined organic layers were washed with 
brine (200 mL), dried (Na2SO4), rotary evaporated and chromatographed 
(EtOAc:hexanes 1:3) to provide 353 (9.8 g, 98%) as a clear oil:  
 
Rf 0.25 (EtOAc:hexanes 1:3); IR (neat) 2940, 1664, 1418, 1381, 1148, 1096, 1000, 
730 cm-1; 1H NMR (CDCl3, 400 MHz) δ 7.33 (d, J = 1.9 Hz, 1H, H1), 6.30 (dd, J = 
3.2, 1.9 Hz, 1H, H2), 6.19 (d, J = 3.2 Hz, 1H, H3), 3.80 (s, 2H, H6), 3.65 (s, 3H, H12), 
3.18 (s, 3H, H10); 13C NMR (CDCl3, 100 MHz) 169.9, 148.5, 141.7, 110.4, 107.8, 
61.3, 32.1, 32.0; MS (EI) m/z 170 [M + H]+; HRMS (EI) calcd. C8H12NO3: [M + H]+, 
170.0871; found: [M + H]+, 170.0813.  
 
 
 261 
2-(furan-2-yl)-N-methoxy-N-methylpent-4-enamide (354) 
 
 
 
n-BuLi (0.24 mL, 0.40 mmol) was added dropwise to HMDS (0.07 mL, 0.5 mmol) in 
THF (4 mL) at –78 °C and stirred for 20 min. Furan 353 (30 mg, 0.18 mmol) in THF 
(2 mL) was added dropwise with stirring to the solution at –78 °C and stirred for 30 
min. Allyl bromide (189) (19.8 mg, 0.16 mmol) in THF (1 mL) was slowly added and 
the mixture stirred at RT for 1 h and poured into aq. HCl (1 M; 5 mL). Et2O was 
added (5 mL), the layers separated and the aqueous phase extracted with Et2O (5 mL). 
The combined organic phases were washed with brine (8 mL), dried (MgSO4), rotary 
evaporated and chromatographed (Et2O:hexanes 1:5) to give furan 354 (12.3 mg, 
36%) as a clear oil:  
 
Rf 0.4 (EtOAc:hexanes 1:4); IR (neat) 2945, 1645, 1420, 1344, 819, 794 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 7.34 (d, J = 2.0 Hz, 1H, H1), 6.32 (dd, J = 3.1, 2.0 Hz, 1H, 
H2), 6.18 (d, J = 3.1 Hz, 1H, H3), 5.81 (m, 1H, H7), 5.36-5.28 (m, 2H, H8), 3.94 (m, 
1H, H5), 3.68 (s, 3H, H11), 3.21 (s, 3H, H10), 2.84 (m, 2H, H6); MS (CI) m/z 210 [M + 
H]+. 
 
 262 
2-bromo-2-(5-bromofuran-2-yl)-N-methoxy-N-methylacetamide (355) 
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NBS (10.5 g, 59.1 mmol) was added to a stirred solution of substrate 353 (5.0 g, 29.6 
mmol) in CH2Cl2 at -78 °C in the dark. The reaction mixture was stirred for 1h at this 
temperature then for 8h at -25 °C and at 0 °C for 1h. The reaction mixture was 
quenched with 20% aqueous sodium sulfite and extracted with CH2Cl2. The combined 
organic layers were washed with H2O, brine, dried (MgSO4), rotary evaporated and 
chromatographed (EtOAc:hexanes 1:4) to provide 355 (7.6 g, 79%) as a yellow oil:  
 
Rf 0.4 (EtOAc:hexanes 1:3); IR (neat) 2940, 1668, 1484, 1387, 993, 787, 727 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 6.72 (d, J = 3.4 Hz, 1H, H2), 6.31 (d, J = 3.4 Hz, 1H, H3), 
6.08 (s, 1H, H6), 3.76 (s, 3H, H12), 3.26 (s, 3H, H10); 13C NMR (CDCl3, 100 MHz) 
166.0, 150.4, 123.5, 114.3, 113.4, 61.8, 34.3, 32.6; MS (CI) m/z 326 [M + H]+; HRMS 
(ESI) calcd. C8H10Br2NO3: [M + H]+, 325.9027; found: [M + H]+, 325.9028. Anal. 
calcd for C8H9Br2NO3: C, 29.39; H, 2.77; N, 4.28. Found: C, 29.47; H, 2.83; N, 4.36. 
 
 263 
2-(5-bromofuran-2-yl)-N,2-dimethoxy-N-methylacetamide (356) 
 
 
 
Dibromofuran 355 (100 mg, 0.3 mmol), zinc dust (40 mg, 0.6 mmol) and AcOH (0.5 
mL) were sonicated in MeOH (5 mL) for 1 h. The reaction mixture was filtered, rotary 
evaporated and chromatographed (EtOAc:hexanes gradient 1:3 to 1:2) to provide 356 
(71.2 mg, 62%) as a clear oil:  
 
Rf 0.3 (EtOAc:hexanes 1:2); IR (neat) 2945, 1655, 1483, 1367, 940, 785 cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 6.42 (d, J = 3.4 Hz, 1H, ArH), 6.31 (d, J = 3.4 Hz, 1H, 
ArH), 5.25 (s, 1H, H6), 3.52 (s, 3H, -CH3), 3.42 (s, 3H, -CH3), 3.22 (s, 3H, -CH3); MS 
(CI) m/z 279 [M + H]+. 
 
 264 
2-(5-bromofuran-2-yl)-N-methoxy-N-methylacetamide (357) 
 
 
 
Dibromofuran 355 (3.0 g, 9.2 mmol), zinc dust (1.2 g, 18.4 mmol) and AcOH (6.5 
mL) were sonicated in THF (70 mL) for 1 h. The reaction mixture was filtered, rotary 
evaporated and chromatographed (EtOAc:hexanes gradient 1:4 to 1:3) to provide 357 
(2.4 g, 63%) as a clear oil:  
 
Rf 0.4 (EtOAc:hexanes 1:3); IR (neat) 2940, 1667, 1384, 1122, 1000, 958, 783 cm-1; 
1H NMR (CDCl3, 400 MHz) δ 6.24 (d, J = 3.3 Hz, 1H, H2), 6.22 (d, J = 3.3 Hz, 1H, 
H3), 3.80 (s, 2H, H6), 3.70 (s, 3H, H12), 3.21 (s, 3H, H10); 13C NMR (CDCl3, 100 
MHz) 169.2, 150.6, 120.3, 112.2, 110.8, 61.4, 32.2, 31.1; HRMS (ESI) calcd. 
C8H11BrNO3: [M + H]+, 247.9922; found: [M + H]+, 247.9929. Anal. calcd for 
C8H10BrNO3: C, 38.73; H, 4.06; N, 5.65. Found: C, 38.69; H, 4.17; N, 5.67. 
 
 
 265 
2-(5-allylfuran-2-yl)-N-methoxy-N-methylacetamide (357) 
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Pd2dba3 (263.6 mg, 0.29 mmol, 3 mol%) and tBu-X-Phos (366.8 mg, 0.86 mmol, 9 
mol%) were sonicated under argon in DMA (10 mL) for 1 h. The resulting mixture, 
furan 357 (2.4 g, 9.6 mmol) and allyltributylstannane (318) (4.5 mL, 14.4 mmol) were 
heated at 90 °C in DMA (37 mL) overnight under argon. The mixture was cooled to 
RT and subsequently quenched with a sat. NH4Cl solution (10 mL). After extraction 
with Et2O (3 x 15 mL), the combined organic layers were washed with brine, dried 
(MgSO4), rotary evaporated and chromatographed (EtOAc:hexanes 1:4) to give 17 
(1.9 g, 69%) as a colourless oil:  
 
Rf 0.45 (EtOAc:hexanes 1:4); IR (neat) 2938, 1669, 1418, 1384, 999, 919, 784 cm-1; 
1H NMR (CDCl3, 400 MHz) δ 6.12 (d, J = 3.0Hz, 1H, H2), 5.95 (d, J = 3.0Hz, 1H, 
H3), 5.91 (ddt, J = 17.1, 10.3, 6.5Hz, 1H, H14), 5.16-5.08 (m, 2H, H15), 3.78 (s, 2H, 
H6), 3.68 (s, 3H, H12), 3.36 (d, J = 6.5Hz, 2H, H13), 3.21 (s, 3H, H10); 13C NMR 
(CDCl3, 100 MHz) 170.2, 153.1, 147.2, 134.0, 116.8, 108.5, 106.5, 61.3, 32.6, 32.2; 
HRMS (ESI) calcd. C11H16NO3: [M + H]+, 210.1130; found: [M + H]+, 210.1128. 
Anal. calcd for C11H15NO3: C, 63.14; H, 7.23; N, 6.69. Found: C, 63.02; H, 7.10; N, 
6.59. 
 266 
6-(3-chloro-2-oxopropyl)-2,2-dimethyl-4H-1,3-dioxin-4-one (90) 
 
 
 
LiN(SiMe3)2 in THF (1 M; 17 mL, 17 mmol) was added dropwise with stirring to 
dioxinone 8 (2 mL, 15 mmol) in THF (250 mL) and the resulting pale yellow solution 
stirred at –70 °C for 50 min, when acid chloride 89 (0.39 mL, 5 mmol) was added. 
The reaction temperature was maintained at –70 °C for 30 min after which time the 
solution was poured onto aq. HCl (1 M, 50 mL) and Et2O (100 mL) was added. The 
organic phase was washed with brine (3 x 100 mL), dried (MgSO4), rotary evaporated 
and chromatographed (Et2O:hexanes gradient 1:1 to 2:1) gave keto-dioxinone 90 
(769.8 mg, 70%) as a yellow solid: 
 
Rf 0.45 (EtOAc:hexanes 1:4); IR (neat) 1730 1645 cm-1; 1H NMR (CDCl3, 400 MHz) 
δ 5.40 (s, 1H), 4.18 (s, 2H), 3.59 (s, 2H), 1.73 (s, 6H); MS (ESI) m/z 219 [M + H]+. 
This data is in accordance with the literature.53 
 
 
 267 
1-(5-allylfuran-2-yl)-5-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-
yl)pentane-2,4-dione (312) 
 
 
 
n-BuLi (11.9 mL, 19.11 mmol) was added dropwise to (i-Pr)2NH (2.97 mL, 21.0 
mmol) in THF (26 mL) at –78 °C and stirred for 20 min. Keto-dioxinone 16 (1.76 g, 
9.56 mmol) in THF (9.5 mL) was added dropwise with stirring to the solution at –78 
°C and the resulting cloudy yellow solution was slowly allowed to warm up to –40 °C 
and stirred for 30 min. Weinreb amide 17 (1 g, 4.78 mmol) in THF (4.8 mL) was 
slowly added and the mixture stirred at –40 °C for 1 h and poured into aq. HCl (1 M, 
60 mL). Et2O was added (60 mL), the layers separated and the aqueous phase 
extracted with Et2O (60 mL). The combined organic phases were washed with brine 
(80 mL), dried (MgSO4), rotary evaporated and chromatographed (Et2O:hexanes 1:1) 
to give diketo-dioxinone 312 (1.08 g, 63%) as a yellowish solid:  
 
Rf 0.3 (EtOAc:hexanes 1:3); mp 48-49 °C (Et2O/hexanes); IR (neat) 2914, 1714, 
1587, 1376, 1273, 1196, 1013, 780 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.11 (d, J = 
3.1Hz, 1H, ArH), 5.98 (d, J = 3.1Hz, 1H, ArH), 5.91 (ddt, J = 16.8, 10.2, 6.7Hz, 1H, 
H12), 5.51 (s, 1H, H8), 5.36 (s, 1H, H17), 5.16 - 5.11 (m, 2H, H13), 3.63(s, 2H, H6), 3.36 
(d, J = 6.7Hz, 2H, H11), 3.19 (s, 2H, H14), 1.66 (s, 6H, H22 and H23); 13C NMR 
(CDCl3, 100 MHz) 189.9, 187.2, 164.7, 160.6, 153.9, 146.5, 133.7, 117.0, 109.3, 
107.1, 106.6, 99.3, 96.4, 43.0, 37.3, 32.6, 24.9 (2C); MS (CI) m/z 350 [M + NH4]+; 
HRMS (ESI) calcd. C18H21O6: [M + H]+, 333.1338; found: [M + H]+, 333.1334. Anal. 
calcd for C18H20O6: C, 65.05; H, 6.07. Found: C, 64.93; H, 5.92. 
 268 
(R,E)-1-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-5-(5-(5-hydroxyhex-
2-enyl)furan-2-yl)pentane-2,4-dione (372) 
 
 
 
Diketo-dioxinone 312 (80 mg, 0.24 mmol), alcohol 18 (25 mg, 0.28 mmol) and 
Grubbs- Hoveyda 2nd generation catalyst 223 (18.9 mg, 0.03 mmol, 15 mol%) in 
CH2Cl2* (4 mL) were stirred at 40 °C for 1 h. Rotary evaporation and chromatography 
(EtOAc:hexanes gradient 1:1 to 3:1) gave an inseparable diastereoisomeric mixture of 
alcohols Z and E 372 (56.7 mg, 61%) as a red oil in a ratio 1:9, Z:E:  
 
Rf 0.2 (EtOAc:hexanes 1:1); IR (neat) 3439, 1725, 1634, 1456, 1376, 1272, 1203, 
1015, 973 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.10 (d, J = 3.1Hz, 1H, ArH), 5.95 (d, 
J = 3.1Hz, 1H, ArH), 5.63 – 5.57 (m, 2H, H23 and H24), 5.50 (d, J = 3.9Hz, 1H, H9), 
5.37 (d, J = 3.9Hz, 1H, H3), 3.89 – 3.77 (m, 1H, H26), 3.62 (s, 2H, H12), 3.33 (d, J = 
5.9Hz, 2H, H18), 3.20 (s, 2H, H7), 2.63 – 2.13 (m, 2H, H25), 1.67 (s, 6H, H20 and H21), 
1.19 (d, J = 6.1Hz, 3H, H28); 13C NMR (CDCl3, 100 MHz) 189.8, 187.3, 164.8, 160.6, 
154.3, 146.5, 128.9, 109.3, 107.1, 106.4, 99.3, 96.3, 67.1, 43.0, 42.3, 37.3, 31.5, 24.9 
(3C), 22.7; HRMS (ESI) calcd. C21H26O7Na: [M + Na]+, 413.1576; found: [M + Na]+, 
413.1576. Anal. calcd for C21H26O7: C, 64.60; H, 6.71. Found: C, 64.71; H, 6.62. 
 
                                                 
*
 Solvents were degassed with N2 
 269 
(R,E)-7-hydroxy-5-((5-(5-hydroxyhex-2-enyl)furan-2-yl)methyl)-2,2-
dimethyl-4H-benzo[d][1,3]dioxin-4-one (374) 
 
 
 
Diketo-1,3-dioxinone 372 (30 mg, 0.08 mmol) was stirred with  Et3N (1.5 mL) 1 h in 
CH2Cl2 (3 mL). The solution was evaporated and chromatographed (EtOAc:hexanes 
gradient 1:2 to 1:1) to give an inseparable diastereoisomeric mixture of 
benzodioxinones Z and E 374 (18.2 mg, 64%) as a clear oil in a ratio 1:9, Z:E:  
 
Rf 0.45 (EtOAc:hexanes 1:1); IR (neat) 3371, 1715, 1614, 1291, 1207, 1172, 1053, 
860 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.28 (d, J = 2.3Hz, 1H, ArH), 6.16 (d, J = 
2.3Hz, 1H, ArH), 6.09 (d, J = 2.9Hz, 1H, ArH), 5.99 (d, J = 2.9Hz, 1H, ArH), 5.77-
5.71 (m, 1H, =CH-), 5.59-5.55 (m, 1H, =CH-), 4.52 (d, J = 17.6Hz, 1H, H12), 4.36 (d, 
J = 17.6Hz, 1H, H12), 3.99-3.85 (m, 1H, H25), 3.35 (d, J = 6.4Hz, 2H, H18), 2.39-2.35 
(m, 1H, H24), 2.06-2.03 (m, 1H, H24), 1.67 (s, 6H, H22 and H23), 1.36 (d, J = 6.9Hz, 
3H, H26); 13C NMR (CDCl3, 100 MHz) 163.1, 159.1, 152.8, 151.8, 146.1, 132.0, 
127.5, 111.8, 108.5, 106.6, 104.9, 103.7, 102.4, 67.2, 41.5, 32.1, 31.3, 25.6, 22.2; MS 
(ESI) m/z 373 [M + H]+. 
 270 
(R)-pent-4-en-2-yl 2-((5-allylfuran-2-yl)methyl)-4,6-
dihydroxybenzoate (365) 
 
Diketo-1,3-dioxinone 312 (500 mg, 1.5 mmol) and alcohol 18 (647.8 mg, 7.5 mmol) 
were heated in PhMe (35 mL) at reflux for 5 h. The solution was rotary evaporated 
and dissolved in MeOH (35 mL) when Cs2CO3 (2.5 g, 7.5 mmol) was added in one 
portion and the mixture was stirred at RT for 1 h. The mixture was quenched by 
addition of an aqueous solution of HCl (1 M) until pH 4 and the solution was stirred 
vigorously for 15 min. Brine (30 mL) was added and the mixture extracted with 
EtOAc (3 x 30 mL). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc:hexanes 1:4) to provide resorcylate 365 
(396.2 mg, 78%) as a clear oil:  
 
Rf 0.55 (EtOAc:hexanes 1:4); [α]D -28.0 (c 0.21, CH2Cl2); IR (neat) 3341, 1741, 1640, 
1447, 1606, 1255, 1157, 782 cm-1; 1H NMR (CDCl3, 400 MHz) δ 11.87 (s, 1H, H7), 
6.34 (d, J = 2.7Hz, 1H, ArH), 6.17 (d, J = 2.7Hz, 1H, ArH), 5.92 (ddt, J = 17.0, 10.2, 
6.7Hz, 1H, =CH-), 5.90 (d, J = 3.0Hz, 1H, ArH), 5.71 (ddt, J = 17.2, 10.0, 7.2Hz, 1H, 
=CH-), 5.69 (d, J = 3.0Hz, 1H, ArH), 5.22–5.06 (m, 5H, H12, H24 and H25), 4.26 (d, J 
= 16.4Hz, 1H, H16), 4.14 (d, J = 16.4Hz, 1H, H16), 3.35 (d, J = 6.3Hz, 2H, H22), 2.42 - 
2.26 (m, 2H, H14), 1.22 (d, J = 6.3Hz, 3H, H13); 13C NMR (CDCl3, 100 MHz) 170.6, 
165.5, 160.2, 153.1, 152.4, 143.1, 134.1, 133.4, 118.1, 116.7, 111.2, 106.8, 106.2, 
105.8, 102.2, 72.1, 40.1, 35.2, 32.7, 19.3; HRMS (ESI) calcd. C20H23O5: [M + H]+, 
343.1545; found: [M + H]+, 343.1544. Anal. calcd for C20H22O5: C, 70.16; H, 6.48. 
Found: C, 70.09; H, 6.48. 
 271 
(R)-5-((5-allylfuran-2-yl)methyl)-4-((pent-4-en-2-yloxy)carbonyl)-1,3-
phenylene diacetate (375) 
 
 
 
Ac2O (4.3 mL) and DMAP (15.4 mg, 0.126 mmol) were added to resorcylate 365 
(429.8 mg, 1.26 mmol) in THF (45 mL) and the solution was stirred at RT for 70 min. 
The reaction mixture was quenched with EtOAc
 
(40 mL) and washed with H2O, 
NaHCO3 sat. aq. solution, brine. The organic layer was dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc:hexanes 1:4) to provide 375 (390.9 mg, 
73%) as a clear oil:  
 
Rf 0.25 (EtOAc:hexanes 1:4); [α]D -4.1 (c 0.4, CH2Cl2); IR (neat) 1772, 1723, 1428, 
1368, 1185, 1134, 1091, 1017, 906 cm-1; 1H NMR (CDCl3, 400 MHz) δ 6.90 (d, J = 
2.2Hz, 1H, ArH), 6.85 (d, J = 2.2Hz, 1H, ArH), 5.90 (ddt, J = 17.0, 10.3, 6.5Hz, 1H, 
H15), 5.88 (d, J = 5.0Hz, 2H, ArH), 5.75 (ddt, J = 17.2, 10.0, 7.2Hz, 1H, H23), 5.22 – 
5.06 (m, 5H, H12, H24 and H25), 4.05 (d, J = 16.4Hz, 1H, H16), 3.35 (d, J = 6.3Hz, 2H, 
H22), 2.42 - 2.26 (m, 2H, H14), 2.26 (m, 6H, H7 and H8), 1.27 (d, J = 6.3Hz, 3H, H13); 
13C NMR (CDCl3, 100 MHz) 168.5 (2C), 165.1, 153.1, 151.6, 151.0, 148.9, 139.3, 
133.9, 133.3, 124.2, 120.6, 118.1, 116.7, 115.0, 108.0, 106.3, 71.8, 40.1, 32.6, 32.2, 
21.1, 20.9, 19.2; HRMS (ESI) calcd. C24H27O7: [M + H]+, 427.1757; found: [M + H]+, 
427.1763. Anal. calcd for C24H26O7: C, 67.59; H, 6.15. Found: C, 67.67; H, 6.02. 
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(R,E)-diacetate-dechloro-pochonin H (376) 
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Grubbs-Hoveyda 2nd generation catalyst 223 (86.2 mg, 0.137 mmol) in PhMe (5 mL) 
was added to resorcylate 375 (390.9 mg, 0.92 mmol) in PhMe* (1 L) and the mixture 
was stirred at 90 °C for 2 h. Rotary evaporation and chromatography (EtOAc:hexanes 
1: 4) gave the inseparable diastereoisomeric mixture of macrolactones Z and E 376 
(197.1 mg, 54%) as a clear oil in a ratio 1:3, Z:E:  
 
Rf 0.3 (EtOAc:hexanes 1:4); 1H NMR (CDCl3, 400 MHz) δ 6.93 (d, J = 2.3Hz, 1H, 
ArH), 6.83 (d, J = 2.3Hz, 1H, ArH), 5.94 (d, J = 3.0Hz, 1H, ArH), 5.81 (d, J = 3.0Hz, 
1H, ArH), 5.60–5.47 (m, 2H, H12 and H13), 5.38–5.33 (m, 1H, H10), 4.70 (d, J = 
14.4Hz, 1H, H20), 3.60 (d, J = 14.4Hz, 1H, H20), 3.22–3.20 (m, 2H, H14), 2.27 (s, 3H, -
CH3), 2.26 (s, 3H, -CH3), 1.40 (d, J = 6.3Hz, 3H, H23); 13C NMR (CDCl3, 100 MHz) 
168.4 (2C), 165.7, 151.6, 151.5, 151.2, 149.3, 141.5, 130.4, 127.7, 126.7, 121.2, 
114.9, 105.8, 105.7, 71.9, 38.7, 31.9, 30.9, 21.4, 21.2, 21.1; HRMS (ESI) calcd. 
C22H23O7: [M +H]+, 399.1444; found: [M + H]+, 399.1447. 
 
                                                 
*
 Solvents were degassed with N2 
 273 
(R,E)-dechloro-pochonin H (366) 
 
 
 
Aq. NaHCO3 (16 mL) was added with stirring to macrolactone 376 (197.1 mg, 0.49 
mmol) in MeOH (16 mL) at RT. After 14 h, EtOAc (10 mL) and saturated NH4Cl 
solution (10 mL) were added, extracted with EtOAc (3 x 10 mL). The combined 
organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(EtOAc:hexanes 1:2) to provide resorcylate 366 (104.9 mg, 68%) as a white solid:  
 
Rf 0.25 (EtOAc:hexanes 1:2); [α]D +118.0 (c 0.2, MeOH); mp 147-151 °C 
(EtOAc/hexanes); IR (neat) 3385, 1699, 1619, 1255, 1051, 1027, 970, 785cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 8.51 (s, 1H, H21), 6.30 (d, J = 2.5Hz, 1H, ArH), 6.25 (d, J 
= 2.5Hz, 1H, ArH), 5.88 (d, J = 2.9Hz, 1H, ArH), 5.82 (d, J = 2.9Hz, 1H, ArH), 5.68–
5.59 (m, 2H, H10 and H12), 5.54–5.48 (m, 1H, H13), 5.07 (d, J = 14.3Hz, 1H, H20), 3.49 
(d, J = 14.3Hz, 1H, H20), 3.31–3.15 (m, 2H, H14), 2.45–2.24 (m, 2H, H11), 1.47 (d, J = 
6.5Hz, 3H, H23); 13C NMR (CDCl3, 100 MHz) 164.8, 159.7, 159.2, 152.2, 151.1, 
144.6, 129.7, 128.4, 111.1, 108.8, 105.7, 105.7, 102.2, 70.3, 40.0, 33.3, 30.8, 21.6; 
HRMS (ESI) calcd. C18H19O5: [M + H]+, 315.1232; found: [M + H]+, 315.1230. Anal. 
calcd for C18H18O5: C, 68.78; H, 5.77. Found: C, 68.81; H, 5.76. 
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(R,5E,9Z)-14,16-dihydroxy-3-methyl-3,4-dihydro-1H-
benzo[c][1]oxacyclotetradecine-1,8,11(7H,12H)-trione (382) 
 
 
 
SO2Cl2 (70 µL, 0.70 mmol, 1 M in CH2Cl2) was added dropwise with stirring to 
macrolactone 366 (20 mg, 0.064 mmol) in THF (0.8 mL) at –30 °C and stirred at this 
temperature for 1 h. The resulting solution was slowly allowed to warm up to 0 °C and 
stirred for another 30 min. The reaction mixture was quenched with NH4Cl (2 mL) and 
extracted with EtOAc. The organic layer was dried (MgSO4), rotary evaporated and 
chromatographed (EtOAc:hexanes 1:1) to provide 382 (2.51 mg, 12%) as a white 
solid:  
 
Rf 0.25 (hexanes:EtOAc 1:1); mp 98-104 °C (EtOAc/hexanes); IR (neat) 3342, 2922, 
1697, 1643, 1609, 1452, 1313, 1258, 1085, 1104, 973 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 12.11 (s, 1H, H22), 6.38 (d, J = 2.5Hz, 1H, -CH=), 6.34 (d, J = 11.8Hz, 1H, -
CH=), 6.26 (d, J = 11.8Hz, 1H, ArH), 6.12 (d, J = 2.5Hz, 1H, ArH), 5.61–5.53 (m, 
1H, H10), 5.50–5.42 (m, 1H, H8), 5.36–5.33 (m, 1H, H7), 4.47 (d, J = 18.1Hz, 1H, H3), 
3.53 (d, J = 18.1Hz, 1H, H3), 3.21 (dd, J = 15.5, 6.9Hz, 1H, H6), 3.13 (dd, J = 15.5, 
8.4Hz, 1H, H6), 2.65 – 2.58 (m, 1H, H9), 2.27–2.21 (m, 1H, H9), 1.39 (d, J = 6.6Hz, 
3H, H24); 13C NMR (CDCl3, 100 MHz) 205.2, 195.1, 170.4, 166.4, 161.0, 140.8 (2C), 
128.9 (2C), 127.9, 125.5, 112.8, 103.2, 72.2, 51.1, 47.3, 36.6, 18.4; HRMS (ESI) 
calcd. C18H19O6: [M + H]+, 331.1182; found: [M + H]+, 331.1174. 
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(R,5E,9Z)-14,16-dihydroxy-3-methyl-3,4-dihydro-1H-
benzo[c][1]oxacyclotetradecine-1,8,11(7H,12H)-trione (382) 
 
O
O
O
OH
HO
366 382
m-CPBA
THF
O
O
O
O
OH
HO
 
 
m-CPBA (41.18 mg, 0.23 mmol) and macrolactone 366 (50 mg, 0.16 mmol) was 
stirred in CH2Cl2 (10 mL) at RT for 1 h. The resulting solution was rotary evaporated 
and chromatographed (EtOAc:hexanes 1:1) to provide 382 (37.76 mg, 72%) as a 
white solid:  
 
Rf, IR, 1H NMR, 13C NMR and MS were identical to the product obtained in the 
previous experiment. 
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Appendix 1: Crystal structure data for compound 170 
 
 
 
Empirical formula C11 H14 O5 
Formula weight 226.22 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Monoclinic, P2(1) 
Unit cell dimensions a = 5.50497(9) Å α = 90° 
 b = 11.32104(19) Å β = 92.9393(15)° 
 c = 17.9323(3) Å γ = 90° 
Volume, Z 1116.11(3) Å3, 4 
Density (calculated) 1.346 Mg/m3 
Absorption coefficient 0.107 mm-1 
F(000) 480 
Crystal colour / morphology Colourless needles 
Crystal size 0.38 x 0.31 x 0.10 mm3 
θ range for data collection 2.90 to 32.38° 
Index ranges -8<=h<=8, -16<=k<=16, -23<=l<=26 
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Reflns collected / unique 12526 / 6748 [R(int) = 0.0175] 
Reflns observed [F>4σ(F)] 5883 
Absorption correction Analytical 
Max. and min. transmission 0.990 and 0.967 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6748 / 3 / 299 
Goodness-of-fit on F2 0.995 
Final R indices [F>4σ(F)] R1 = 0.0361, wR2 = 0.0796 
 R1+ = 0.0361, wR2+ = 0.0796 
 R1- = 0.0361, wR2- = 0.0796 
R indices (all data) R1 = 0.0427, wR2 = 0.0812 
Absolute structure parameter x+ = 0.0(5), x- = 1.1(5) 
 Absolute structure indeterminate 
Largest diff. peak, hole 0.205, -0.190 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Table 1: Bond lengths [Å]  
 
Bond Bond length 
O(1A)-C(6A) 1.3603(14) 
O(1A)-C(2A) 1.4444(14) 
C(2A)-O(3A) 1.4422(14) 
C(2A)-C(7A) 1.5061(18) 
C(2A)-C(8A) 1.5064(17) 
O(3A)-C(4A) 1.3575(14) 
C(4A)-C(5A) 1.3511(17) 
C(4A)-C(9A) 1.4547(16) 
C(5A)-C(6A) 1.4359(16) 
C(6A)-O(6A) 1.2233(14) 
C(9A)-C(10A) 1.3370(18) 
C(10A)-C(14A) 1.5001(19) 
C(10A)-C(11A) 1.5183(16) 
C(11A)-C(12A) 1.5039(17) 
C(12A)-O(12A) 1.2123(15) 
C(12A)-O(13A) 1.3223(14) 
O(1B)-C(6B) 1.3714(16) 
O(1B)-C(2B) 1.4381(15) 
C(2B)-O(3B) 1.4407(15) 
C(2B)-C(8B) 1.5071(19) 
C(2B)-C(7B) 1.5130(17) 
O(3B)-C(4B) 1.3571(14) 
C(4B)-C(5B) 1.3489(18) 
C(4B)-C(9B) 1.4565(18) 
C(5B)-C(6B) 1.4385(19) 
C(6B)-O(6B) 1.2120(17) 
C(9B)-C(10B) 1.3374(18) 
C(10B)-C(14B) 1.5022(18) 
C(10B)-C(11B) 1.5134(18) 
C(11B)-C(12B) 1.5122(18) 
C(12B)-O(12B) 1.2015(17) 
C(12B)-O(13B) 1.3218(16) 
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Table 2: Bond angles [°] 
 
Bond Bond angle 
C(6A)-O(1A)-C(2A) 117.00(9) 
O(3A)-C(2A)-O(1A) 109.93(9) 
O(3A)-C(2A)-C(7A) 110.77(9) 
O(1A)-C(2A)-C(7A) 109.53(10) 
O(3A)-C(2A)-C(8A) 105.93(10) 
O(1A)-C(2A)-C(8A) 106.39(10) 
C(7A)-C(2A)-C(8A) 114.13(11) 
C(4A)-O(3A)-C(2A) 115.77(9) 
C(5A)-C(4A)-O(3A) 120.38(10) 
C(5A)-C(4A)-C(9A) 121.44(11) 
O(3A)-C(4A)-C(9A) 118.09(11) 
C(4A)-C(5A)-C(6A) 120.38(11) 
O(6A)-C(6A)-O(1A) 117.19(10) 
O(6A)-C(6A)-C(5A) 126.06(11) 
O(1A)-C(6A)-C(5A) 116.61(10) 
C(10A)-C(9A)-C(4A) 130.95(11) 
C(9A)-C(10A)-C(14A) 128.19(11) 
C(9A)-C(10A)-C(11A) 116.74(11) 
C(14A)-C(10A)-C(11A) 115.07(11) 
C(12A)-C(11A)-C(10A) 113.93(10) 
O(12A)-C(12A)-O(13A) 122.49(12) 
O(12A)-C(12A)-C(11A) 125.73(11) 
O(13A)-C(12A)-C(11A) 111.76(10) 
C(6B)-O(1B)-C(2B) 117.89(10) 
O(1B)-C(2B)-O(3B) 110.70(9) 
O(1B)-C(2B)-C(8B) 106.54(10) 
O(3B)-C(2B)-C(8B) 106.42(10) 
O(1B)-C(2B)-C(7B) 110.11(10) 
O(3B)-C(2B)-C(7B) 109.88(10) 
C(8B)-C(2B)-C(7B) 113.09(11) 
C(4B)-O(3B)-C(2B) 116.38(9) 
C(5B)-C(4B)-O(3B) 120.41(11) 
C(5B)-C(4B)-C(9B) 123.00(11) 
O(3B)-C(4B)-C(9B) 116.53(11) 
C(4B)-C(5B)-C(6B) 121.36(12) 
O(6B)-C(6B)-O(1B) 118.08(13) 
O(6B)-C(6B)-C(5B) 126.28(13) 
O(1B)-C(6B)-C(5B) 115.53(11) 
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Bond Bond angle 
C(10B)-C(9B)-C(4B) 129.43(12) 
C(9B)-C(10B)-C(14B) 126.40(12) 
C(9B)-C(10B)-C(11B) 119.42(12) 
C(14B)-C(10B)-C(11B) 114.18(11) 
C(12B)-C(11B)-C(10B) 113.46(11) 
O(12B)-C(12B)-O(13B) 123.25(13) 
O(12B)-C(12B)-C(11B) 124.68(12) 
O(13B)-C(12B)-C(11B) 112.06(11) 
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Appendix 2: 1H-NMR Data for zearalenone (6) 
 
O
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1H-NMR Spectrum (400 MHz, CDCl3): 
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Appendix 3: Crystal structure data for montagnetol (2) 
 
The absolute structure of 2 could not be determined from the X-ray diffraction data, 
and so was assigned on the basis of the known S and R stereochemistries at C(10) and 
C(11) respectively (these correspond to C2 and C3 respectively in the chemical 
numbering scheme). The O–H protons in this structure could not be reliably located, 
and so were added using the SHELX HFIX 147 command which places them with an 
idealised X–O–H angle at a position that matches the local electron density maximum 
and then allows the proton to rotate about the X–O bond to find the best fit. The C(18) 
methyl protons were placed in idealised positions and allowed to rotate about the 
C(6)–C(18) bond to find the best fit (AFIX 137). 
 
The molecular structure of 2 (50% probability ellipsoids): 
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Formula C12 H16 O7 
Formula weight 272.25 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 7.2141(2) Å α = 90° 
 b = 8.1883(3) Å β = 90° 
 c = 19.9569(6) Å γ = 90° 
Volume, Z 1178.88(6) Å3, 4 
Density (calculated) 1.534 Mg/m3 
Absorption coefficient 1.092 mm-1 
F(000) 576 
Crystal colour / morphology Colourless needles 
Crystal size 0.23 x 0.03 x 0.01 mm3 
θ range for data collection 4.43 to 72.21° 
Index ranges -7<=h<=8, -9<=k<=9, -24<=l<=22 
Reflns collected / unique 14460 / 2266 [R(int) = 0.1105] 
Reflns observed [F>4σ(F)] 1124 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.66757 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2266 / 0 / 178 
Goodness-of-fit on F2 0.877 
Final R indices [F>4σ(F)] R1 = 0.0451, wR2 = 0.0866 
 R1+ = 0.0451, wR2+ = 0.0866 
 R1- = 0.0452, wR2- = 0.0869 
R indices (all data) R1 = 0.1051, wR2 = 0.1084 
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Absolute structure parameter x+ = 0.0(4), x- = 1.7(4) 
 Absolute structure indeterminate, 
 assigned on basis of known chiral 
 centres at C(10) and C(11) 
Largest diff. peak, hole 0.236, -0.210 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
 
 
Table 1: Bond lengths [Å] 
 
Bond Bond length 
C(1)-C(6) 1.408(5) 
C(1)-C(2) 1.413(5) 
C(1)-C(7) 1.472(5) 
C(2)-O(16) 1.365(4) 
C(2)-C(3) 1.394(5) 
C(3)-C(4) 1.370(5) 
C(4)-O(17) 1.356(4) 
C(4)-C(5) 1.402(5) 
C(5)-C(6) 1.395(5) 
C(6)-C(18) 1.516(5) 
C(7)-O(7) 1.228(5) 
C(7)-O(8) 1.352(4) 
O(8)-C(9) 1.449(4) 
C(9)-C(10) 1.507(5) 
C(10)-O(13) 1.426(4) 
C(10)-C(11) 1.525(5) 
C(11)-O(14) 1.430(4) 
C(11)-C(12) 1.504(5) 
C(12)-O(15) 1.437(4) 
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Table 2: Bond angles [°] 
 
Bond Bond angle 
C(6)-C(1)-C(2) 118.3(4) 
C(6)-C(1)-C(7) 125.4(4) 
C(2)-C(1)-C(7) 116.2(4) 
O(16)-C(2)-C(3) 116.7(4) 
O(16)-C(2)-C(1) 122.0(4) 
C(3)-C(2)-C(1) 121.3(4) 
C(4)-C(3)-C(2) 119.3(4) 
O(17)-C(4)-C(3) 123.3(4) 
O(17)-C(4)-C(5) 115.5(4) 
C(3)-C(4)-C(5) 121.1(4) 
C(6)-C(5)-C(4) 119.8(4) 
C(5)-C(6)-C(1) 120.1(4) 
C(5)-C(6)-C(18) 116.3(4) 
C(1)-C(6)-C(18) 123.7(4) 
O(7)-C(7)-O(8) 120.1(4) 
O(7)-C(7)-C(1) 123.7(4) 
O(8)-C(7)-C(1) 116.2(4) 
C(7)-O(8)-C(9) 113.6(3) 
O(8)-C(9)-C(10) 108.0(3) 
O(13)-C(10)-C(9) 113.9(3) 
O(13)-C(10)-C(11) 105.4(3) 
C(9)-C(10)-C(11) 110.0(3) 
O(14)-C(11)-C(12) 109.6(3) 
O(14)-C(11)-C(10) 109.5(3) 
C(12)-C(11)-C(10) 111.9(3) 
O(15)-C(12)-C(11) 110.6(3) 
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Appendix 4: Chiral HPLC analysis of synthetic (2S,3R)-( _)-
montagnetol (244) versus synthetic (2R,3S)-(+)-montagnetol (2) 
 
Running conditions for chiral HPLC (flow unit: ml/min): 
 
 
 
Chiral HPLC analysis of synthetic (2S,3R)-( _)-montagnetol (244): 
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Chiral HPLC analysis of synthetic (2R,3S)-(+)-montagnetol (2): 
 
 
 
Chiral HPLC analysis of a mixture of synthetic (2S,3R)-( _)-montagnetol (244) and 
(2R,3S)-(+)-montagnetol (2): 
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Appendix 5: 1H-NMR Data for erythrin (4) 
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1H-NMR Spectrum (400 MHz, CD3OD): 
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Appendix 6: Chiral HPLC analysis of synthetic (2S,3R)-(_)-erythrin 
(248) against (2R,3S)-(+)-erythrin (4) 
Chiral HPLC analysis of synthetic (2S,3R)-(_)-erythrin (248): 
 
Chiral HPLC analysis of synthetic (2R,3S)-(+)-erythrin (4): 
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Chiral HPLC analysis of isolated (+)-erythrin (natural compound)*: 
 
 
Superposition of  chiral HPLC spectra of synthetic (2S,3R)-(_)-erythrin (248) and 
(2R,3S)-(+)-erythrin (4) over isolated (+)-erythrin (natural compound): 
                                                 
*
  The isolated natural (+)-erythrin was kindely provided by Prof. V. Karunaratne (University of 
Peradeniya, Sri Lanka). 
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Appendix 7: 15N HMBC Data for 2,2-dimethyl-6-((5-methyl-1H-
pyrazol-3-yl)methyl)-4H-1,3-dioxin-4-one (301) 
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15N HMBC Spectrum (400 MHz, DMSO-d6): 
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Appendix 8: UPLC-MS Data for 2-methylpyrazolo[1,5-a] 
pyridine-5,7-diol (20) 
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Appendix 9: Crystal structure data for deschloro-ponchonin H 366 
 
 
 
Formula C18 H18 O5 
Formula weight 314.32 
Temperature 173 K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 5.17997(13) Å α = 90° 
 b = 9.0374(2) Å β = 90° 
 c = 33.5342(8) Å γ = 90° 
Volume, Z 1569.85(6) Å3, 4 
Density (calculated) 1.330 Mg/m3 
Absorption coefficient 0.803 mm-1 
F(000) 664 
Crystal colour / morphology Colourless needles 
Crystal size 0.3016 x 0.0576 x 0.0401 mm3 
θ range for data collection 2.64 to 72.28° 
 295 
Index ranges -5<=h<=6, -11<=k<=11, -32<=l<=40 
Reflns collected / unique 4374 / 2603 [R(int) = 0.0329] 
Reflns observed [F>4σ(F)] 2340 
Absorption correction Analytical 
Max. and min. transmission 0.972 and 0.877 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2603 / 2 / 217 
Goodness-of-fit on F2 1.061 
Final R indices [F>4σ(F)] R1 = 0.0319, wR2 = 0.0792 
 R1+ = 0.0319, wR2 = 0.0792 
 R1- = 0.0320, wR2 = 0.0796 
R indices (all data) R1 = 0.0363, wR2 = 0.0841 
Absolute structure parameter x+ = 0.1(2), x- = 0.9(2) 
 Indicated absolute structure agrees 
 with known stereochemistry at C18 
Extinction coefficient 0.0015(4) 
Largest diff. peak, hole 0.141, -0.155 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Table 1: Bond lengths [Å] 
 
Bond Bond length 
O(1)-C(2) 1.347(2) 
O(1)-C(18) 1.464(2) 
C(2)-O(2) 1.209(2) 
C(2)-C(3) 1.490(2) 
C(3)-C(8) 1.405(2) 
C(3)-C(4) 1.407(2) 
C(4)-O(19) 1.372(2) 
C(4)-C(5) 1.385(2) 
C(5)-C(6) 1.379(3) 
C(6)-O(20) 1.356(2) 
C(6)-C(7) 1.398(3) 
C(7)-C(8) 1.385(3) 
C(8)-C(9) 1.528(2) 
C(9)-C(10) 1.493(2) 
C(10)-C(11) 1.346(3) 
C(10)-O(10) 1.369(2) 
O(10)-C(13) 1.375(2) 
C(11)-C(12) 1.430(3) 
C(12)-C(13) 1.342(3) 
C(13)-C(14) 1.495(3) 
C(14)-C(15) 1.495(3) 
C(15)-C(16) 1.319(3) 
C(16)-C(17) 1.499(3) 
C(17)-C(18) 1.518(3) 
C(18)-C(21) 1.510(3) 
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Table 2: Bond angles [°] 
 
Bond Bond angle 
C(2)-O(1)-C(18) 118.89(14) 
O(2)-C(2)-O(1) 122.88(16) 
O(2)-C(2)-C(3) 124.64(16) 
O(1)-C(2)-C(3) 112.45(14) 
C(8)-C(3)-C(4) 118.53(15) 
C(8)-C(3)-C(2) 121.09(14) 
C(4)-C(3)-C(2) 120.07(15) 
O(19)-C(4)-C(5) 116.36(14) 
O(19)-C(4)-C(3) 122.24(15) 
C(5)-C(4)-C(3) 121.39(15) 
C(6)-C(5)-C(4) 119.52(15) 
O(20)-C(6)-C(5) 123.74(15) 
O(20)-C(6)-C(7) 116.27(16) 
C(5)-C(6)-C(7) 119.97(16) 
C(8)-C(7)-C(6) 121.00(17) 
C(7)-C(8)-C(3) 119.53(15) 
C(7)-C(8)-C(9) 117.41(16) 
C(3)-C(8)-C(9) 122.66(15) 
C(10)-C(9)-C(8) 109.93(14) 
C(11)-C(10)-O(10) 109.45(16) 
C(11)-C(10)-C(9) 135.13(19) 
O(10)-C(10)-C(9) 115.10(16) 
C(10)-O(10)-C(13) 107.44(15) 
C(10)-C(11)-C(12) 106.7(2) 
C(13)-C(12)-C(11) 107.1(2) 
C(12)-C(13)-O(10) 109.27(19) 
C(12)-C(13)-C(14) 135.9(2) 
O(10)-C(13)-C(14) 114.83(18) 
C(13)-C(14)-C(15) 111.34(15) 
C(16)-C(15)-C(14) 123.1(2) 
C(15)-C(16)-C(17) 124.67(19) 
C(16)-C(17)-C(18) 111.84(16) 
O(1)-C(18)-C(21) 107.60(15) 
O(1)-C(18)-C(17) 107.36(15) 
C(21)-C(18)-C(17) 113.22(17) 
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Appendix 10: 1H-NMR Data for (R,5E,9Z)-14,16-dihydroxy-3-methyl-
3,4-dihydro-1H-benzo[c][1]oxacyclotetradecine-1,8,11(7H,12H)-
trione (382) 
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